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ABSTRACT 
This thesis examines aspects of oxygen transport and uptake in patients with 
acute and chronic liver disease with specific reference to the management of fulminant 
hepatic failure (FHF) and the intraoperative management of patients undergoing liver 
transplantation. 
A prospective randomised controlled study was carried out in patients with 
FHF evaluating the effect of the drug N- acetylcysteine on DO2, VO2, and tissue 
oxygen extraction. A previous study showed that this drug increased all of these 
oxygen kinetic variables, which was considered of therapeutic benefit. The present 
study showed that this earlier finding was an artifact related to the method of 
calculating oxygen consumption (the Fick method). This method produced unreliable 
results in patients with FHF because it was inaccurate, non -reproducible, the the 
relation between DO2 and VO2 was subject to mathematical couplig error. No 
clinically significant improvements in any oxygen kinetic variables were observed after 
N- acetylcysteine administration, even when followed for a prolonged period. Variable 
effects on cardiovascular parameters were found, but overall no differences from the 
control group were demonstrated. No relationship was found between plasma N- 
acetylcysteine concentrations and clinical response. 
A prospective study examining energy expenditure and the acute phase 
response was carried out in patients with FHF. Energy expenditure was increased by 
approximately 20 -25% in FHF in comparison with spontaneously breathing healthy 
volunteers and physically anhepatic patients with chronic liver disease studied during 
liver transplantation. Plasma TNFa, IL -6, and C- reactive protein were measured. 
These were significantly elevated in comparison with healthy controls in keeping with 
a significant acute phase response. The study indicated hypermetabolism during severe 
FHF despite the loss of functioning liver cell mass and the effects of sedation, 
analgesia, and mechanical ventilation. This was most likely attributable to a systemic 
inflammatory response. 
In patients undergoing liver transplantation indirect calorimetry was used to 
examine changes in metabolic rate and pulmonary physiology following graft 
reperfusion. Significant changes in metabolic rate, oxygen transport, and acid -base 
balance were demonstrated the factors which influence these changes were discussed. 
The use of the piggyback surgical technique was associated with greater metabolic 
stability than the use of venovenous bypass. 
A prospective observational study compared the two methods for managing 
the anhepatic phase of liver transplantation, namely venovenous bypass or the 
piggyback surgical technique. This study demonstrated higher cardiac output, VO2, 
and blood temperature during the anhepatic phase with the piggyback surgical 
technique. This suggested better preservation of tissue oxygenation with this 
approach, which may translate into improved postoperative function. 
Two techniques of graft reperfusion, namely via the portal vein or the hepatic 
artery, were compared in another prospective observational study. This study 
indicated that the increase in VO2 after reperfusion occurred more slowly when the 
hepatic artery was used, but was accompanied by a slower release of acid load into 
the circulation and less requirement for vasopressor support. Reperfusion via the 
hepatic artery may therefore be preferable in the patient at risk of haemodynamic or 
cerebral decompensation following reperfusion, although further studies are required 
to ensure graft outcome is equivalent with both techniques. 
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Oxygen is essential to life. This extremely reactive chemical is capable of reaction with 
most constituents of cells. Using oxygen organisms are able to oxidise more 
completely the molecules they ingest, thereby improving the efficiency of energy 
production through the process of respiration. Respiration drives the synthesis of 
adenosine triphosphate (ATP) which acts as energy substrate for biological reactions. 
The reactivity of oxygen make it at once essential and potentially toxic to cells. 
Oxygen derived free radicals damage cellular constituents and require rapid 
neutralisation. With evolution oxygen balance has become a complex process by 
which oxygen is taken up within lungs and transported within blood via the 
cardiovascular system to individual organs and tissues, from which it moves into 
individual cells. Within cells oxygen takes part in oxidative phosphorylation which 
generates ATP. Each of these processes is under complex physiological control 
which, during critical illness, may become deranged resulting in cellular dysfunction 
and, ultimately, death. A primary goal of critical care research is to accurately 
measure and understand the physiology and pathophysiology of oxygen in humans. 
MEASUREMENT OF OXYGEN CONSUMPTION 
There are two approaches to determining oxygen consumption in humans. Firstly, 
oxygen uptake by the body can be measured by techniques which examine gas 
exchange across the lungs. Secondly, oxygen consumption can be calculated using the 
Fick principle. 
Gas exchange Techniques 
Oxygen consumption can be calculated by measuring the oxygen content of inspired 
and expired gas according to the equation: 
I 
VO2 = (VI x FI02) - (VE x FEO2) [1] 
where VI and VE are inspired and expired volumes, and FI02 and FEO2 are inspired 
and expired oxygen fractions respectively. The accurate and rapid measurement of gas 
fractions is possible with current technology such as the paramagnetic oxygen 
analyser and infrared carbon dioxide analyser. It remains technically difficult to 
determine gas volumes with the accuracy necessary for clinical measurements, 
particularly problematic is the detection of differences between inspired and expired 
gas volumes. 
A common approach in gas exchange measurements is to determine VE and then 
recalculate VI using Haldane's hypothesis, which assumes all metabolically inert gases 
(principally nitrogen) are at a steady state. 
Thus: VI x FIN2 = VE x FEN2 
and: VI = VE(FEN2/FIN2) 
From [1] and [2] : 
VO2 = VE[(FIO2 x FEN2/FIN2) -FE02] 
If inspired gas contains no gases other than 02 and N2: 
FIN2 = 1 - FI02 
and FEN2 = 1 - FE02 - FECO2 
Combining [3], [4], and [5] gives: 







The application of Haldane's principle to transform the measurement of VO2 from a 
requirement to measure both inspired and expired volumes to a formula requiring 
measurement of gas fractions and expired volume alone (often termed the Haldane 
transformation) allows the use of various "open circuit" techniques of determining 
VO2. The simplest of these is the Douglas bag method with which all expired gas is 
collected for a timed period from the breathing circuit. The gas is then sampled for its 
oxygen and carbon dioxide concentration which are measured. The collected gas 
volume is then determined together with temperature and ambient barometric 
pressure. The volume is then corrected to standard dry temperature and pressure and 
VO2 calculated using the above formula. This method is time consuming and the 
potential for measurement errors is large such that it is not suitable for routine use in 
ventilated patients. In the 1970s and 1980s many "metabolic carts" were developed 
which sought to automate this process. These were developed primarily for metabolic 
studies in healthy spontaneously breathing subjects and are frequently called indirect 
calorimeters because they calculated energy expenditure from VO2 and VCO2. The 
need to determine VO2 and energy expenditure in critically ill ventilated patients led to 
their adaptation and modification for this setting. 
Initial studies using metabolic carts in the critically ill suggested that this method was 
inaccurate. Inaccuracies occurred because of methodological problems which were 
not addressed with early devices. 
Methodological problems associated with indirect calorimetry. 
Influence of PIO,: In the Haldane transformation equation the measured value for 
FI02 is involved in divisional, multiplicative, and subtractive calculations (equation 6). 
Thus small errors in the measurement of FI02 and FEO2 are propagated and 
multiplied in the final calculation. If a subject is breathing room air errors are likely to 
be relatively small because the FI02 is constant and the difference between FI02 and 
FEO2 is relatively large. In ventilated patients in whom a high FI02 is required the 
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difference between FI02 and FEO2 may be small. This, combined with small 
fluctuations in FI02 which occur with the oxygen/air blenders of some ventilators, 
may cause considerable errors (Welch and Pedersen 1981, Ultman and Bursztein 
1981, Browning et al 1982). Errors of this type can be reduced by the presence of 
mixing chambers after the oxygen blenders and /or prior to analysing expired gas 
mixtures. The development of rapid response oxygen analysers has also improved 
accuracy by enabling averaging of many data points, and the virtually simultaneous 
measurement of both inspired and expired gases. 
Presence of gas leaks: Gas leaks generally result in an underestimation of VO2 and are 
particularly problematic. The commonest site is around the endotracheal tube, 
particularly in children, but leaks from other parts of the breathing system, from chest 
drains, or from within the indirect calorimeter itself can cause significant errors 
(Bracco et al 1995, Selby et al 1995). Leaks may be difficult to detect but can 
represent a significant proportion of the expired gas volume, particularly in children or 
if airway pressures are high as occurs in ARDS and during the application of positive 
end -expiratory pressure (PEEP). 
Hum idity: Measurements of gas volume are expressed under standard conditions 
which include the absence of humidity. Measurements of gas fractions usually assume 
complete drying of gas which may be difficult in ventilated patients, particularly when 
humidifiers are used. The presence of water in gas analysers also alters their accuracy. 
Problems associated with humidity have been solved in most modern metabolic 
monitors by including water permeable tubing and water traps in the circuits. 
Lack of a steady state: The Haldane transformation makes the assumption that 
there is no difference between inspired and expired nitrogen fractions. Following a 
change in FI02 inverse alterations in FIN2 occur, and as body stores of nitrogen are 
considerable several minutes are required until a steady state is reestablished. Changes 
in alveolar ventilation also disrupt the steady state for nitrogen although the errors are 
small and shortlived. 
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Significant errors in the measurement of VCO2 occur if the steady state for carbon 
dioxide is disrupted. This also affects the accuracy of VO2 measurements because 
expired carbon dioxide fractions are required in the Haldane transformation 
calculation. A typical adult has carbon dioxide stores of approximately 16 litres in the 
body which exist in multiple forms and in many different biological compartments 
(Nunn 1977). If a change in alveolar ventilation occurs it may take 30 -60 minutes for 
complete reequilibration of carbon dioxide stores to occur (Henneberg et al 1987, 
Taskar et al 1995). Although this is a multiexponential process, most of which occurs 
during the initial minutes, significant inaccuracy in VO2 may occur during this period. 
Sudden alterations in acid -base balance alter carbon dioxide stores which can alter the 
steady state resulting in inaccuracy, although this is difficult to quantify. Finally, 
changes in cardiac output, and therefore tissue perfusion, may alter gas stores in the 
body although there are no studies which have attempted to quantify the magnitude of 
these changes and their effect on VO2 measurements by indirect calorimetry. 
Thiel" erenee of other gases: The Haldane equation assumes the absence of other 
gases. Thus the presence of volatile anaesthetics, or other gases such as nitric oxide 
may significantly reduce accuracy (Aukberg et al 1985). Many gases also interfere 
with the function of gas analysers. 
The Reverse Fick Method 
The Fick principle, stated originally in 1870, is widely used to calculate physiological 
variables which are difficult to measure directly. It states that the amount of a 
substance taken up by an organ, or by the whole body, per unit of time is equal to the 
arterial level of the substance minus the venous level, times the blood flow. This 
principle was classically applied to the measurement of cardiac output, by measuring 
oxygen uptake by the lungs and sampling arterial and venous blood, but the 
development of the pulmonary artery catheter in the 1960s, and specifically the Swan - 
Ganz catheter in the early 1970s, resulted in the "reversal" of the principle to back- 
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calculate oxygen consumption: 
VO2 = cardiac output x (arterial oxygen content - mixed venous oxygen content) 
With this methodology cardiac output is usually measured using the thermodilution 
technique with a pulmonary artery catheter. Cardiac output measurement in critically 
ill patients is subject to many confounding factors such that, even under experimental 
conditions, the accuracy of bolus thermodilution may only be ±5 -10% (Nishikawa and 
Dohi 1993). Originally, blood oxygen content was measured directly using equipment 
such as the van Slyke or Scholander apparatus, but this demands considerable 
technical expertise and is time consuming. A more straightforward method of 
determining blood oxygen content became available with the development of 
integrated machines which measure haemoglobin concentration, oxygen tension, and 
haemoglobin oxygen saturation. With these primary measurements the oxygen content 
of blood could be calculated from the formula: 
Oxygen content = ([Hb] x SO2 x Constant 1) + (pO2 x Constant 2) 
Where: [Hb] haemoglobin concentration 
SO2 haemoglobin oxygen saturation 
Constant 1 combining capacity of oxygen with haemoglobin 
pO2 oxygen tension/partial pressure 
Constant 2 solubility coefficient for oxygen in plasma 
Constant 2, the solubility coefficient for oxygen in plasma, is a true physiological 
constant. Furthermore, the contribution of dissolved oxygen to the total oxygen 
content is relatively insignificant under normal physiological circumstances such that 
errors associated with oxygen tension measurement are unimportant. Constant 1, the 
combining capacity of haemoglobin with oxygen, is more problematic. Experimental 
studies suggest that when fully saturated 1g of pure haemoglobin can combine with 
1.39mL of 02. This figure is widely quoted but has been disputed as being too high 
(Nunn 1996, Jolliet et al 1996). Blood normally contains small amounts of 
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haemoglobin derivatives such as carboxyhaemoglobin and methaemoglobin in 
quantities which vary according to exposure to environmental factors such as 
cigarette smoke. It is generally assumed that these haemoglobins take no part in active 
oxygen transport and that they effectively reduce the combining capacity for oxygen 
per unit of haemoglobin. As a result a combining capacity of 1.34mL is frequently 
used for calculations in vivo. Many modern cooximeters actually measure and 
quantify the proportions of haemoglobin subtypes in blood samples. However, there is 
no literature which examines which value for the combining capacity of haemoglobin 
is best for use in the critically ill even if true haemoglobin oxygen saturation is known. 
In early studies, and in some contemporary work, haemoglobin oxygen saturation was 
calculated from blood gas variables rather than measured directly by cooximetry. 
Several formulae are available for this purpose all of which rely on assumptions 
regarding the shape and position of the oxygen dissociation curve (Gabel 1980). 
Recent work indicates that calculated oxygen saturation is subject to considerable 
error in comparison to cooximetry in critically ill patients, which introduces significant 
errors into the calculation of oxygen consumption by the reverse Fick method (Woda 
et al 1996). The errors associated with cooximeter measurement of saturation may 
also be significant, particularly for values on the steep part of the oxygen dissociation 
curve (Woda et al 1996, Beards et al 1994), and the accuracy of commercially 
available machines may differ significantly (Beards et al 1994). 
The formula used almost universally for calculating VO2 in the critically ill since the 
early 1970s has thus been: 
V02= Cardiac output x {([Hb x Sa02 x 1.34] + [Pa02 x 0.003]) - ([Hb x Sv02 x 
1.34] + [Pv02 x 0.003])} 
It is clear from the above discussion that errors associated with each measurement 
may be significant. Despite the enormous literature on oxygen kinetics in the critically 
ill, and the widespread use of these variables to guide therapy, there have been 
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virtually no studies examining the magnitude of errors in the final value for VO2 or the 
factors which influence the size of the errors in individual patients. Most published 
studies give no indication of the repeatability of the primary or derived measurements 
made and although these shortcomings are widely appreciated there is little work 
exploring the validity of the Fick method in the clinical setting. 
OXYGEN KINETICS 
Normal Physiology 
Under normal resting conditions the global oxygen delivery (DO2) to tissues is the 
product of the cardiac output and the oxygen content of arterial blood: 
DO2 = Cardiac output x ([Hb x SaO2 x 1.34] + [Pa02 x 0.003]) 
Oxygen consumption by tissues is determined by cellular requirements, primarily a 
function of metabolic rate. At rest the tissues extract approximately 30% of delivered 
oxygen (OER 0.3)(Leach and Treacher). Minor alterations in oxygen requirement by 
most tissues is accommodated by changes in oxygen extraction. If a significant 
increase in tissue oxygen requirement occurs there are two physiological responses. 
Firstly, tissue oxygen extraction may increase further; a global OER of up to 0.8 is 
possible in trained healthy individuals. This highest achievable extraction ratio is 
termed the critical OER (cOER) and has been determined in healthy humans from 
exercise studies (Leach and Treacher 1992). The OER of different tissues at rest and 
their cOER during increased demand varies widely such that global measurements do 
not reflect individual organs. The ability of tissues to increase their OER is probably a 
function of the improvement in convective transport to tissues (ie flow), and diffusive 
transport down a gradient for pO2. The latter is determined by the pO2 itself and by 
the nutritive capillary density, control of which is extremely complex and incompletely 
understood. The second physiological response to increased oxygen demand is to 
increase global oxygen delivery via an increase in cardiac output. In health cardiac 
output can increase up to 5 times normal in response to increased demand (Leach and 
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Treacher 1992). 
Thus under normal physiological conditions the supply of oxygen to tissues occurs in 
response to altered demand, demand and supply are coupled, and the condition can be 
termed physiological supply dependency. 
Further understanding of the relationship between oxygen delivery and consumption 
came from animal studies in which oxygen delivery was actively manipulated under 
conditions of constant demand and the effect on consumption determined. These 
indicate that if DO2 is augmented VO2 remains constant and the response of the 
tissues is to decrease the OER (Cain 1983). If oxygen delivery is decreased artificially 
there is initially no change in oxygen consumption until a critical level of DO2 is 
reached below which oxygen consumption falls progressively (Cain and Curtis 
1991)(figure 1.1). Below this point, the critical DO2 (cDO2), oxygen consumption 
becomes truly supply limited, and anaerobic metabolism occurs in the tissues. The 
value of cDO2, as with cOER, appears to be tissue and organ dependent during 
health. There are no studies in healthy humans which examine the effects of 
progressive reduction in DO2 on oxygen consumption since these would be unethical. 
From animal studies the classic two phase relationship has been demonstrated 
convincingly and indicate that, under laboratory conditions, the cDO2 varies from 6- 
10 mL.kg'.min-', and the cOER from 0.5 -0.8 (Leach and Treacher 1992). The only 
studies which have addressed this question in "healthy" humans examined 
anaesthetised patients undergoing cardiac surgery immediately prior to and 
immediately following cardiopulmonary bypass (Shibutani et al 1983; Komatsu et al 
1987). Many data pairs for DO2 and VO2 (calculated by the Fick method) in many 
patients were pooled and plotted. From this a cDO2 of about 330 mL.min'.m2 was 
obtained, below which the mean slope by linear regression analysis for the DO2 /VO2 
relationship was 0.14, and above which the slope was zero (Shibutani et al 1983). The 
cOER associated with the cDO2 was only 0.30 -0.35, significantly lower than in 
exercise studies or in animal studies (Komatsu et al 1987). 
9 
Figure 1.1: Classic description of the relation between oxygen delivery and oxygen 











Oxygen Kinetics in the Critically Ill. 
Oxygen consumption. 
Oxygen consumption is the primary determinant of metabolic rate, which is increased 
in most forms of critical illness. Many factors influence metabolic rate in the critically 
ill and are considered later in this introduction. An important consideration in studies 
of oxygen kinetics in the critically ill is that metabolic rate varies spontaneously and 
significantly in response to therapeutic and non -therapeutic events as diverse as 
physiotherapy and the presence of relatives (Weissman et al 1984,1991). 
Relationship between Oxygen Delivery and Consumption. 
The frequent occurrence of metabolic acidosis and high circulating lactate 
concentrations in critically ill patients has led to the view that tissue hypoxia occurs 
frequently in these patients (Soni et al 1993). As a result, research efforts have 
focussed on defining the relationship between DO2 and VO2 during critical illness. 
The considerable literature in this area is confusing because of varying methodology, 
differing patient groups, and apparently contradictory findings. The majority of 
studies have indicated that the D02 /V02 relationship is altered in the critically ill with 
the following features (figure 1.1): 
1) The D02 /V02 curve is shifted to the right. This implies that oxygen extraction 
capability is impaired at the tissue level. Clinical studies have demonstrated low 
OER in critically ill patients and an inability to increase OER in response to 
therapeutic interventions (Danek et al 1980). 
2) The shape of the curve is different. Many studies suggest a curvilinear or linear 
relationship between DO2 and VO2 over the range of DO2 studied (Leach and 
Treacher 1992). In virtually all studies the range of DO2 examined was well above 
the normal cDO2 suggested by animal studies and the limited human work, which 
has led many to suggest that the cDO2 is considerably increased during critical 
illness. The dependence of VO2 on DO2 has been termed pathological supply 
dependency. This relationship has been demonstrated in animal models of sepsis 
(Nelson et al 1988, Cain and Curtis 1991). In man it was first reported in patients 
with ARDS (Powers et al 1973, Danek et al 1980), and subsequently in sepsis and 
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septic shock (Kaufman et al 1984, Astiz et al 1987, Bihari et al 1987). Perhaps 
surprisingly, others studies also reported pathological supply dependency in 
hypovolaemic shock (Kaufman et al 1984), congestive cardiac failure (Mohsenifar 
et al 1987), and chronic obstructive lung disease (Brent et al 1984). 
In considering available studies it is useful to examine the possible confounding 
factors in oxygen kinetics studies in the critically ill: 
1) The direction of altering DO2: The majority of studies have used therapeutic 
interventions which increase DO2 (Smithies and Bihari 1993). Many of these 
studies indicate an accompanying increase in V02, but none have demonstrated a 
plateau phase or a cD02 at a higher level than observed in healthy humans and in 
animal studies. There are few studies which decreased DO2 as this is generally 
unethical. However, in patients with ARDS, moderate reductions in DO2 induced 
by PEEP did not reduce VO2 (Annat et al 1986, Carlile and Gray 1989). The most 
important study in this area, and the only which has identified the cD02 and cOER 
in individual critically ill humans, studied critically ill humans during withdrawal of 
therapy after this decision had been made on clinical grounds (Ronco et al 1993). 
This group studied 9 septic and 9 non -septic patients during progressive reduction 
in DO2 and found the cD02 was about 4ml.miri'.kg' and the cOER was about 0.6. 
There was also no difference between septic and non septic patients. This work 
suggested that cD02 was less than the levels of DO2 usually present in critically ill 
patients, in direct contradiction to work in which DO2 was increased. 
2) The method of altering DO2: A concern with the interpretation of many studies 
which increased DO2 has been that the inotropic agents used may themselves have 
increased metabolic rate such that linkage between DO2 and VO2 was physiological 
coupling rather than pathological supply dependency. The thermogenic effects of 
adrenaline, noradrenaline, dobutamine, and dopamine have been clearly 
demonstrated in healthy humans (Ruttiman et al 1991, Bhatt et al 1992, Green et al 
1992, Ensinger et al 1993 and 1995), although during metabolic stress 
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thermogenesis attributable to inotropes may be blunted (Uusaro et al 1995). The 
relative importance of these effects in studies of oxygen kinetics in the critically ill 
remains controversial. 
3) Method of measuring VO2: Until the 1990s the reverse Fick method was used 
almost universally in oxygen kinetics studies in the critically ill because it was 
cheap and feasible, whereas the technology for gas analysis was unavailable to 
most researchers. As discussed above few studies have addressed the accuracy of 
this method in the critically ill. A further potential confounding factor in these 
studies was mathematical coupling whereby an artificial relationship between DO2 
and VO2 might occur because measurements of cardiac output and arterial oxygen 
content are used to calculate both variables of interest. This problem was 
considered by Archie (1982) but, despite widespread appreciation of the potential 
for mathematical coupling to explain the supply dependency observed in studies, 
few studies examined its importance in practice until after 1990. The only group to 
address the issue were Stratton and colleagues (1987) who applied a statistical 
solution which sought to correct for mathematical coupling to pooled retrospective 
data from several different studies. Their conclusion, that supply dependency still 
existed after the effect of mathematical coupling was removed, was widely quoted 
as justification for the continued use of the Fick method to determine VO2. 
Early automated gas exchange monitors were insufficiently accurate for use in 
ventilated patients, but technological developments resulted in several metabolic 
monitors becoming commercially available in the late 1980s. When these were used 
to measure VO2 independent from DO2 investigators found no evidence of supply 
dependency in resuscitated patients with sepsis or ARDS (Ronco et al 1991 and 
1993, Hanique et al 1994a). Furthermore, these studies found that simultaneous 
calculations of VO2 with the reverse Fick method did indicate supply dependency 
implicating mathematical coupling as a major confounding factor. Finally, Phang 
and colleagues (1994) prospectively applied the statistical solution for 
mathematical coupling proposed by Stratton and colleagues to DO2/VO2 data from 
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individual patients and found that, after correction, no supply dependency was 
present. It is now widely accepted that mathematical coupling is potentially 
important and that oxygen kinetics studies should use independent methods of 
determining DO2 and VO2 (Pinsky 1994). 
4) Volume status: In many early studies patients were probably fluid deplete in 
comparison with current levels of fluid resuscitation. Under these conditions 
increasing DO2 may increase VO2 because some tissues, such as the splanchnic 
tissues, were below their cDO2. These studies may have simply indicated 
inadequate volume resuscitation rather than pathological supply dependency 
(Smithies and Bihari 1993). In those recent studies which failed to demonstrate 
supply dependency volume resuscitation, as measured by the central venous and 
pulmonary artery occlusion pressures, was more aggressive prior to manipulating 
DO2. 
5) Data numbers: Many studies have used small numbers of data, often only two data 
pairs, to construct DO2 /VO2 curves, a feature which amplifies the effect of 
measurement error and mathematical coupling (Bartlett and Dechert 1990, Walsh 
and Lee 1998). In addition the range of DO2 examined has frequently been small. 
Few studies have constructed curves in individual patients with many data pairs 
over a wide range of DO2. 
There are very few studies in which all of these methodological problems are 
adequately considered (Russell and Phang 1994). Although a subject of continuing 
controversy most studies in which potentially confounding factors are eliminated or 
minimised conclude that pathological supply dependency either does not exist, or 
occurs far less frequently than suggested by earlier work (Russell and Phang 1994, 
Hanique et al 1994a) 
14 
Relationship between DO2, VO2, and outcome. 
The pioneering work of Schoemaker (1972) resulted in many studies which have 
examined the relationship between oxygen derived variables and outcome in various 
groups of critically ill patients. These can be divided broadly into three categories for 
consideration: 
1) Studies which examine the association between oxygen derived variables and 
outcome 
2) Studies in which oxygen delivery was increased by intervention, and the 
relationship between the resultant change in VO2 or OER and outcome examined. 
3) Studies which examined the effect on outcome of targeting a particular level of 
DO2 or VO2 in all patients; so- called "goal- directed therapy ". 
Association between oxygen derived variables and outcome: In observational 
studies Schoemaker demonstrated that patients in whom cardiac output, DO2 and 
VO2 were elevated following surgery or during critical illness had higher survival rates 
than those with normal or decreased values (Schoemaker et al 1972, 1973, 1993). 
This association has been confirmed by others in patients with ARDS (Hankeln et al 
1987, Russell et al 1990) and sepsis (Abraham et al 1984, Tuchschmidt et al 1989, 
Hayes et al 1993), as well as following major procedures such as liver transplantation 
(Nasraway et al 1995). 
Response to therapy aimed at increasing DO2: Several studies indicate that a 
failure to increase DO2 in response to therapeutic interventions aimed at achieving this 
predicts a poor outcome in comparison with patients in whom DO2 does increase 
(Hayes et al 1997, Vallet et al 1993, Yu et al 1995). In most studies an inability to 
increase VO2 in response to such interventions was also strongly associated with 
subsequent poor outcome (Hayes et al 1994, 1997; Vallet et al 1993) although one 
much quoted study had opposite findings (Bihari et al 1986). 
Goal -directed therapy: As a result of the association between high levels of 
DO2, cardiac output, VO2 and improved outcome many investigators have attempted 
15 
to test the hypothesis that increasing levels of these variables to predefined 
"supranormal" goals in all patients improves overall outcome. Studies of "goal 
oriented therapy" (usually cardiac index >4.51.miri 1.m 2, DO2 >600ml.miri l.m 2, VO2 
>170ml.miri'.m 2) have been performed in high risk surgical patients (Schoemaker et 
al 1982, Schoemaker et al 1988, Boyd et al 1993, Ziegler et al 1997), trauma patients 
(Fleming et al 1992, Bishop et al 1995), septic patients (Edwards et al 1989, 
Tuchschmidt et al 1992) and heterogeneous groups of critically ill patients (Yu et al 
1993, Hayes et al 1994, Gattinoni et al 1995). The results of these studies have been 
contradictory and interpretation complicated by methodological problems such as 
method of randomisation, level of fluid resuscitation, choice of inotrope, and post hoc 
analyses (Gasman et al 1996). A recent meta- analysis concluded that goal directed 
therapy conferred no benefit in patients with established critical illness but may be of 
value in those undergoing high risk surgery (Heyland et al 1996, Hinds and Watson 
1995). 
ENERGY METABOLISM IN CRITICAL ILLNESS 
The metabolic response to injury and sepsis is extremely complex. In general terms it 
is characterised by an increase in resting energy expenditure, increased catabolism of 
protein and fat, negative nitrogen balance, hyperglycaemia, and increased hepatic 
glucose production (Chiolero et al, 1997). As a result of these processes there is a 
progressive reduction in body cell mass. These processes occur as part of a systemic 
inflammatory response which appears to be a non -specific stereotyped response to 
injury which is caused by the activation of a complex system of mediators. This stress 
response is thought to promote elimination of infection and facilitate healing and 
recovery. It is currently hypothesised that, under poorly understood circumstances, 
the stress response can itself become harmful to an organism by causing organ 
damage and ultimately multiple organ failure (Barton and Cerra 1989). Understanding 
the balance between the beneficial and detrimental effects of the inflammatory 
response, and how they are modulated, has been a focus of intense research in the 
critically ill but is not yet fully understood (Bone 1996). The known mediators which 
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control the inflammatory response include cytokines, oxygen derived free radicals, 
prostanoids, leukotrienes, and endothelins (Blackwell and Christman 1996). Release 
of these mediators occurs in association with activation of white blood cells which is 
an energy consuming process (Nunn 1996). Inflammatory mediators have the 
potential to induce alterations in metabolism in virtually all tissues which have been 
studied. These alterations include changes in the pattern and rate of synthesis of 
biological molecules which increases energy requirement by cells. In the liver the 
stress response induces changes in hepatic protein synthesis which include increased 
synthesis of the "positive" acute phase proteins, including C Reactive Protein (CRP), 
serum amyloid A, al -acid glycoprotein, al- antichymotrypsin and haptoglobin, and 
decreased synthesis of normal export proteins, notably albumin and transferrin 
(Wigmore et al 1998). Increases in circulating concentrations of the classic counter - 
regulatory hormones, namely adrenaline, noradrenaline, cortisol, and glucagon, induce 
protein breakdown, lipolysis, glycogenolysis, and gluconeogenesis. There is also 
evidence of increased resynthesis of proteins and lipids consistent with a generalised 
increase in the cycling of biochemical pathways (Burzstein et al 1989). These 
processes are all energy consuming. 
Components of Energy Expenditure 
In healthy adults the Total Energy Expenditure (TEE) is usually considered to have 3 
main components: basal metabolic rate (BMR), thermogenesis, and physical work. 
Basal metabolic rate is defined as the energy expenditure of an individual at least 10 
hours after previous nutritional intake, resting in a lying position, awake, and at 
normal body and ambient temperature, and without physical or psychological stress 
(Burzstein et al 1989). It is determined primarily by the Lean Body Mass. BMR 
maintains basic metabolic functions and represents approximately 60 -70% of TEE in 
sedentary individuals (Chiolero et al 1997). Only 10 -20% of BMR is devoted to 
mechanical work, primarily cardiac contraction and the work of breathing. The 
remaining 80 -90% corresponds to the energy cost of biochemical pathways and 
cycles, and the function of membrane ion pumps. 
17 
Thermogenesis accounts for about 10% of TEE in healthy individuals. This 
proportion may change dramatically in response to altered ambient temperature. A 
decrease in ambient temperature results in an increase in energy expenditure due 
either to shivering or by activation of metabolic reactions releasing heat via hydrolysis 
of ATP. Shivering may increase energy expenditure by up to 300% (MacIntyre et al 
1987). If ambient temperature rises energy expenditure will initially decrease, reaching 
a minimum in healthy individuals at about 27 °C. Above this temperature energy 
expenditure again rises because sweating and other heat -losing processes are energy 
consuming. The ambient temperature within which energy expenditure is at a 
minimum is termed the "zone of thermal neutrality" and is 27 -29 °C in healthy men 
(Burzstein et al 1989). Injury increases this temperature (for example in burned 
patients it is typically 32 °C), and the response may also be influenced by the 
administration of anaesthetic drugs (Sessler 1997). 
The other thermogenic component of energy expenditure is food. Energy expenditure 
increases in response to feeding irrespective of the route of administration. The 
factors which account for this diet or substrate induced thermogenesis are 
incompletely understood but are probably the energy associated with absorption, 
handling, and storage, and also a nutrient- induced activation of the sympathetic 
nervous system (facultative thermogenesis)(Chiolero et al 1997). The proportion of 
the energy content of nutrients devoted to thermogenic processes amounts to about 
20 -30% for proteins, 5 -10% for carbohydrates and less than 5% for fats, unless 
nutrients are given in excess when thermogenesis can be considerably greater. 
Physical work represents 20 -30% of TEE in healthy individuals but is highly 
dependent on the level of physical activity. 
Resting energy expenditure (REE) is a term often used to describe BMR plus diet - 
induced thermogenesis. 
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Determinants of energy expenditure during illness 
Stage of Illness: Classic studies of the metabolic response to injury describe 2 phases: 
the initial ebb phase followed by the flow phase (Cuthbertson 1942, Moore 1953). 
Each phase varies in duration and severity in proportion to the extent and nature of 
the injury. The ebb phase is characterised by hypovolaemia, hypotension, 
hypothermia, and increased sympathetic activity, but energy expenditure is actually 
decreased. In modern terminology this period represents hypovolaemic shock, or the 
pre fluid resuscitation state during which oxygen consumption and energy metabolism 
is limited by oxygen supply to the tissues. With contemporary resuscitation techniques 
this period should be shortlived. The flow phase is characterised by hypermetabolism 
and increased energy expenditure, and is equivalent to the classic stress response. In 
clinically resuscitated critically ill patients energy expenditure may change dramatically 
during the course of their illness. For example, Kreyman et al (1993) found energy 
expenditure was approximately 160% of reference values in patients with sepsis 
(clinical signs of infection but no organ failure), and in those recovering from septic 
shock, but was significantly lower (about 120 %) in patients with sepsis syndrome 
(sepsis plus organ failure), and lowest of all (about 100 %) in patients with septic 
shock (sepsis syndrome with hypotension requiring vasopressors). 
Age and Sex: As described above the principal determinant of BMR is lean body or 
fat free mass. Lean body mass decreases with increasing age, which accounts for the 
decreases in BMR and REE which are features of increasing age. The pattern of the 
metabolic response to injury is, however, similar irrespective of age (Watters et al 
1989, Chiolero et al 1997). Energy expenditure is lower in females than males of 
similar size because the former have a lower lean body mass. 
Temperature: Fever is an energy -consuming process which is associated with a 10- 
15% increase in energy expenditure for each degree Celsius elevation of temperature 
(Chiolero et al 1997). The effect of cooling on energy expenditure is complex and, as 
described above, depends on the level of activation of temperature conserving and 
generating processes. Manthous and colleagues (1995a) found that during cooling of 
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febrile critically ill patients, oxygen consumption decreased by approximately 10% per 
degree Celsius, which corresponds to similar changes in energy expenditure. 
Treatments: Catecholamines used for haemodynamic support activate metabolism. 
This is true for all commonly used agents but is maximal for the naturally occurring 
adrenergic agents adrenaline, noradrenaline, and dopamine, and less marked with 
synthetic agents such as dobutamine (Chiolero et al 1997). In healthy individuals 
adrenaline, noradrenaline, dobutamine, and dopamine all have dose -dependent effects 
on metabolic rate (Ensinger et al 1993, 1995, Bhatt et al 1992, Ruttiman et al 1991, 
Green et al 1992). However, these thermogenic effects may be attenuated in the 
presence of an established stress response (Uusaro et al 1995), and assessment of the 
thermogenic response to catecholamines in individual critically ill patients is difficult. 
Mechanical ventilation reduces the work of breathing which may be considerable in 
critically ill patients, particularly those with respiratory failure (Viale et al 1988, 
Shikora et al 1990, Manthous et al 1995b). Sedative and analgesic drugs, and 
neuromuscular paralysis all decrease energy expenditure by reducing anxiety, pain, 
and muscular activity (Chiolero et al 1997). 
Diet -induced thermogenesis: The effect of diet on energy expenditure was considered 
earlier. In healthy individuals the thermic effect of food is dependent on the nature of 
the substrates ingested and is directly proportional to the amount of calories ingested 
(D'Alessio et al 1988). In hypermetabolic critically ill patients diet -induced 
thermogenesis may be blunted, and the close relationship with the nature of the 
substrate blurred (Chiolero et al 1997). In view of the unpredictable effects of feeding 
on energy expenditure most studies of energy expenditure are carried out in the 
fasting state. 
Prediction of Energy Expenditure 
In normal healthy subjects REE can be predicted with reasonable accuracy from body 
weight, height, age and sex. Numerous predictive formulae are described for this 
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purpose, of which the best known is the Harris -Benedict equation (Harris and 
Benedict 1919). 
Harris Benedict equations: Wt= weight in kg, Ht= height in cm. 
Men REE (kJ) = 278 + 57.5Wt + 20.93Ht - 28.35age 
Women REE (kJ) = 2741 + 40.0Wt + 7.74Ht - 19.56age 
Although widely used, predictive equations have been shown to be unreliable in 
malnourished patients (Roza and Shizgal 1984), and have a low predictive value in 
critically ill patients (Weissman et al 1986, Makk et al 1990, Weissman and Kemper 
1992). 
ACUTE LIVER FAILURE 
Acute liver failure is an umbrella term which encompasses various clinical 
presentations resulting from acute loss of hepatic function of varying aetiology. 
Fulminant hepatic faihne is the term traditionally used to define sudden onset of liver 
failure accompanied by hepatic encephalopathy developing within 8 weeks of the 
onset of illness, in the absence of previous liver disease (Trey and Davidson 1970). 
Definition of fulminant hepatic failure and its subtypes is a subject of debate 
internationally which is influenced by local aetiology and diagnostic practice (Gimson 
1996). The most recent UK terminology suggests the term hyperacute liver failure 
for patients developing encephalopathy within 7 days of jaundice, subacute liver 
failure when it develops within 8 -28 days of jaundice, and subacute liver failure when 
it develops between 29 -72 days of jaundice. The aetiology, clinical course, and 
prognosis differ between these clinical syndromes. A high incidence of cerebral 
oedema but relatively good prognosis are associated with hyperacute liver failure; 
conversely prognosis is poor with medical management alone in patients in whom the 
delay between jaundice and encephalopathy is prolonged >7days. 
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Aetiology 
The aetiology of fulminant hepatic failure is summarised in table 1(1). 
TABLE 1(1): Aetiology of acute liver failure. 
CAUSE AGENTS /PATHOGENESIS 
Viral Hepatitis Hepatitis A, B, C, D, E 
Herpes Simplex Virus 
Drugs Paracetamol 
Halothane 
Miscellaneous idiosyncratic reactions 
Toxins Amanita Phalloides 
Carbon tetrachloride 
Vascular Ischaemia 




Miscellaneous Wilson's Disease 
Acute Fatty Liver of Pregnancy 
Reye's Syndrome 
Paracetamol hepatotoxicity is the commonest cause in the UK usually after ingestion 
of more than 150mg.kg 1. Lower doses may prove hepatotoxic in patients with 
enzyme induction due to alcohol abuse or the use of enzyme inducing drugs which 
result in induction of the cytochrome system (eg anticonvulsants or isoniazid)(Vale 
and Proudfoot 1995). Ingestion of multiple lower "therapeutic" doses of paracetamol 
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over several days can also result in severe hepatic damage. Paracetamol 
hepatotoxicity can be prevented by the administration of N- acetylcysteine which is 
considered later in this introduction. In most other countries viral hepatitis is the most 
common aetiology, although fulminant hepatic failure complicates <1% cases of viral 
hepatitis overall (Gimson 1996). The factors which cause progression to liver failure 
are incompletely understood but probably include host factors, primarily 
immunological, viral innoculum, and strain of virus (Gimson 1996). 
Clinical Features and Management 
Hepatic Encephalopathy and Cerebral Oedema 
The severity of encephalopathy in fulminant hepatic failure is generally graded 
clinically (table 1.2). 
TABLE 1.2: Clinical grading of hepatic encephalopathy. 
GRADE 1 Mild confusion, poor concentration, dysphoria, sleep pattern reversal. 
Fully coherent when roused 
GRADE 2 Increasing confusion and disorientation but still rousable and able to be 
rational. 
GRADE 3 Sleeping most of the time, but rousable to command. May be markedly 
agitated and aggressive. 
GRADE 4 Not rousable to command. Variable response to pain. 
Hyperventilation, pupillary abnormalities, extensor plantars, and 
opisthotonus may all occur but correlate poorly with the presence of 
raised intracranial pressure. 
Most patients with grade 4 encephalopathy require tracheal intubation for airway 
protection. The pathogenesis of hepatic encephalopathy in acute liver failure is unclear 
(Gimson 1996). Neurotoxicity secondary to ammonia accumulation is traditionally 
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implicated although recent evidence implicates y- aminobutyric acid (GABA) pathways 
as a major cause of neuronal depression although pharmacological reversal with 
benzodiazepine antagonists only improves coma temporarily (Mullen et al 1988). 
Serotoninergic, dopaminergic, and glutaminergic pathways may also be important 
(Ferenci 1994). 
Cerebral oedema accounts for up to 50% of deaths from fulminant hepatic failure. It is 
associated with intracranial hypertension and occurs in 70 -80% of patients with grade 
4 encephalopathy (Gimson 1996). The aetiology of cerebral oedema is unclear. Brain 
water is increased in this condition probably as a result of both directly cytotoxic and 
vasogenic (blood -brain barrier leakage) mechanisms (Blei 1991). Inhibition of brain 
Na +/K+ ATPase, altered permeability, glutamine accumulation, and direct astrocyte 
toxicity have all been proposed but are unproven. The relationship between 
intracranial hypertension and radiological evidence of oedema is poor (Munoz et al 
1991), and oedema alone is unlikely to explain the precipitous changes in intracranial 
pressure which can accompany this condition (Lidofsky et al 1992). These may result 
from acute alterations in cerebral blood flow or cerebral blood volume. Contradictory 
data exist concerning cerebral blood flow in patients with fulminant hepatic failure; 
most data indicate that it is decreased in the majority of patients, but it may be 
increased in some patients with severe encephalopathy, possibly in association with 
altered autoregulation (Ferenci 1994). 
Clinical signs of cerebral oedema and intracranial hypertension are unreliable in 
patients with hepatic encephalopathy and accurate detection relies on the use of direct 
intracranial pressure monitoring (Gimson 1996), although no prospective study has 
been performed to evaluate the safety and efficacy of this potentially hazardous 
procedure. The use of mannitol in severe fulminant hepatic failure is associated with 
improved survival, but steroids and hyperventilation are of no value (Canalese et al 
1982, Ede et al 1986). There is evidence that mannitol and N- acetylcysteine increase 
cerebral blood flow in patients with fulminant hepatic failure (Wendon et al 1994). It 
is unclear if cerebral autoregulation is deranged in humans with fulminant hepatic 
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failure, but the response to acute hypocapnia appears to preserved (Wendon et al 
1994). 
Cardiovascular and Pulmonary Disturbance 
Profound haemodynamic changes occur in fulminant hepatic failure. Characteristically 
peripheral vasodilatation occurs in association with an increase in cardiac output. 
Hypotension occurs in approximately 50% of patients with grade 4 encephalopathy 
and is associated with a poor prognosis (Gimson 1996). As a result of high cardiac 
output, DO2 is generally high, and is further increased by vasodilators such as 
prostacyclin (Harrison et al 1991). Oxygen extraction ratio is frequently extremely 
low and plasma lactate concentrations elevated, which led Bihari and colleagues 
(1985) to hypothesise that tissue hypoxia was present in these patients. Studies which 
manipulated oxygen delivery in patients with fulminant hepatic failure are considered 
later in this introduction. 
Pulmonary vascular resistance is low in most patients. Significant acute lung injury 
occurs in up to 30% of cases of paracetamol hepatotoxicity, particularly when acute 
renal failure coexists, and is associated with poor outcome (Baudouin et al 1995). 
Pneumonia and gastric aspiration also occur frequently. 
Renal and Metabolic Dysfunction 
Acute renal failure complicates about 50% of cases and is a strong predictor of 
adverse outcome (Lee 1994). The aetiology is multifactorial and includes 
hypovolaemia, direct tubular toxicity (in the case of paracetamol), and functional renal 
failure (the hepatorenal syndrome). Electrolyte abnormalities are almost universal and 
include hyponatraemia, hypokalaemia, and hypophosphataemia (Gimson 1996). 
Alkalosis occurs more frequently than acidosis and may be respiratory 
(hyperventilation associated with encephalopathy) or metabolic (impaired hepatic urea 
synthesis)(Hawker 1993). Metabolic acidosis, when present, is associated with a poor 
prognosis. Hypoglycaemia occurs frequently due to impaired hepatic gluconeogenesis, 
and possibly hyperinsulinaemia resulting from reduced insulin clearance (Lee 1994) 
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Renal replacement therapy in fulminant hepatic failure is problematic. Intermittent 
haemodialysis is associated with significant morbidity because of hypotension and 
exacerbation of intracranial hypertension. Continuous modes of therapy cause less 
haemodynamic disturbance and greater neurological stability (Davenport et al 1993a, 
1993b). The use of lactate based replacement solutions during high volume 
haemofiltration, in a condition characterised by hyperlactataemia, has been associated 
with worsening acidosis although there are no published studies using bicarbonate 
based solutions (Davenport et al 1990). 
Coagulopathy 
Reduced synthesis of coagulation factors results in prolongation of the prothrombin 
and activated partial thromboplastin times. Only plasma levels of factor VIII are 
maintained. The prothrombin time and factor V concentrations have been shown to 
correlate closely with outcome and are widely used prognostically. Coagulopathy may 
be worsened by intravascular coagulation although disseminated intravascular 
coagulation and fibrinolysis are rarely severe clinically (Gimson 1996). 
Sepsis 
Cell- mediated and humoral immunity are both compromised in fulminant hepatic 
failure. Bacterial sepsis occurs in approximately 80% of patients, most frequently with 
gram positive organisms (Rolando et al 1990). Fungal infection occurs in about 30% 
of patients and is associated with the use of antibiotics and coexistence of renal failure 
and leucopaenia. 
Prognosis 
Despite intensive research into specific therapies such as charcoal haemoperfusion, 
steroids, prostaglandins, and glucagon no treatment other than supportive intensive 
care and liver transplantation have been widely proven to improve survival from 
fulminant hepatic failure (Lee 1994). As a result efforts have centred on defining 
criteria which predict death with sufficient sensitivity and specificity to guide the need 
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for liver transplantation. Two systems are currently widely used although neither is 
universally accepted, a fact which probably reflects different patterns of disease world 
wide. The King's College criteria, defined from a multivariate analysis of 588 patients 
managed over the 1973 -1985 period, distinguish paracetamol from non -paracetamol 
aetiology and is used in the UK (table 1.3)(O'Grady et al 1989). Factor V 
concentrations and age (the Clichy criteria) are widely used in mainland Europe where 
paracetamol- induced liver failure occurs rarely (Bernuau et al 1986). 
TABLE 1.3: Prognostic criteria used to guide liver transplantation in patients with 
fulminant hepatic failure. 
KING'S CRITERIA Paracetamol overdose 
Arterial pH < 7.30 
or all of the following: 
Prothrombin time > 100 seconds 
Creatinine > 30011mo1.L "' 
Grade 3 or 4 encephalopathy 
Prothrombin time increasing on day 4 
Non -paracetamol overdose 
Any three (irrespective of grade of encephalopathy) of. 
Aetiology non -A -non -B hepatitis, halothane or drug reaction 
Age <10 or >40 years 
>7 days between onset jaundice and onset encephalopathy 
Serum bilirubin > 300p.mo1.L:' 
Prothrombin time > 50 seconds 
or Prothrombin time > 100 seconds irrespective of grade of 
encephalopathy 
CLICHY CRITERIA Both of 
Coma or confusion 
Factor V < 20% (age < 30 years) or < 30% (age > 30 years) 
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N- Acetylcysteine in Fulminant Hepatic Failure 
N- acetylcysteine has proven benefit for treating paracetamol poisoning if given within 
15 hours of ingestion (Vale and Proudfoot 1995). Harrison et al (1990) reported a 
retrospective survey of patients presenting with fulminant hepatic failure to King's 
College Hospital who received N- acetylcysteine between 10 and 36 hours after 
paracetamol ingestion. They documented an improved outcome in patients who had 
first received the drug during this period in comparison with those who had not, 
despite no measurable effect on hepatic function as judged by the prothrombin time. 
The same group subsequently reported a small prospective randomised trial of 50 
patients with paracetamol- induced fulminant hepatic failure who had not previously 
received N- acetylcysteine (Keays et al 1991). After admission to the liver unit patients 
were randomised to receive either N- acetylcysteine, using a standard infusion rate 
which continued until recovery or death, plus "conventional intensive liver care ", or 
conventional intensive liver care alone. In these patients the mean time elapsed from 
paracetamol ingestion to N- acetylcysteine administration was 55 hours, significantly 
longer than reported in any other study. There was a statistically significant difference 
in mortality between the groups with a 28% reduction in the N- acetylcysteine- treated 
group, representing a difference of 7 deaths between the two groups of 25 patients. 
Patients in the N- acetylcysteine group developed fewer clinical signs of cerebral 
oedema (intracranial pressure was not measured) and had reduced requirements for 
inotropic drug support. The incidence of acute renal failure was 20% less (a difference 
of 5 patients) in the N- acetylcysteine group although this was not statistically 
significant. As with the earlier uncontrolled study there was no difference in 
prothrombin time, considered the best measure of liver function, between the groups 
at any time. 
This study was provocative but critical appraisal raises several important issues. 
Firstly, the study was not blinded introducing the potential for bias particularly when 
"soft" data such as "clinical evidence of cerebral oedema" was collected. Secondly, 
there is little available data concerning the conduct of "conventional intensive care ", 
such as protocols for fluid resuscitation, antibiotic therapy, or nutrition. Thirdly, there 
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is no data regarding the incidence of infection which is the second most common 
cause of death after cerebral oedema (Lee 1994). Finally, complications known to be 
strongly associated with adverse outcome in fulminant hepatic failure, namely cerebral 
oedema, cardiovascular collapse, and acute renal failure, occurred more frequently in 
the control group. The authors hypothesised that these differences were explained by 
a therapeutic effect of N- acetylcysteine, but in a study of this size it was unclear 
whether differences in the incidence of these complications could have occurred by 
chance and accounted for the difference in mortality observed. Of particular relevance 
was the management of acute renal failure which occurred in 50% of the patients. 
This was managed using either intermittent haemodialysis or continuous arteriovenous 
haemofiltration but it was not stated which patients received which treatment and 
whether differences existed between the groups. As noted above serious 
complications occur more frequently when intermittent haemodialysis is used in 
comparison with continuous arteriovenous haemofiltration (Davenport et al 1993a, 
Davenport et al 1993b). 
The mechanism of the proposed beneficial effect of N- acetylcysteine in these studies 
was unclear. It was unlikely that the drug significantly altered liver function as 
laboratory measures of hepatic function were no different from untreated patients. 
The King's group proposed an alternative mechanism of action based on other work 
from their centre. In an uncontrolled study Harrison et al (1991) examined the short 
term effect of the same dosage regimen for N- acetylcysteine on oxygen delivery, 
haemodynamic state, and oxygen consumption in 12 patients with paracetamol - 
induced fulminant hepatic failure and 8 patients with acute liver failure from other 
causes. Measurements of cardiac output, pulmonary artery pressures, and pulmonary 
capillary wedge pressure were made using a pulmonary artery catheter. Oxygen 
delivery, oxygen consumption, and oxygen extraction were calculated using standard 
formulae. Measurements were made at a baseline time point and then on one occasion 
30 minutes after starting the N- acetylcysteine infusion. With the protocol used the 
authors also studied the effects of prostacyclin infusion alone and in combination with 
N- acetylcysteine. The principal findings of this study were that 30 minutes after 
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starting the N- acetylcysteine infusion significant increases in cardiac output, oxygen 
delivery, mean arterial pressure, left ventricular stroke volume, left ventricular stroke 
work, oxygen consumption, and oxygen extraction ratio occurred, accompanied by a 
decrease in systemic vascular resistance. These changes were most pronounced in the 
patients with paracetamol -induced fulminant hepatic failure in whom a 46% increase 
in oxygen consumption was described, but were also observed in the non -paracetamol 
group. These findings were equally provocative to those of the outcome study. In a 
group of critically ill patients N- acetylcysteine appeared to improve cardiac function, 
peripheral perfusion, and oxygen delivery and extraction consistent with the 
amelioration of tissue hypoxia. These observations were made at a time when intense 
research interest was focused on pathological supply dependency and tissue hypoxia 
in the critically ill. Many agents had been utilised which increase oxygen delivery to 
tissues but none had consistently been shown to improve oxygen extraction. Another 
study from the King's College group, using similar methodology, had suggested that 
adrenaline and noradrenaline might worsen oxygen extraction and consumption 
despite improving blood pressure (Wendon et al 1992). As low oxygen delivery, 
consumption and extraction were clearly associated with poor outcome, the discovery 
of an agent which might improve all of these variables was of major significance. The 
authors hypothesised that this might account for the reduction in mortality attributed 
to the late administration of N- acetylcysteine in patients with fulminant hepatic failure. 
They also hypothesised that the ability of N- acetylcysteine to replenish tissue 
sulphydryl groups might improve microvascular blood flow by increasing production 
of nitric oxide. 
Critical appraisal of this study raises several important issues. Firstly, the results may 
have been affected by mathematical coupling because the reverse Fick method was 
used to calculate oxygen consumption. Secondly, only two data points were collected, 
before and after starting N- acetylcysteine, yet no estimation of the measurement 
errors present was made. Thirdly, none of the patients studied required inotropic 
support and median plasma lactate concentration at 2.5 mmo1.1"1 was only marginally 
elevated suggesting that some patients despite being studied 33 to 96 hours after 
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paracetamol overdose did not have severe liver failure. Finally, patients were only 
studied 30 minutes after starting N- acetylcysteine. With the dosage regimen used a 
very large loading dose is administered over 15 minutes which results in high plasma 
concentrations of the drug which subsequently decline rapidly (Prescott et al 1989). It 
was unclear from the study whether the effects observed were related to plasma 
concentrations or if they were sustained during the subsequent infusion. 
These studies have never been repeated but their conclusions are widely cited in the 
hepatology and critical care literature. N- acetylcysteine has become a standard 
treatment for fulminant hepatic failure in many centres worldwide. 
LIVER TRANSPLANTATION 
The anaesthetic and surgical management of liver transplantation involves an 
understanding of the complex cardiopulmonary, metabolic, and haematological 
changes which occur at different stages of the procedure in patients with deranged 
physiology as a result of acute or chronic liver disease. The procedure is usually 
considered in three phases: the preanhepatic, anhepatic, and postanhepatic. 
The preanhepatic phase. 
During this stage the liver is mobilised through a bilateral subcostal incision. The 
onset of the anhepatic phase occurs with the occlusion of the recipient portal vein 
followed by occlusion of the hepatic veins or perihepatic inferior vena cava after 
which the recipient liver is removed. Most patients undergoing liver transplantation 
have a high cardiac output and low vascular resistance as is typical in acute and 
chronic liver disease. Patients are generally haemodynamically stable during the 
preanhepatic period although the sudden drainage of massive ascites can be associated 
with rapid fluid shifts (Carton et al 1994). 
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The anhepatic phase. 
The anhepatic phase lasts from clamping the recipient portal vein until vascular 
reperfusion of the donor liver. A number of specific problems are associated with this 
period: 
Haennodynanzic instability: When the inferior vena cava is clamped above and 
below the liver, and the portal vein occluded, venous return to the heart is acutely 
decreased. This results in arterial hypotension and a decrease in cardiac output (Estrin 
et al 1989, Carton et al 1994, Kang et al 1989). In addition, infrahepatic venous 
pressures increase such that the perfusion pressure to organs such as the gut and 
kidneys may be reduced, and venous blood loss increased (Merritt et al 1990). Partial 
reversal of these changes can be achieved by fluid loading, although excessive 
administration may be complicated by fluid overload when the clamps are removed at 
reperfusion. Clamping of major vessels alone was the original surgical technique 
described for liver transplantation and it is still used in many centres either universally 
or in selected patients. However, two techniques have been devised which seek to 
maintain venous return to the heart during the anhepatic phase. 
1) Venovenous bypass. 
There are many variations on this technique but the principle is to divert blood via an 
extracorporeal circuit from the inferior vena cava (usually from the femoral vein) and 
portal vein to the subclavian or internal jugular veins. Flow is usually generated with a 
centrifugal pump system with maximum achieved flow rates typically of 2 -3 L.min"1. 
Anticoagulation is rarely used. The proposed benefits of venovenous bypass are 
greater haemodynamic stability, reduced blood product requirement, improved 
perioperative renal function, and reduced metabolic disturbance (Carton et al 1994). 
Complications include hypothermia, air embolism, thromboembolism, neurovascular 
complications of cannulation, and the requirement for trained operators. 
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2) Piggyback technique. 
With this technique venous return to the heart is maintained without the need for 
extracorporeal circulation. Instead of cross clamping the inferior vena cava above 
and below the recipient liver and anastomosing the donor liver with donor vena 
cava en bloc, the recipient liver is carefully dissected from around the vena cava 
and the hepatic veins identified and dissected high up into the liver parenchyma. A 
side -biting clamp is then applied across the hepatic veins and part of the inferior 
venal cava such that vena caval flow to the heart continues. The hepatic veins are 
then divided and the recipient liver removed. For anastomosis of the donor liver the 
recipient hepatic veins are fashioned into a single vessel and the donor superior 
vena cava piggybacked on to the recipient vena cava (Tzakis et al 1989). During 
the anhepatic period the portal vein can either remain clamped or be drained into 
the inferior vena cava via a temporary portacaval shunt ( Tzakis et al 1993). The 
advantages claimed for this approach include greater haemodynamic stability, 
improved renal and splanchnic perfusion, reduced cost, and greater post 
reperfusion stability (Figueras et al 1993, Belghiti et al 1995, Steib et al 1997, 
Howard 1997). However, it demands greater surgical skill and dissection, 
particularly if the recipient liver is closely applied to the vena cava. 
There are no prospective randomised studies which compare these surgical techniques 
although a large number of anecdotal reports and small unrandomised studies have 
been published, reflecting the strong influence of personal preference on surgical 
practice in this area. These have conflicting results and there is a need for well - 
designed detailed studies examining both the physiological changes which occur with 
these different approaches and their relevance to morbidity and mortality. 
Coagulopathy: Coagulopathy during liver transplantation is of multifactorial 
aetiology but requires careful correction in order to minimise blood loss. Preoperative 
liver disease results in variable reduction in coagulation factor production and 
abnormal platelet function. Intraoperative coagulopathy may worsen because of 
dilution, massive blood loss, hypothermia, and calcium chelation by citrate from blood 
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products (Carton et al 1994). Fibrinolysis can occur, typically at the time of 
reperfusion. Management of coagulopathy requires close monitoring with coagulation 
tests and the appropriate use of clotting factors. Aprotinin is widely used as 
prophylaxis against fibrinolysis and is associated with reduced transfusion 
requirements (Grosse et al 1993, Segal et al 1994). 
Metabolic Changes: Progressive metabolic acidosis is classically described during 
the anhepatic phase as a result of tissue hypoperfusion, hypothermia, blood 
transfusion, and sometimes renal dysfunction. Acidosis is frequently accompanied by 
hyperlactataemia (Steib et al 1992). Although hypoglycaemia may complicate acute 
and chronic liver faillure it occurs rarely during transplantation and hyperglycaemia 
occurs more frequently (Carton et al 1994). Various electrolyte abnormalities may 
occur during the anhepatic period the most important and frequent of which is ionic 
hypocalcaemia resulting primarily from citrate binding and hypothermia. 
Reperfusion and the post anhepatic period. 
Reperfusion of the donor graft is the time associated with greatest clinical instability 
and most complications. Typically the rapid increase in venous return results in 
increased central venous pressure and an increase in cardiac output. This is associated 
with a variable increase in pulmonary artery pressures but systemic hypotension and 
vasodilatation (Webster et al 1994). The term "postreperfusion syndrome" describes 
severe forms of this haemodynamic pattern in which a decrease in mean arterial 
pressure of >30% occurs for at least 1 minute within 5 minutes of reperfusion 
(Aggarwal et al 1987). Other changes include cardiac dysrhythmias, heart block, and 
cardiac arrest. Hypothermia is also most severe at this time point because the graft, 
which is preserved in crushed ice, rapidly absorbs heat from the recipient's blood. 
These changes arise when surgical complications such as massive haemorrhage and air 
or thrombotic embolism may occur. The aetiology of post- reperfusion syndrome is 
unclear. Cardiac function appears to be well preserved although acute decreases in 
coronary perfusion pressure may occur and left and right ventricular dysfunction are 
described (De Wolf et al 1993, Carton et al 1994). Substances released from the graft 
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itself, or from tissues which were ischaemic during the anhepatic period, have been 
implicated (Goode et al 1994, Bellamy et al 1997). Rapid metabolic changes may 
contribute including hyperkalaemia, hyperglycaemia, hypocalcaemia, hyperlactataemia 
and worsening acidosis. Management of reperfusion involves correcting metabolic 
abnormalities during the anhepatic phase, and the careful use of fluids and inotropes 
(Carton et al 1994). Patients with fulminant hepatic failure are particularly at risk at 
the time of reperfusion because of cardiovascular instability and intracranial 
hypertension which often worsens at this time point and can result in cerebellar coning 
(Carton et al 1994). The factors which cause these complications and the best means 
of preventing them are poorly understood. 
Following reperfusion surgery involves securing haemostasis, completing vascular 
anastomoses, and anastomosing the bile duct. During this period the production of 
bile, and improvements in acidosis and hyperlactataemia are evidence of graft 
function. Patients with fulminant hepatic failure often demonstrate a rapid 
improvement in neurological status. Post -operative monitoring in an intensive care 
unit is usual until consciousness is regained and tracheal extubation is performed. 
During this period close monitoring of biochemical and haematological parameters, 
together with clinical variables such as urine output are advisable. 
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CHAPTER TWO 
THE DELTATRAC METABOLIC MONITOR 
INTRODUCTION 
For the studies which form the basis of this thesis gas exchange measurements were 
performed with the Deltatrac metabolic monitor (Datex, Helsinki, Finland). This 
device is designed primarily to determine oxygen consumption and carbon dioxide 
elimination in both spontaneously breathing and mechanically ventilated patients. 
From these measurements secondary variables including energy expenditure and 
respiratory quotient can be calculated. The Deltatrac system was designed to avoid 
the need for accurate measurement of gas volumes which has proved most 
problematic in the development of automated systems for measuring gas exchange. 
This is done by a flow dilution system using an accurate fixed flow generator in an 
open system of measurement. The problem of rapid and accurate measurement of gas 
fractions has been solved using infrared CO2 analysers and paramagnetic oxygen 
analysers. The system has been validated under clinical conditions and in lung models 
by several independent groups. 
MODE OF ACTION 
Spontaneous Ventilation 
A canopy is used to surround the subjects head and inspired gas is sucked through the 
canopy at a known, constant rate of about 40L.min' (figure 2.1). The difference 
between inspired and expired oxygen fractions is measured with a rapid response, 
paramagnetic differential oxygen analyser (0M -101, Datex, Helsinki). The response 
time of this analyser is 130msec and the resolution 0.01 %; responses are linear over 
the measurement range with negligible non- linearity error. The expired CO2 fraction is 
measured with an infrared CO2 analyser (CX -104, Datex, Helsinki). The resolution of 
this analyser is 0.01%, and its linearity is checked and corrected within the monitor by 
computer program. The system relies on the accuracy of the constant flow generator 
which is constructed from a centrifugal fan. The construction of the fan enables it to 
generate a flow of 700L.min 1, but a flow restrictor at the outlet of the fan decreases 
the flow down to 45L.min 1 which makes it insensitive to pressure fluctuations 
upsteam. Compensation is made for ambient pressure and gas temperature which are 
both measured by the machine. 
VCO2 is calculated as the product of constant flow (Q) and the fraction of CO2 in the 
diluted expiratory flow (FECO2). Thus: 
VCO2 = Q x FECO2 
Oxygen consumption is calculated using a modification of the Haldane transformation 
from the equation: 
VO2 = (Q/[1 - FIOzJ) x (FI02 -FED?, -F102 x [FECO2 - FICO2J) 
Where FEO2 and FECO2 are the fractions of oxygen and CO2 in the mixed expiratory 
gas flowing through the monitor. 
Mechanical Ventilation 
During mechanical ventilation inspired gas is sampled from the inspiratory circuit and 
all expired gas is collected via tubing from the common gas outlet of the ventilator 
from which it passes into a mixing chamber (figure 2(2)). The respiratory quotient 
(RQ) is calculated from inspiratory and expiratory gas fractions alone, using a formula 
derived using the Haldane transformation, from measurements made at appropriate 







VCO2 is calculated as the product of the constant flow and the concentration of CO2 
downstream from the mixing chamber. The VO2 is subsequently calculated from RQ 
and VCO2 from the equation: 
VO2 = VCOz/RQ 
Correction for humidity 
Water vapour in respiratory gases or dry calibration gases is balanced with ambient air 
using a water trap and Nafion tubing. With this system the humidity of analysed gases 
is equalised with ambient air prior to measurements. Thereafter, gas fractions are 
expressed at Standard Temperature and Pressure. 
Calibration 
Calibration of the Deltatrac system occurs at 3 levels. First, during use the machine 
performs baseline checks for CO2 and 02 every 10 minutes. Correction for inspired 
CO2 fraction is made by assuming that the CO2 fraction of the oxygen/air mixture 
decreases linearly from 0.04 to 0% as FI02 changes from 21 to 100 %. Second, prior 
to each use the machine is calibrated against a standard gas mixture (in the present 
studies 95% 02 and 5% CO2) and ambient barometric pressure (measured with an 
anaeroid barometer). Third, approximately every 3 -6 months the accuracy of the flow 
generator is checked using an alcohol burn. A qualitative alcohol burn checks the 
overall accuracy of the machine and is quick and simple; the RQ measured by the 
machine should be 0.67. A quantitative burn of an accurately measured volume of 
pure alcohol, which will produce a predictable volume of CO2, can be used to make 
fine adjustment to the flow generator. The drift in flow generator calibration has been 
shown to be negligible over 3 months. Gas injection techniques using CO2 and /or N2 







































































































































































































































































































A number of studies have assessed the accuracy of the machine in laboratory studies 
and under clinical conditions. Laboratory validations are summarised in table 2(1). 
Most of these authors found negligible inaccuracy in association with increasing levels 
of positive end -expiratory pressure (PEEP) up to about 20cm.H2O. The effect of 
increasing FIO2 was also small and relative errors of <5% occurred even at F1020.8 
(Ronco and Phang 1991). Using lung model simulations of increases in oxygen 
consumption, Ronco and Phang (1991) found the Deltatrac could detect changes with 
an error of less than 1 %. 
TABLE 2(1): Summary of studies which evaluated the accuracy of the Deltatrac 
metabolic monitor in lung models. 
Authors 
Takata et al (1989) 
Makita et. al (1990) 
Weissman et. al (1990) 
Phang et al (1990) 
Findings 
Errors expressed as (1 - measured /predicted 
value).100 
N2 and CO2 injections 
Respirator: VCO2 2 ± 2 %, VO2 4 ± 4% 
Canopy: VCO2 3 ± 2 %, VO2 4 ± 2% 
Mean Relative Errors expressed as 
(measured - predicted value /predicted value).100 
Butane burning 
Respirator: VCO2 2.9 %, VO2 4 %, RQ 4% 
Errors expressed as ± (measured /predicted value).100 
N2 and CO2 injections 
Respirator: VCO2± 7 %, VO2 ± 7% 
Mean Relative Errors expressed as 
(measured - predicted value /predicted value).100 
N2 and CO2 injections 
Respirator: VCO2 1.5 %, VO2 1.9% 
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The most detailed clinical validation in ventilated patients was carried out by Tissot 
and colleagues (1995) who compared VO2 and VCO2 by the Deltatrac with 
measurements made using a mass spectrometer and with the Douglas bag method in 
ventilated critically ill patients. The Deltatrac gave values which agreed closely with 
measurements with either of these methods and any disparity was clinically 
insignificant. These authors also examined the effect on VO2 accuracy of fluctuation 
in FI02 during the inspiratory cycle with different ventilators and concluded that the 
Servo C ventilators performed best because of the presence of a mixing chamber. 
CALCULATION OF ENERGY EXPENDITURE 
Energy expenditure is calculated from measured VO2 and VCO2 using the formula: 
EE (kJ.min') = 14.98 VO2 (L.min') + 6.06 VCO2 (L.min 1) - 0.092 
(Bursztein et al, 1977, 1989) 
SUMMARY 
The Deltatrac metabolic monitor is an automated open circuit indirect calorimeter 
designed for measuring V02, VCO2, RQ, and energy expenditure in spontaneously 
breathing and mechanically ventilated patients. When used appropriately it has been 
demonstrated to have good accuracy in lung models and in the clinical setting. 
Accuracy relies on correct calibration, an absence of leaks, and steady state conditions 
for gas exchange. 
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CHAPTER 3 
N- ACETYLCYSTEINE AND OXYGEN KINETICS IN FULMINANT 
HEPATIC FAILURE 
OBJECTIVES 
The primary objectives of the studies performed in this chapter were: 
I) To explore the measurement errors associated with the Fick method and indirect 
calorimetry when used to determine oxygen consumption in patients with fulminant 
hepatic failure. 
2) To document the haemodynamic effects of N- acetylcysteine in patients with severe 
fulminant hepatic failure during the first 5 hours of the standard infusion regimen. 
3) To examine the relationship between oxygen delivery, oxygen consumption and 
oxygen extraction during N- acetylcysteine infusion in these patients. 
4) To examine the effect of N- acetylcysteine on indirect markers of impaired tissue 
perfusion and hypoxia (lactate and acid -base status). 
5) To explore the relationship between the physiological effects of N- acetylcysteine 
and plasma drug concentrations. 
BACKGROUND 
N- acetylcysteine and paracetamol poisoning 
The drug N- acetyl -L- cysteine is the treatment of choice for paracetamol 
hepatotoxicity, which occurs most frequently as a result of self -poisoning (Vale and 
Proudfoot 1995). Protection by the drug is dependent on early administration 
following paracetamol ingestion and is mediated primarily via replenishment of 
hepatic glutathione stores (Vale and Proudfoot 1995). Early reports indicated 
complete protection from hepatotoxicity, renal failure and death when N- 
acetylcysteine was administered within 8 hours of paracetamol ingestion, with a 
progressive reduction in efficacy between 8 and 15 hours (Prescott et al 1979). 
Treatment given more than 15 hours after ingestion was initially thought to be 
ineffective. Subsequent studies have confirmed the protective effect of the drug when 
given within 10 hours of paracetamol ingestion but the efficacy of treatment given 
between 10 and 24 hours is less clearly established (Smilkstein et al 1988, Smilkstein 
et al 1991). During this period delay in N- acetylcysteine administration is associated 
with more severe liver damage and, in comparison with historical controls, case 
fatality rates were significantly reduced in patients who received the drug (Vale and 
Proudfoot 1995). The clinical benefit of late administration of N- acetylcysteine was 
initially questioned because of anaphylactoid reactions in up to 15% of cases 
(Bateman et al 1984, Mant et al 1984, Chan et al 1994), and a possible detrimental 
effect in some animal studies (Banda and Quart 1987). However, these potential 
adverse effects have proved clinically irrelevant (Parker et al 1990, Beckett et al 
1990), and it is currently recommended that N- acetylcysteine is administered if more 
than 8 hours have elapsed from paracetamol ingestion and >150mg.kg'' were ingested 
(Vale and Proudfoot 1995). 
Gluatathione and N- acetylcysteine 
Glutathione is a tripeptide composed of the amino acids glutamic acid, cysteine and 
glycine. It is the most widespread cellular thiol, occurs in virtually all mammalian 
cells, and is synthesised intracellularly via the y- glutamyl cycle (Meister 1984, 
1988)(figure 3.1). The glutathione redox cycle catalyses interconversion between the 
reduced (GSH) and oxidised (GSSG) form of the compound such that the vast 
majority of cellular glutathione is in the reduced form (ratio reduced to oxidised 
100:1). GS SG is actively reduced to GSH by the enzyme glutathione reductase, with 
NADPH as cofactor, either within cells themselves, or in the liver following transport 
into the circulation. Cellular levels of glutathione are regulated via interrelated 
mechanisms involving membrane transport of precursor amino acids, intracellular 
synthetic activity, feedback mechanisms, and intracellular complexing of GSH 
(Deneke and Fanberg 1989). The liver is the primary exporter of GSH for use by 
other organs (primarily lung and kidney) and the availability of cysteine is the rate 
limiting step for glutathione synthesis. Cysteine is not an essential amino acid in 
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humans as it can be synthesised from methionine, but although cysteine synthesis 
occurs in vivo, dietary supplementation or direct intravenous administration appears 
to improve glutathione concentrations in both animals and humans (Beutler 1989). In 
animal models hepatic cysteine and glutathione concentrations are dependent on the 
dietary intake of cysteine, and exogenous supply is important in humans particularly 
following acute depletion (Baumann et al 1988). Therapeutic administration of 
cysteine is problematic because preparations are unstable (cysteine is rapidly oxidised 
to the relatively insoluble compound cystine) and high plasma concentrations have 
neurotoxic effects. 
Glutathione is an antioxidant concerned primarily with biological defence against a 
wide variety of potentially toxic agents of both exogenous and endogenous origin. It 
serves either as an obligatory substrate or a cofactor in enzymatic reactions which are 
essential to maintain cell viability. Ghuiathione peroxidase catalyses the conversion of 
hydrogen peroxide, an important by- product of cellular metabolism, to water using 
GSH as a hydrogen ion donor. Hydrogen peroxide is a potential precursor of reactive 
oxygen species which, if uncontrolled by antioxidant defences, cause widespread 
cellular injury. Glrriathione thioltransferase and related enzymes catalyse the 
reduction of sulphydryl groups in many proteins which require to be kept in the 
reduced form in order to function correctly, using GSH as substrate. 
N- acetylcysteine is a synthetic derivative of cysteine (figure 3(2)). It was originally 
developed as a mucolytic agent for inhalational administration, acting via disruption of 
disulphide bonds in mucus thereby reducing viscosity (Scheffner 1963). It was 
subsequently shown to be effective orally and has been used in the treatment of 
chronic obstructive pulmonary disease and cystic fibrosis (Boman et al 1983, Mitchell 
and Elliot 1982). N- acetylcysteine can function as a precursor of cysteine which is the 
basis of its therapeutic efficacy in the treatment of conditions in which cysteine and 
glutathione are depleted, and in this respect it is often considered an antioxidant. 
Human studies have shown that N- acetylcysteine is capable of increasing cysteine and 
glutathione concentrations in the plasma and lungs of patients with chronic 
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obstructive pulmonary disease, idiopathic pulmonary fibrosis, and ARDS, conditions 
in which antioxidant defences may be chronically or acutely depleted (McNee et al 
1991, Bridgeman et al 1994, Meyer et al 1995, Bernard et al 1997). 
Reactive metabolites of paracetamol, formed in the liver and kidney, are detoxified by 
reduced glutathione (Flanagan and Meredith 1991). Depletion of intracellular 
glutathione, as occurs following paracetamol overdose, results in accumulation of 
these reactive metabolites (primarily N- acetylbenzoquinoneimine) which are potent 
oxidising agents. These probably mediate hepatic and renal injury by binding 
covalently to cellular macromolecules. Animal studies indicate that the protective 
effect of N- acetylcysteine is mediated primarily via glutathione production following 
conversion in vivo to cysteine (Miners et al 1984). These findings are supported in 
humans in whom N- acetylcysteine has been shown to increase depleted plasma 
cysteine and glutathione concentrations following ingestion of paracetamol 
(Burgunder et al 1989). It is also hypothesised that N- acetylcysteine may have some 
direct antioxidant activity in this setting (Vale and Proudfoot 1995). The efficacy of 
N- acetylcysteine in treating paracetamol- induced hepatotoxicity has led to interest in 
its use in many other conditions in which antioxidant depletion and oxidant stress are 
thought to be important. These are considered later in this thesis. 
N- acetylcysteine metabolism and pharmacokinetics. 
The metabolism and clinical pharmacology of N- acetylcysteine are incompletely 
understood. The drug exists in a variety of different forms in the plasma, and 
metabolism gives rise to a number of products (Olsson et al 1988)(figure 3(2)). 
Despite the widespresad use of N- acetylcysteine over 30 years there are few 
pharmacokinetic or pharmacodynamic studies in animals or humans. This has resulted 
in part from methodological difficulties in measuring plasma concentrations of the 
drug and its major metabolites. Pharmacokinetic studies have used radiolabelled N- 
acetylcysteine (Scheffner et al 1966, Bonanomi and Gazzaniga 1980), or various 
techniques of gas -liquid or high performance liquid chromatography (Morgan et al 
1983, Lewis et al 1985, Cotgreave and Moldeus 1987, Johansson and Westerlund 
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1986). With these techniques it has been shown that N- acetylcysteine may be present 
in plasma in intact reduced form (the parent drug) or in various oxidised forms 
(Olsson et al 1988). These oxidised forms result from reactions between N- 
acetylcysteine molecules to form N,N'- diacetylcysteine, with low molecular weight 
thiols such as cysteine or glutathione, or with the thiol groups of plasma proteins 
(figure 3(2)). Following a single intravenous dose of N-acetylcysteine in healthy 
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volunteers the plasma clearance of reduced N- acetylcysteine is rapid and biphasic with 
most of the drug cleared within 1 hour (Olsson et al 1988, Burgunder et al 1989). 
Oxidised forms, and total concentrations of the drug with its various metabolites, are 
cleared much more slowly with a terminal half life of 2 -6 hours in published studies 
(Borgstrom et al 1986, Olsson et al 1988, Burgunder et al 1989). The disulphide 
binding of the drug to plasma and tissue proteins increases progressively following 
administration and is probably >50% ( Olsson et al 1988). The main metabolites of N- 
acetylcysteine are cysteine and cystine which increase in concentration in plasma 
following administration of the drug (Scheffner et al 1966, Rodenstein et al 1978, 
Bonanomi and Gazzaniga 1980). Deacetylation probably occurs primarily in the liver. 
N- acetylcysteine does not alter plasma glutathione concentrations in healthy 
volunteers, but is effective in replenishing them following acute depletion by 
paracetamol (Poulsen et al 1993, Burgunder et al 1989). 





N- acetyl- L- cysteine 
Oxidation products occurring in vivo following administration: 
N, N' -Di acetylcystei ne 
N- Acetylcysteine -cysteine 
N- Acetylcysteine- protein 
N- Acetylcysteine -glutathione 
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Various dosing regimens have been used for the drug. Following oral administration 
absorption is rapid, but the bioavailability is low (less than 10 %) because of high first 
pass intestinal and hepatic metabolism (Borgstrom et al 1986). For treatment of 
paracetamol- induced hepatotoxicity intravenous administration is recommended (Vale 
and Proudfoot 1995). The intravenous administration regimen used in most studies is 
identical, or very similar to, that described by Prescott et al (1977, 1979). This 
regimen was designed for treatment of paracetamol overdose and gives a very large 
dose of drug in a short time (150mg.kg' over 15 minutes) in order to rapidly 
replenish hepatic and renal glutathione. Thereafter 50mg.kg 1 is given over 4 hours 
followed by 100mg.kg' over 16 hours. This regimen was originally chosen arbitrarily 
(Prescott et al 1989) and the plasma concentration of N- acetylcysteine required for 
maximum therapeutic benefit is unknown in patients both following paracetamol 
overdose and in the other diagnostic groups in which it has been used. A 
pharmacokinetic study in patients presenting after paracetamol overdose 
demonstrated very high peak plasma concentrations of total N- acetylcysteine which 
declined rapidly after the loading dose was completed (Prescott 1989). Reduced N- 
acetylcysteine, cysteine, and glutathione concentrations were not measured. These 
studies indicate that the volume of distribution of the drug (all forms) is about 500 
ml.kg', the clearance about 3ml.min-1.kg', and the elimination half life about 6 hours 
(Borgstrom et al 1986, Olsson et al 1988, Prescott et al 1989). Up to 30% of the drug 
is cleared unchanged in urine, the rest is cleared by metabolism (Borgstrom et al 
1986). There are no published studies concerning N- acetylcysteine kinetics in patients 
with established fulminant hepatic failure. 
MATERIALS AND METHODS 
S111L1) Desigii 
This was designed as a prospective randomised controlled study. In the only previous 
study in this area Harrison et al (1991) observed a highly significant increase in 
oxygen delivery 30 minutes after starting N- acetylcysteine in 12 patients with 
paracetamol -induced fulminant hepatic failure (mean increase 119 ml.min 1m2, 95% 
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confidence intervals 51 -196). An increase in oxygen delivery of 100 ml.min l.m 2 in 
response to a therapeutic intervention is widely considered clinically significant in the 
oxygen kinetics literature (equivalent to an increase in cardiac output of about 0.7 -1.0 
l.min' assuming normal arterial oxygen content). From rates of admission to the 
Scottish Liver Transplant Unit in 1994 of patients with fulminant hepatic failure who 
subsequently required admission to the intensive care unit, I anticipated approximately 
20 patients might be recruited over the 18 month period available for the study. 
Harrison et al (1991) did not include a control group in their study but I considered 
control patients essential for proper evaluation of the drug. In order to achieve the 
same power to study a mean increase of at least 100 ml.min'.m 2, I chose to 
randomise 14 patients to receive N- acetylcysteine and 7 to receive placebo infusions. 
This was done by means of sealed envelopes at the time of study entry. 
Patient population 
Patients were studied between March 1995 and July 1996. All studies were carried 
out within 24 hours of admission to the Intensive Care Unit at the Royal Infirmary of 
Edinburgh. Admission criteria for the study were as follows: 
1) Diagnosis of fulminant hepatic failure. 
2) Consent for inclusion in the study from relatives. 
3) Patient had either not previously received N- acetylcysteine during this illness, or if 
they had done so it had been discontinued at least 24 hours before study entry. This 
time period represented approximately 4 half -lives using published data in healthy 
individuals and in patients studied within 16 hours of paracetamol overdose. 
4) No history of adverse reaction to N- acetylcysteine. 
5) Patient required sedation, tracheal intubation, and mechanical ventilation for 
clinical management. 
6) Patient required insertion of an arterial catheter and pulmonary artery catheter for 
clinical management. 
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General Intensive Care Management 
All patients were sedated (propofol and alfentanil infusions) and paralysed (atracurium 
infusion) and the lungs ventilated using a Servo 900C or 900D ventilator (Siemens - 
Elema, Soln, Sweden) to achieve a PaCO2 of between 3.5 and 5.0 kPa. Changes in 
ventilator settings were only made if clinically indicated. The FIO2 was adjusted to 
achieve an arterial PaO2 of 15 -25 kPa and then remained unchanged during the study 
period. Prior to commencing the study patients were resuscitated with 0.9% NaC1 
solution, colloid solutions, or red cell concentrate until the pulmonary artery wedge 
pressure was >_Bmmlig and the haemoglobin concentration was ?8 g.d1-1. This figure 
was chosen as a compromise between the beneficial effects for tissue perfusion of 
aggressive fluid loading and the potentially detrimental effects of fluid overload on 
cerebral perfusion and cerebral oedema. If clinically indicated, noradrenaline was then 
administered by infusion and titrated to achieve a mean arterial pressure of >_70mmHg. 
During the study period colloid infusion was administered to maintain the pulmonary 
artery wedge pressure at the baseline value. Changes in noradrenaline therapy were 
only made if the mean arterial pressure decreased below 70mmHg. Patients requiring 
renal replacement therapy were established on continuous venovenous hemofiltration 
at least 2 hours prior to starting the study. In all cases prostacyclin (2- 4ng.kg'1.min 1) 
was used as an anticoagulant and the infusion rate remained unchanged throughout 
the study period. During the study blood glucose concentration was measured hourly 
and maintained between 4 and 6 mmol.1-1 by dextrose infusion. No patients received 
enteral or parenteral nutrition during the 24 hours prior to or during the study. 
Data collection 
Arterial blood pressure was monitored with an indwelling radial or femoral artery 
catheter. Cardiac output and central venous pressure were monitored using a 
continuous cardiac output (CCO) pulmonary artery catheter (Baxter Vigilance 
system, Irvine, CA, USA). Correct positioning of the catheter was confirmed 
radiologically before the study commenced. This system provides a semicontinuous 
estimation of cardiac output by adding pulses of heat to right ventricular blood via a 
thermal filament every 30 -60 seconds. The resulting increase in blood temperature is 
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sensed by a thermistor at the catheter tip and cardiac output is calculated using the 
thermodilution principal (Munro et al 1994). The machine displays a running average 
of measurements made over the past 3 -6 minutes. Haemodynamic data were recorded 
to computer during the study period from the monitoring systems (Hewlett Packard 
Merlin, Palo Alto, CA, USA; Baxter Vigilance). 
Determination of oxygen consumption 
Direct gas exchange measurement: VO2 was measured with the Deltatrac metabolic 
monitor. For the remainder of the thesis this is termed VO2calorimetry. 
Calculation of oxygen consumption: The Fick method was used to calculate oxygen 
consumption index using the standard formula (refer to introduction). For the 
remainder of this thesis this is termed VO7Fick. 
A mean value for cardiac index was taken over a 10 minute period from the CCO 
recording for the calculation of oxygen consumption by the Fick method. This time 
period was chosen as a balance between maximising the number of averaged data 
points, and therefore the accuracy of cardiac output measurements, and avoiding 
spontaneous variations in cardiac output. At the midpoint of this period 2 ml samples 
of systemic and pulmonary arterial blood were drawn. The presence of an unwedged 
pulmonary artery pressure trace was confirmed prior to sampling and the mixed 
venous sample was aspirated over at least 30 seconds. Blood samples were analysed 
within 5 minutes of collection using an IL 482 cooximeter and an IL BGE 1400 series 
acid -base analyser (Instrumentation Laboratories, Lexington, MA, USA). The 
manufacturer quotes the accuracy (95% confidence intervals) of measurements as 
±1% (haemoglobin oxygen saturation), ±0.3g.d1 "1 (haemoglobin), and ± 0.22 kPa 
(oxygen tension, over the normal physiological range). 
Study protocol 
The study commenced after a stable baseline period of at least 30 minutes during 
which the range of cardiac output and VO2 values was less than 10% of the mean for 
the period. Patients in the N- acetylcysteine group received a loading dose of N- 
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acetylcysteine followed by an infusion according to the standard regimen widely used 
in the treatment of paracetamol overdose (Prescott et al 1979, 1989) and identical to 
the regimen used in the study by Harrison et al (1991): 150mg.kg' body weight in 
200 ml 5% dextrose over 15 minutes, followed by 50 mg.kg' in 500 ml 5% dextrose 
over 4 hours, followed by 100mg.kg' in 1 litre over 16 hours. Patients in the control 
group received volume -matched control infusions of 5% dextrose alone. 
The following study points were chosen for blood sampling over the 5 hour study 
period: baseline (prior to administration of N- acetylcysteine), 30, 60, 120, 180, and 
300 minutes after starting the infusion. At each study point blood was sampled from 
the arterial catheter and pulmonary artery catheter for determination of oxygen 
delivery and Fick -derived oxygen consumption. Arterial blood was drawn for acid - 
base, lactate measurements, and for measurement of plasma N- acetylcysteine 
concentrations 
Whole blood lactate concentration was measured using a YSI 2300 Stat Plus analyser 
(Yellow Springs Instrument Co, Yellow Springs, Ohio). A further sample was spun 
and the serum frozen at -60 °C for subsequent determination of N- acetylcysteine 
concentration. Ten minute averages were calculated for VO2, cardiac index, mean 
arterial pressure, and central venous pressure. DO2, OER, and systemic vascular 
resistance index (SVRI) were calculated using standard formulae (see Appendix 1). 
Data were indexed against body surface area. 
Measurement of N- acetylcysleine concentrations. 
N- acetylcysteine concentrations were batch analysed using the high performance 
liquid chromatographic method described by Lewis et al (1984) with modificatons 
described subsequently (Lewis et al 1985, Holdiness et al 1986). This work was 
carried out in the Edinburgh University Department of Clinical Chemistry by Dr David 
Jarvie. Plasma was diluted with water as required, and N- glycylglycine pre- reacted 
with 2,4-dinitrofluorobenzene was used as the internal standard. After reaction with 
dinitrofluorobenzene, the mixture was acidified with 0.5 ml of 1M HC1 before 
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extraction into ether. The glycylglycine and N- acetylcysteine derivatives were eluted 
in 2.8 and 5.3 minutes respectively. This method measures total oxidised and reduced 
N- acetylcysteine together with drug bound to other thiols and proteins. 
RESULTS 
Patient demographics and clinical data. 
Numbers Studied: In the available time 18 patients were enrolled into the study. 
Randomisation resulted in 11 allocations to the N- acetylcysteine group and 7 to the 
control group. 
Demographics and clinical data: Patient demographics, and baseline 
haemodynamic and gas exchange data are shown in table 3(1) . All patients had severe 
fulminant hepatic failure indicated by the prolongation of the prothrombin time, 
severity of encephalopathy, and high incidence of renal failure. Patients were 
characterised by a high cardiac output, high mixed venous oxygen saturation, low 
oxygen extraction ratio, and low peripheral vascular resistance. 
Analysis of Data 
The results of this study are considered in 2 separate sections each with a discussion: 
SECTION 1: 
Comparison between the reverse Fick method and indirect calorimetry for 
determining oxygen consumption in patients with,fulminant hepatic failure. 
SECTION 2: 
Analysis of the effect of N- acetylcysteine on oxygen transport and uptake in 
patients with fulminant hepatic failure. 
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TABLE 3.1: Patient characteristics and baseline measurements. All values are mean (sd) 
unless otherwise stated. No significant differences in physiological variables between 
groups. 
N- acetylcysteine Group Placebo Group 
Patients (no.) 11 7 
Age (yr) (mean [range]) 27 (16 -65) 31 (15 -54) 
Aetiology: Paracetamol 10 6 
NANB hepatitis 1 1 
Prothrombin time at time of study (sec.) 
(mean [range]) 
118 (59 -205) 120 (60 -200) 
Renal failure (creatinine >300 tmo1.1.') (no.) 8 3 
Patients requiring noradrenaline infusion (no.) 6 1 
FIO2 0.39 (0.09) 0.34 (0.08) 
PaO2 (kPa) 17.6 (4.8) 19.6 (4.2) 
PaCO2 (kPa) 4.6 (0.5) 4.5 (0.6) 
Haemoglobin concentration (g.1-1) 102 (13) 104 (19) 
Cardiac Index (1.min'.m 2) 5.6 (1.8) 4.7 (0.9) 
MAP (mmHg) 81 (16) 84 (8) 
SVRI (dyne.sec.cm "5.m 2) 1124 (525) 1381 (360) 
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SECTION ONE. 
Comparison between the reverse Fick method and indirect calorimetry 
measurements of oxygen consumption in patients with fulminant hepatic failure. 
Data 
In 14 patients 6 data pairs were collected. In 4 patients only 5 data pairs were 
collected giving a total of 104 data pairs. Missing data points occurred because of 
acute increases in intracranial pressure requiring altered ventilation and mannitol 
therapy (2 patients), severe hypotension requiring rapid changes in noradrenaline dose 
(1 patient), and transfer to the operating theatre for liver transplantation (1 patient). 
Agreement between methods of determining VO2 
The agreement between the two methods of measuring VO2 was compared using the 
Bland and Altman method (1986) which estimates the bias between the methods and 
the limits within which most differences are expected to lie. I determined whether the 
bias between the methods was dependent on the size of the VO2 measurement by 
calculating the correlation coefficient between the bias and the mean oxygen 
consumption for the 18 patients. 
It could not assumed that the oxygen consumption of individual patients remained 
constant throughout the study period so the repeatability of the two methods of 
measurement could not be assessed since this would attribute all differences to 
measurement error. 1 therefore compared the reproducibility of the two methods. The 
reproducibility of each method of measurement was assessed using one way analysis 
of variance (ANOVA) to calculate the within patients standard deviation (WPSD, 
So) of oxygen consumption measurements for the 18 patients (Bland and Altman 
1996). This is a measure of the dispersion of the measurements which results from 
both measurement errors and physiological variations in VO2 during the study period. 
As all data pairs were obtained simultaneously any physiological variability in VO2 
applied to both methods of measurement. The ratio of the WPSDs for the two 
techniques therefore compared dispersion attributable to measurement error alone and 
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enabled an estimation of the relative reproducibility of each method of measurement 
to be made. A similar approach has been used previously (Hanique et al 1994b). 
The dispersion of data obtained by the two methods was also illustrated by calculating 
the coefficient of variation ([SD /mean].100) of VO2Fick and VO2calorimetry for each 
patient. Coefficients of variation for cardiac output for each patient over the study 
period were also calculated. 
I ffect of mathematical coupling 
For the patients who received N- acetylcysteine D02 /V02 data pairs were plotted 
using both the VO2Fick and VO2calorimetry data and the slope of the relationship 
with each method of measurement calculated using linear regression analysis. In order 
to compare data with the study of Harrison and colleagues (1991) D02 /V02 slopes 
were calculated using the 3 data pairs from the first hour of the study as well as for 
the entire study period. To explore changes in VO2 with respect to time rather than 
D02, pooled VO2 data using each method of measurment was plotted for the N- 
acetylcysteine and control groups. 
Results 
Cardiorespiratory data for the patients is shown in table 3.2. In most patients only 
minor alterations in gas exchange and acid -base status occurred during the study 
period (table 3.3). 
Agreement between the methods. 
The Bland and Altman plot for the data is shown in figure 3.3. The mean bias between 
the methods of measurement was -41 ml.min-1m 2 (95% confidence intervals -35 to - 
47 ml.min -'.m 2) with VO2Fick less than VO2calorimetry, the precision (sd of the bias) 
was 30 ml.min "'.m2, the upper limit of agreement was +19 ml.min'.m 2 (95% 
confidence intervals +14 to +24 ml.min-'.m2 ), and the lower limit of agreement was - 
101 ml.min-'.m -2 (95% confidence interval -96 to -106 ml.min'.m 2). The bias varied 
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widely both within and between patients (table 3.4). There was no relationship 
between the mean bias and the mean VO2 for each of the 18 patients (r = 0.1) 
indicating that the size of the measurement was unlikely to influence the bias between 
the methods. 
Table 3.2: Cardiorespiratory data for the 18 patients with fulminant hepatic failure. All 
values mean (SD)[range]. 
Cardiac index 5.7(0.4) [3.4 -9.5] 
(L.miri I.m 2) 
Systemic vascular resistance index 1245(116) [519 -2142] 
(Dyne. sec. cm'5. m-2) 
Sa02 ( %) 99.1(0.3) [95.4 -100] 
Sv02 ( %) 86.7(1.0) [75.1 -92.0] 
Hb (g.L"') 101(3) [84 -127] 
Arteriovenous oxygen content difference 1.6(0.1) [1.0 -2.8] 
(mL.dL"') 
Reproducibility of the methods. 
The WPSD was 15 ml.min'.m 2 for the VO2Fick data and 7 ml.min'.m 2 for the 
VO2calorimetry data giving a ratio of 2.14. Over the study period the dispersion of 
measurements was greater for VO2Fick than VO2calorimetry in all the patients studied 
(figure 3.4). Cardiac output varied significantly over the period of measurement in 
some patients (figure 3.4). For the 18 patients, coefficients of variation for cardiac 
output correlated with those for both VO2Fick (r = 0.51, p <0.05) and VO2calorimetry 
(r = 0.76, p <0.001). 
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Table 3.3: Variation in arterial carbon dioxide tension (PaCO2), hydrogen ion 
concentration ([H+]), standard bicarbonate concentration ([SBC]), and arterial oxygen 
tension to fractional inspired oxygen ratio (PaO2/FIO2) in each patient during the 
study period. Mean (sd). 
Patient PaCO2 [H+] [SBC] PaO2 /FIO2 ratio 
(kPa) (nmol.1 -1) (mmo1.1.1) (kPa) 
1 5.47 (0.34) 72.0 (1.9) 14.6 (0.6) 39.7 (2.3) 
2 3.87 (0.27) 44.7 (0.8) 19.1 (0.4) 57.6 (2.5) 
3 4.53 (0.27) 41.9 (1.2) 21.9 (0.4) 48.0 (9.7) 
4 4.80 (0.27) 37.2 (1.5) 25.4 (0.8) 24.9 (4.9) 
5 4.53 (0.34) 30.8 (1.2) 28.9 (0.7) 62 (2.4) 
6 4.53 (0.13) 29.3 (0.8) 30.3 (0.8) 57.1 (2.3) 
7 4.80 (0.27) 53.8 (1.5) 17.7 (1.2) 39.2 (2.3) 
8 4.40 (0.13) 30.1 (2.1) 28.9 (1.4) 62.8 (2.9) 
9 5.07 (0.53) 27.0 (1.2) 26.3 (1.4) 52.1 (1.7) 
10 5.20 (0.67) 37.8 (3.9) 26.6 (1.0) 57.1 (12.8) 
11 4.13 (0.13) 54.9 (5.3) 16.4 (1.8) 63.1 (6.7) 
12 5.47 (0.27) 59.0 (2.9) 18.1 (0.5) 18.5 (2.8) 
13 4.27 (0.27) 34.0 (1.5) 25.5 (0.2) 61.2 (2.4) 
14 3.87 (0.27) 26.3 (1.2) 30.3 (0.4) 45.9 (6.1) 
15 4.13 (0.13) 35.1 (2.6) 24.6 (1.1) 61.6 (15.1) 
16 4.67 (0.27) 27.5 (1.4) 32.2 (0.9) 58.8 (8.0) 
17 4.40 (0.67) 57.1 (7.5) 16.1 (1.0) 37.6 (4.7) 
18 5.64 (0.43) 34.4 (1.9) 30.0 (0.3) 46.0 (1.3) 
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Effect of mathennatical coupling 
Table 3.5 shows the slopes of the D02 /V02 relationships for the patients who 
received N- acetylcysteine using either the first 3 data pairs alone or all data pairs. The 
spread of data around the best -fit slope was much greater for the VO2Fick data than 
for the VO2calorimetry data as indicated by the 95% confidence intervals for the 
slopes. Using only the first 3 data pairs the DO2 /VO2Fick slopes were significantly 
greater than the D02 /VO2calorimetry slopes [mean 16 (sd 22) vs 2(1), P <0.05]. There 
was a trend for the DO2 /VO2Fick slopes to be greater than the DO2 /VO2calorimetry 
slopes when data pairs for the entire study period were used but the difference was 
not statistically significant. D02/VO2Fick slopes were significantly greater when only 
the first 3 data pairs were used than when data for the entire study period were used 
[16(22) vs 7(8), P <0.05]. VO2calorimetry slopes were similar using either 3 or all data 
points. 
When pooled data for the patients were plotted with respect to time, there was a trend 
for VO2Fick data to increase during the first hour of the study period. This trend was 
not present for the VO2calorimetry data (figure 3.5). However, differences between 
the groups were not statistically significant. 
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Table 3.4: Summary of values for oxygen consumption measured by indirect 
calorimetry (VO2calorimetiy) and calculated by the Fick method (VO2Fick) in each 
patient (mean (sd)). The mean bias between the methods and variability which 





Range of bias 
(max,min) 
1 149 (5) 96 (27) -53 (29) -102, -16 
2 140 (6) 87 (6) -53 (5) -59, -46 
3 113 (6) 88 (16) 25 (15) -49, -11 
4 140 (4) 135 (23) -5 (11) -30, +35 
5 159 (7) 81 (12) -78 (14) -96, -60 
6 148 (4) 80 (8) -69 (9) -80, -55 
7 133 (7) 109 (8) -23 (11) -37, -10 
8 117 (4) 75 (4) -42 (7) -53, -32 
9 106 (6) 81 (16) -24 (10) -39, -11 
10 152 (10) 75 (22) -77 (29) -109, -40 
11 146 (7) 73 (13) -73 (7) -85, -67 
12 102 (3) 114 (9) +13 (13) -1, +26 
13 126 (7) 72 (9) -54 (7) -61, -44 
14 136 (6) 104 (8) -31 (6) -39, -22 
15 114 (16 91 (30) -23 (15) -34, +2 
16 130 (6) 61 (14) -68 (12) -85, -52 
17 122(5) 110 (17) -12 (15) -36, +1 

















































































































































































































































































































































































































































































































































































































The agreement between the two methods of measurement, VO2Fick and 
VO2calorimetry, was very poor in the patients studied. Using the Bland and Altman 
analysis the limits of agreement predicted that the two methods of measurement might 
differ by up to 130 ml.min-'.m-2. Measurement errors of this magnitude are highly 
significant. Neither of the methods which were used could be considered a "gold 
standard" and the poor agreement between them may have been attributable to errors 
with either of the techniques or because the methods were estimating different 
physiological variables. 
L'rrors associated with Fick calculations. 
Large errors can occur when cardiac output is determined by thermodilution using 
bolus injections of fluid (Stetz et al 1982, Pinsky 1990). The method used in the study 
was an automated thermodilution system in which errors due to injection technique 
are eliminated and the effect of random error is thought to be reduced by averaging 
multiple data points. It is generally assumed that this improves the accuracy of the 
method although most studies have only compared it with bolus thermodilution which 
is not itself a "gold standard ". Studies which have compared the Vigilance CCO 
system with bolus thermodilution have demonstrated good agreement between the 
two methods although the agreement may be worse in hyperdynamic patients 
particularly during periods of haemodynamic change (Mitsuo et al 1995, Boldt et al 
1994, Bottiger et al 1997). Bizouarn et al (1995) showed that the repeatability of 
VO2Fick was good in stable post cardiac surgery patients when cardiac output was 
measured with the Vigilance system and attributed this to the precision of cardiac 
output measurements. Despite using the same system for measuring cardiac output 
and taking an average measurement over 10 minutes the agreement between VO2Fick 
and VO2calorimetry was poor in patients with fulminant hepatic failure. 
Cardiac output was high, all the patients were sedated and paralysed, and oxygen 
extraction ratios were low. As a result most patients had an arteriovenous oxygen 
content difference consistently less than 2 ml.d1 -1. A possible source of error for SvO2 
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was aspiration of arterialised blood from the pulmonary artery catheter (i.e. 
oxygenated blood from pulmonary capillaries). However, I checked that the 
pulmonary artery pressure trace was unwedged prior to each sample and aspirated 
blood slowly which, in the presence of high pulmonary blood flows, made 
arterialisation unlikely. Blood oxygen content was calculated from measurements of 
haemoglobin oxygen saturation, oxygen tension, and haemoglobin concentration each 
of which has an associated measurement error. Inaccuracy attributable to storage and 
transport of samples and operator error was minimised by analysing them 
immediately. However, the accuracy of measurements was still limited by the 
precision of the cooximeter and blood gas analyser used. Errors in cooximeter 
measurements of oxygen saturation can be significant particularly for Sv02 which lies 
on the steep part of the haemoglobin- oxygen dissociation curve (Woda et al 1996, 
Beards et al 1994). Errors associated with haemoglobin concentration measurements 
may also be significant particularly if sample mixing is incomplete. These errors are 
randomly propagated and multiplied in the calculation of arteriovenous oxygen 
content difference such that errors in the final calcuation may be substantially greater 
than the sum of the measurement errors associated with each primary variable. This is 
likely to be particularly true when the arteriovenous oxygen content difference is 
small. In order to quantify the relative importance of this in VO2Fick calculations it is 
possible to derive a mathematical model as follows: 
Suppose during a period of sampling the true arteriovenous oxygen content difference 
does not change, then it is a reasonable assumption that the mean of a large number of 
arteriovenous oxygen content difference calculations is the true value, and that 
measurement errors will result in a range of values around the mean which should be 
normally distributed. If, for simplicity, the contribution of Pa02 and Pv02 which are 
usually very small, are excluded the formula for arteriovenous oxygen content 
difference (AV difference) is: 
AV difference = (1.34 x .Hb x Sa02) - (1.34 x Hb x Sv02) 
The errors in arterial and venous oxygen content can be subdivided on the assumption 
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approximately summate. 
Thus: Ea A=[EHb + Esa ][HbSa02 1.34] 




A: arterial oxygen content (ml.d1-1) 
V: venous oxygen content (ml.d1-1) 
Ear: maximrm1 error in arterial oxygen content estimation ( %, expressed as a 
fraction) 
Ei,: maximum error in venous oxygen content. estimation ( %, expressed as a 
fraction) 
EHb: error in hemoglobin measurement ( %, expressed as a fraction) 
ESa: error in SaO2 ( %, expressed as a faction) 
ES,,: error in Sv02 ( %, expressed as a fraction) 
Errors in AV difference can be defined as: 
and 
Eav=EaA+Ev V 
PEav = Eav 100 
A-V 
Where Ear, maximum absolute error in AV difference (ml.dl-1) 
PEau, maximum percent error in AV difference ( %) 
Combining equations 3 and 4 gives: 





i ms equation predicts the maximum errors which could occur with different levels of 
measurement error. The probability of this degree of inaccuracy is very small but 
allows the dispersion of errors which are likely to occur at different arteriovenous 
oxygen content differences to be compared. These maximum errors are illustrated in 
figure 3.6. This figure indicates that as the true arteriovenous oxygen content 
difference becomes progressively smaller, or as the level of measurement error 
increases, so the chance of a single arteriovenous oxygen content difference 
calculation from clinical measurements being close to the true value decreases 
disproportionately. In clinical practice when the arteriovenous oxygen content 
difference is small the cardiac output is usually large which further magnifies the 
errors in the final calculation of oxygen consumption. This is well illustrated by an 
example: 
Example 1: normal haemodynamic pattern. 
True Value Measured Value % Error 
SaO2 ( %) 98 97 1.0 
Sv02 ( %) 67 67.7 1.0 
Hb (g.1'') 12 12.3 2.5 
Arterial 02 content (mi.dl"') 15.8 16.0 1.3 
Venous 02 content (ml.dl-1) 10.8 11.2 3.7 
AV difference (ml.dl"') 5.0 4.8 4.0 
Cardiac Output (l.miri 1) 5.0 4.7 6.0 
V02 (ml.miri 1) 250 226 9.6 
Example 2: hyperdynamic pattern. 
True Value Measured Value % Error 
SaO2 ( %) 98 97 1.0 
Sv02 ( %) 85 85.9 1.0 
Hb (g.l "') 12 12.3 
2.5 
Arterial 02 content (ml.dl"') 15.8 16.0 
1.3 
Venous 02 content (ml.dl"') 13.7 14.2 
3.6 
AV difference (ml.dl"1) 2.1 1.8 
14.3 
Cardiac Output (1.miri 1) 12 11.3 
5.8 


















































































































































































In both examples the true VO2 is identical and the size of the errors in haemoglobin 
concentration, arterial oxygen saturation, and mixed venous oxygen saturation are similar 
and typical of the accuracy of most cooximeters used in clinical practice. The pattern of 
random errors is the same in both cases (haemoglobin and SvO2 overestimated, SaO2 and 
cardiac output underestimated). Although individual measurement errors are similar, 
greater propagation with the hyperdynamic doubles the error in VO2. 
A further source of error in VO2Fick calculations, which was considered in the 
introduction to this thesis, relates to the assumptions made about the combining capacity 
of haemoglobin with oxygen. Under optimal conditions a value of 1.39m1 02 per gram 
haemoglobin is appropriate, I used a value of 1.34 (which has been widely used during 
critical illness), and recently it has been suggested that 1.31 is more appropriate (Jolliet et 
al 1996, Nunn 1996). A lower value for this constant would have further increased the bias 
between the methods of measurement in the patients but would not have affected the width 
of the limits of agreement or the relative reproducibility of the methods. It is likely that the 
true value is not constant but varies both between and within patients at different times 
making this a significant source of inaccuracy. The accuracy of Fick calculations could be 
increased by directly measuring oxygen content in arterial and mixed venous blood, but the 
equipment and expertise required to carry out these measurements were not available for 
the present study and are rarely, if ever, used in clinical practice. 
Errors associated with indirect calorirnetry. 
The potential sources of inaccuracy with gas exchange measurements were discussed 
in Chapter 1, and clinical performance of the Deltatrac metabolic monitor described in 
Chapter 2. The highest FIO2 used in any of the patients in this study was 0.55 and no 
patients had severe lung injury. Fluctuation in FIO2 during inspiration was minimised 
by using Servo 900 ventilators (Tissot et al 1995). In order to detect leaks a careful 
check was made of the breathing system, and a check that the expired minute volumes 
displayed by the Deltatrac and ventilator corresponded consistently. These were 
therefore unlikely causes of significant error. 
Carbon dioxide stores in the body are large, exist in multiple forms, and in different 
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physiological compartments (Nunn 1977). These are normally in equilibrium but it 
may take 90 minutes after disruption of this steady state for equilibrium to be 
completely re- established although the majority of the process occurs within the first 
20 minutes as might be expected with a multiexponential process (Henneberg et al 
1987, Taskar et al 1995). During this time the accuracy of oxygen consumption 
measurements made with the Deltatrac may be reduced because gas exchange across 
the lungs is not identical to metabolic production by the body. In ventilated patients 
changes made to alveolar ventilation are the most common reason for disruption of 
the steady state but in the patients in this study ventilation was not changed unless 
clinically indicated and when this was necessary at least 1 hour was allowed to elapse 
before further data were collected. In addition patients were paralysed and sedated 
which eliminated spontaneous changes in minute ventilation and reduced spontaneous 
changes in oxygen consumption. Large changes in venous return and cardiac output 
may alter VCO2 and this could have influenced VO2calorimetry in some of the 
patients (Shibutani et al 1994). However there were no major changes in VCO2 even 
during periods of haemodynamic change suggesting that this was not a major source 
of inaccuracy during Deltatrac recordings. A further factor which might have 
disrupted steady state was altered acid -base balance. If the acid -base status of patients 
altered rapidly over the study period, carbon dioxide generated as a result of buffering 
rather than oxidative metabolism could have reduced the validity of VO2calorimetry. 
However, none of the patients received bicarbonate therapy during the study period, 
and hydrogen ion and standard bicarbonate concentrations did not alter significantly. I 
therefore consider it unlikely that this was a significant source of error. 
Kepiodrucihilily 
The estimation of reproducibility indicated that VO2Fick varied more because of 
measurement errors than VO2calorimetry; the ratio of the WPSD of VO2Fick relative 
to VO2calorimetry being 2.1. This was consistent with most of the disagreement 
between the methods being attributable to VO2Fick. The coefficients of variation for 
VO2Fick in individual patients were also substantially larger than for VO2calorimetry. 
It could be argued that these differences in reproducibility occurred because the 
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calorimeter was insufficiently sensitive to detect changes in oxygen consumption in 
response to altered delivery. However, Ronco and Phang (1991) showed that the 
Deltatrac metabolic monitor was able to accurately detect simulated changes in VO2 
made using a lung model, even at higher inspired oxygen fractions than those used in 
the present study. 
In a large mixed group of general intensive care patients Hanique et al (1994b) found 
the ratio of WPSDs of VO2Fick to VO2calorimetry was 1.4. The relative 
reproducibility of VO2Fick may have been better in their study because the mean 
arteriovenous oxygen content difference was larger than in our patients, although they 
do not document a value for this. Bizouarn et al (1995) found the repeatability of both 
methods of measurement was similar in patients studied following cardiopulmonary 
bypass. In that study the mean arteriovenous oxygen content difference was 4.1 ml.dl" 
', mean cardiac output was much lower and, unlike patients in the present study, 
measurements were obtained during a period of complete cardiorespiratory stability. 
The limits of agreement in the present study were +19 to -101 ml.miri'.m "2, which are 
wider than for any other published comparison of VO2Fick and VO2calorimetry, 
indicating very poor agreement between the methods. In previous studies the limits of 
agreement have been reported as ±52 ml.miri'.m 2 (mixed general intensive care 
patients)(Hanique et al 1994b), +3 to -33 ml.miri'.m 2 (post coronary artery bypass 
surgery)(Bizouarn et al 1995), and +27 to -61.5 ml.miri'.m 2 (patients with severe 
sepsis)(Esen et al 1996). These data further indicate the influence of haemodynamic 
pattern and clinical conditions on the relative accuracy of the different methods of 
determining VO2 and support the conjecture that gas exchange methods are preferable 
in hyperdynamic patients. 
In addition to measurement errors the methods may have given differing results 
because they were estimating different physiological parameters. Analysis of 
respiratory gases estimates whole body VO2 since gas exchange across non 
pulmonary surfaces is insignificant. In contrast Fick calculations utilize blood samples 
drawn from the pulmonary artery and a peripheral artery. Oxygen extracted from the 
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circulation between these points is therefore ignored. This may include pulmonary 
oxygen consumption since bronchial venous blood returns to the heart partly via the 
pulmonary veins. When data were pooled VO2Fick was significantly less than 
VO2calorimetry; this was also the case in all but one of the patients when examined 
individually. Most previous studies in humans which have compared VO2Fick with 
VO2calorimetry have similar findings (Bizouarn et al 1995,Takala et al 1989, Jolliet et 
al 1996, Esen et al 1996, Oudemans -van Straaten et al 1993, Myburgh et al 1992, 
Smithies et al 1991, De Backer et al 1994). In a study in pigs VO2Fick was less than 
VO2 measured by spirometry which is generally considered the "gold standard" for 
VO2 measurement (Stock and Ryan 1996) although, for reasons which are unclear, 
another similar study had opposite findings (Thrush 1996). A number of authors have 
suggested that the difference between measurements made with the techniques can be 
used to estimate pulmonary oxygen consumption (Jolliet et al 1996, Oudemans -van 
Straaten et al 1993, Light 1988). With this hypothesis Light (1988) demonstrated that 
pulmonary oxygen consumption increased during experimental pneumonia in dogs. 
More recently, Jolliet et al (1996) used this method to estimate pulmonary oxygen 
consumption in patients with ARDS. In the present study a systematic bias was found 
between the two methods of measurement, but this varied widely both within and 
between patients. A possible explanation for this observation was that pulmonary 
oxygen consumption was significant and varied over the 5 hour study period. 
However, this was an unlikely reason for the wide range of bias observed within 
patients because none had severe lung injury (in all cases lung injury score according 
to Murray et al (1988) was 51) or evidence of pneumonia at the time of the study, and 
in most gas exchange did not alter significantly during the study period. Variability in 
bias was also random during the study period which was not in keeping with an 
ongoing pulmonary inflammatory process. The magnitude of the median bias observed 
in some patients represented 50% of whole body VO2 measured by indirect 
calorimetry which seemed unlikely to be attributable to pulmonary oxygen 
consumption alone. The data most likely indicate that the measurement errors 
associated with this method of estimating pulmonary oxygen consumption are large 
and the clinical validity low, at least in patients with hyperdynamic circulations. The 
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repeatability of pulmonary oxygen consumption calculated in this way has not been 
estimated in published studies. 
Mathematical coupling 
When the VO2Fick data were used the slopes of the DO2 /VO2 relationships were 
greater than if the VO2calorimetry data were used. This was particularly the case 
when data from only the first hour of the study were used. Because VO2Fick data 
were less reproducible, the spread of data around the regression slopes was much 
greater than with VO2calorimetry. The likely explanation for the discrepancy between 
the methods of measurement is mathematical coupling. Taken alone the VO2Fick data 
indicated significant supply dependency in most patients, particularly if confidence 
interval for the slopes were not considered. Harrison and colleagues (1991) pooled 
data and compared 2 data points during the first hour of N- acetylcysteine 
administration. With respect to time the data from the present study indicated that the 
discrepancy between VO2Fick and VO2calorimetry was greatest during this first hour 
which, as will be described in the second section of this chapter, was the period during 
which most alteration in cardiac output occurred. The classic description of how 
mathematical coupling causes an artificial positive relationship between oxygen 
delivery and consumption was made by Archie (1980). Archie used a random number 
generator to produce simulated random data for cardiac output and arteriovenous 
oxygen content difference and plotted the data against one another, which generated a 
random scattergraph (figure 3.7). However, when the product of each data pair was 
calculated, in the same way real data are used to calculate oxygen consumption using 
the reverse Fick method, re- plotted data for cardiac output and VO2Fick were no 
longer random , but generated a significant positive relationship with a product 
moment correlation coefficient close to 0.7. This phenomenon occurs because of 
mathematical coupling and is closely analogous to plotting an oxygen 
delivery/consumption relationship in critically ill patients using the reverse Fick 
method. What has remained unclear in the critical care literature is whether this effect 
explains completely the apparent pathological supply dependency frequently 
documented in critically ill patients. 
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There are problems with the explanation of mathematical coupling put forward by 
Archie (1980) as it stands. In practice patients are not "random number generators" 
and cardiac output and arteriovenous oxygen content difference are physiologically 
coupled. Thus, under conditions of constant VOZ, as cardiac output and oxygen 
delivery increase so less tissue should be extracted by the tissues per volume of blood 
delivered and the arteriovenous oxygen content difference should decrease. However, 
there are 2 mechanisms whereby D02/V02 data may tend to behave like random 
numbers: 
Pooling of data: If data from more than one patient are superimposed and 
plotted together and then the relationship analysed, there is a strong tendency for the 
result to be a positive correlation. The relationship between the variables in individual 
patients may be obscured such that the conclusions drawn from the pooled data are 
different from the true relationships in individuals. This is likely for oxygen kinetics 
data because patients with low oxygen consumption tend to have low oxygen delivery 
and patients with high oxygen consumption tend to have high oxygen delivery. This is 
not a pathological phenomenon but simply the normal physiological matching between 
demand and supply (Weissman et al 1984, 1991, Boyd et al 1992). 
Large measurement errors: The reverse Fick method should accurately determine 
oxygen consumption by the body (with the possible exception of the lungs as 
described previously) as long as all the measurements made are completely accurate. 
In practice this is never the case because all clinical measurements have an associated 
measurement error. I have clearly shown in this study that measurement errors 
associated with VO2Fick measurements were large in the patients with fulminant 
hepatic failure, and investigated the reasons for this using a simple mathematical 

























































































































































































































































































































which are physiologically linked, such as cardiac output and arteriovenous oxygen 
content difference, will behave increasing like random data such that the confounding 
effect of mathematical coupling becomes stronger. In the present study the technology 
used for cardiac output measurement should have resulted in a high degree of 
accuracy, and published work suggests that the repeatability of this technique is good 
(Bizouarn et al 1995). I have hypothesised that much of the error lies in the 
calculation of arteriovenous oxygen content difference because this difference was 
small in virtually all patients. If this were the case the effect of mathematical coupling 
in individual patients should be greatest during the period of greatest change in 
cardiac output because, in effect, VO2Fick mirrors cardiac output. In the 11 patients 
who received N- acetylcysteine cardiac output varied most during the first hour of the 
infusion. This was also the same period after starting N- acetylcysteine that was 
studied by Harrison et al (1991). The data in the present study confirm the hypothesis 
that, in hyperdynamic patients, the effect of coupling is greatest during periods of 
changing cardiac output because D02/VO2Fick slopes were significantly greater for 
the first hour than for the whole study period. This also explains why the discrepancy 
between VO2Fick and VO2calorimetry with respect to time was greatest during the 
first hour after starting N- acetylcysteine administration. 
A third mechanism whereby mathematical coupling might cause a positive correlation 
which was a mathematical artefact relates to studies in which the relationship between 
oxygen delivery and consumption was studied by inducing an increase in oxygen 
delivery and examining its effect on oxygen consumption. An example of this was the 
use of an "oxygen flux test" to reveal oxygen debt (Vincent et al 1990). With this 
approach oxygen delivery and oxygen consumption were calculated before and after 
an intervention, usually an infusion of dobutamine, which increased cardiac output. If 
following a clinically significant increase in oxygen delivery an increase in oxygen 
consumption had occurred, this was considered indicative of pathological oxygen 
supply dependency and the need to maintain a higher level of oxygen delivery to 
reduce tissue hypoxia. These studies generally chose a positive change as an endpoint 
and as a result may have been biased toward selecting positive measurement errors, ie. 
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over -estimations of cardiac output. As any error in cardiac output is transmitted to 
VO2Fick this causes systematic overestimation of VO2. The net result is an impression 
that DO2 and VO2 are positively correlated variables whereas in fact the relationship 
may be wholly artificial. As a specific change in DO2 or cardiac output was not 
targetted in the present study this mechanism of mathematical coupling was not 
relevant. 
Conclusions 
1) The agreement between the reverse Fick method and indirect calorimetry for 
determining oxygen consumption in patients with fulminant hepatic failure is very 
poor. 
2) There is a systematic bias between the methods of measurement whereby oxygen 
consumption calculated using the reverse Fick method is less than that measured by 
indirect calorimetry. This bias is highly variable within and between patients. 
3) The poor agreement between the methods is mostly attributable to the inaccuracies 
associated with the reverse Fick method. This is most likely explained by the 
propagation of measurement errors in patients with a hyperdynamic haemodynamic 
pattern combined with a small arteriovenous oxygen content difference. 
4) When measurement errors are large the potential for mathematical coupling error, 
when examining the relationship between oxygen delivery and consumption using the 
reverse Fick method, is great. 
5) The findings of Harrison and colleagues that N- acetylcysteine increases VO2 in 




The effect of N- acetylcysteine on oxygen transport and uptake in patients with 
fulminant hepatic failure 
Data 
In view of the findings discussed in the first part of this chapter indirect calorimetry 
measurements of oxygen consumption were used for analysis. 
Analysis of Data 
Effect of N- acetylcysteine on haemodynannic variables: The mean cardiac index, 
mean arterial pressure, and systemic vascular resistance index were calculated for a 10 
minute period at baseline minus 30 minutes, baseline, and each hour for 5 hours after 
starting N- acetylcysteine or placebo infusions. Pulmonary artery wedge pressure was 
measured every 30 minutes. 
Effect of N- acetylcysteine on VO2 and OER: In each patient who received N- 
acetylcysteine the 6 data pairs were used to construct a D02 /VO2 relationship, and 
linear regression analysis was used to calculate the slope of each line. The 
relationship was considered significant if the slope was significantly different from 
zero at the P <0.05 level. The same method of analysis was used to examine the 
relationship between DO2 and the OER. Changes in VO2 and OER from baseline in 
relation to time were plotted for both the N- acetylcysteine and placebo groups. 
Effect of N- acetylcysteine on indirect markers of tissue hypoxia: Changes in base 
excess and whole blood lactate from baseline in relation to time were plotted for each 
patient. 
Relationship between plasma N- acetylcysteine levels and haemodynamic changes: 
For patients who received N- acetylcysteine, the relationship between the peak (30 
minutes) and plateau (300 minutes) plasma N- acetylcysteine concentrations and 
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changes in haemodynamic variables from baseline were examined by calculating the 
Pearson product moment correlation coefficients. 
Statistical analysis: Changes in haemodynamic variables, DO2, VO2, OER, base 
excess, and whole blood lactate concentrations over the study period were compared 
with baseline values within each group. Changes for these variables were compared 
between the N- acetylcysteine and placebo groups by calculating the area under the 
curve (AUC) for each patient in relation to time for the 5 hours of the study. Each 
hour of the study period and the incremental AUCs were compared. Non parametric 
tests were used applying Bonferroni's correction for multiple significance tests as 
appropriate. P <0.05 was considered statistically significant. 
Results 
Baseline data indicated that patients were haemodynamically stable prior to receiving 
the N- acetylcysteine or placebo infusions (table 3.6). Pulmonary artery blood 
temperature did not alter significantly in either group over the study period (N- 
acetylcysteine group: baseline mean (sd) 36.4 °C (0.6), 5 hours 36.8 °C (1.1); placebo 
baseline 36.5 °C (0.5), 5 hours 36.4 °C (0.5)). 
Hammodynamic changes. Patients exhibited a variable response to N- acetylcysteine 
and there were clear responders and non -responders within the group (figures 3.8 and 
3.9). Overall, in comparison to baseline no statistically significant changes in cardiac 
index occurred over the study period either within the N- acetylcysteine or placebo 
groups. Comparison of AUCs between the groups indicated a trend towards an 
increase in cardiac output over the first 4 hours after starting N- acetylcysteine (figure 
3.8). However, this trend was not statistically significant for any individual hour of 
the study or comparing incremental AUCs. Mean arterial pressure did not change 
significantly from baseline at any time point over the study period in either group and 
AUC analysis revealed no differences between the groups. Systemic vascular 
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resistance index decreased at 60 minutes in comparison to baseline in the N- 
acetylcysteine group, but AUC analysis revealed no differences from the placebo 
group at any time point (figure 3.9). The mean pulmonary artery wedge pressure was 
slightly lower in the placebo group but this was not statistically significant and values 
remained constant over the study period (figure 3.9). 
Effect of N- acetylcysteine on VO2 and oxygen extraction. The DO2 /VO2 relationship 
for each patient who received N- acetylcysteine is illustrated in figure 3.10 and 
summarised in table 3.7. Delivery- dependent oxygen consumption, defined as a slope 
which was significantly different from zero, was present in only 3 patients. There was 
no relationship between the slope of the DO2 /VO2 relationship and either the baseline 
lactate concentration or base excess (table 3.7). There was no difference between 
patients receiving noradrenaline or prostacyclin during the study period and those 
who did not, although numbers for comparison were small. Oxygen extraction ratio 
was low in the patients and changes in response to altered oxygen delivery were small. 
Despite this, in 10 patients the OER decreased significantly as oxygen delivery 
increased (figure 3.11 and table 3.7). 
In relation to time a statistically significant, but clinically insignificant increase in 
oxygen consumption occurred in comparison with baseline values in the N- 
acetylcysteine group at 30 minutes (median increase 7 ml.miri'm 2, P <0.05) and at 60 
minutes (median increase 7 mi.miñ'.m 2, P <0.05)(figure 3.12). There were no 
significant changes in oxygen consumption in comparison to baseline values in the 
placebo group. AUC comparison between the groups demonstrated no significant 
differences for any hour of the study or comparing incremental AUCs. There was a 
trend for DO2 to increase in the N- acetylcysteine group both in relation to baseline 
and in comparison to the placebo group (figure 3.12). These changes were related to 
changes in cardiac output, and as with cardiac output, were not statistically 
significant. OER, base excess, and whole blood lactate concentrations did not change 
significantly over the study period either in relation to baseline values or in 
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Figure 3.8: Values for cardiac index over the study period 
for each patient with relation to time. 
Individual patient data shown in interrupted lines. 
Mean group data solid lines. No significant differences 
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Figure 3.9: Changes in mean arterial pressure (MAP) and systemic vascular 
resistance index (SVRI), and pulmonary artery wedge pressure (PAWP) 
for the two groups. Triangles N- acetylcysteine, circles control groups. All values 
median (interquartile range). * P <0.05 within N- acetylcysteine group compared 
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Figure 3.10: 
Relationship between oxygen delivery 
index (x -axis, ml.min l.m ) and oxrgen 
consumption index (y -axis, ml.min .m 2) 
for each patient who received 
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Figure 3.11: 
Relationship between oxygen delivery 
index (x -axis, ml.min l.m ) and oxygen 
extraction ratio (y -axis, %) for 
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Figure 3.12: Changes in oxygen delivery (DO2), oxygen consumption (VO2) 
and oxygen extraction ratio (OER) with respect to time in the 
patients who received N- acetylcysteine (triangles) and placebo (circles) 
infusions. All values medians (interquartile ranges). * p <0.05 compared to 












I 1 I I 1 1 
0 1 2 3 4 5 
Time (hour) 
Figure 3.13: Changes in whole blood lactate concentration and 
base excess with relation to time during the study period. 
No significant differences between the groups. 
Triangles N- acetylcysteine group; circles control group. 
All values median (interquartile range) 
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Plasma N- acetylcysteine concentrations. N- acetylcysteine concentrations over the 
study period for each of the 11 patients are illustrated in figure 3.14. No correlations 
existed between changes in mean arterial pressure, cardiac output, or systemic 
vascular resistance from baseline, and peak (30 minutes) or plateau (300 minutes) 
plasma N- acetylcysteine concentrations. No relationship was found between changes 

































































































































The results of this study differ markedly from those of Harrison et al (1991) who 
observed a mean increase in VO2 calculated by the Fick method of 46% 30 minutes after 
starting N- acetylcysteine. There are several possible explanations for the discrepancy 
between the studies. As indicated in the introduction to this thesis, the methodology used 
in oxygen kinetics studies in the critically ill influences the validity of the data obtained. 
Harrison et al (1991) used the Fick method to calculate VO2 from the cardiac output and 
arteriovenous oxygen content difference and pooled data from all patients for analysis. In 
the first part of this chapter it was shown that the accuracy and reproducibility of the 
reverse Fick method in patients with fulminant hepatic failure is poor. Under these 
circumstances I have argued that the confounding effect of mathematical coupling is 
increased, particularly if few data pairs are used to construct a D02 /V02 relationship and 
if data are pooled. For this reason indirect calorimetry data were primarily used in this 
part of the data analysis. 
A further source of error in oxygen kinetics studies is spontaneous variability in VO2 in 
response to altered oxygen demand by the tissues (Weissman et al 1984 and 1991) which 
may occur in response to virtually any clinical intervention and can mimic oxygen supply - 
dependency (Boyd et al 1992). In the present study only paralysed and sedated patients 
were included in order to reduce spontaneous variability in VO2 and fulfil recent 
recommendations for the design of oxygen kinetics studies (Pinsky 1994). In the study by 
Harrison et al (1991) some patients were spontaneously breathing and sedation usage was 
not specified. Using the chosen definition of supply- dependence only 3 of the 11 patients 
who received N- acetylcysteine had a significant positive relationship between DO2 and 
VO2. The most significant delivery- dependence observed predicted a 13 ml.min."i.m2 
increase in VO2 when DO2 increased by 100 ml.mii l.m "2. Changes in VO2 of greater than 
10 -20 ml.min 1 .1T1-2 in response to altered DO2 have been considered indicative of 
clinically relevant supply- dependency (Dhainaut et al 1990). This was not observed in 
any of the patients despite the large range in DO2 observed during the study period in 
most cases. Increases in VO2 of the order observed in the present study occurring in 
association with increased DO2 may be a normal physiological phenomenon because of 
the increase in myocardial oxygen requirement which accompanies increased cardiac 
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work. 
Harrison et al (1991) found that prostacyclin significantly increased DO2 and VO2 in 
patients with fulminant hepatic failure, and observed a synergistic effect between 
prostacyclin and N- acetylcysteine in improving DO2 and VO2. In the present study 8 of 
the 11 patients who received N- acetylcysteine were also receiving prostacyclin infusion 
for anticoagulation during haemofiltration, but despite the concurrent use of both drugs, 
clinically significant supply -dependency was not observed in any individuals. A substantial 
increase in DO2 and VO2 during prostacyclin administration was first described in patients 
with sepsis and was most marked in patients who subsequently died (Bihari et al 1987). 
These findings have not been reproduced in subsequent studies which used either the 
reverse Fick method (De Backer et al 1993) or respiratory gas analysis (Hannemann et al 
1994) to determine oxygen uptake. Bihari has suggested that the results of his study were 
confounded by inadequate fluid resuscitation and by mathematical coupling (Smithies and 
Bihari 1993) and it is possible that similar factors applied in Harrison and colleagues 
studies in fulminant hepatic failure. 
Harrison et al (1991) found that N- acetylcysteine increased oxygen extraction 30 minutes 
after starting administration. In the present study we observed no improvement in oxygen 
extraction during 5 hours of infusion and observed significant decreases in OER in 
response to increased DO2. It is possible that the discrepancy reflects differences between 
the patients studied. In the present study 6 patients who received N- acetylcysteine 
required noradrenaline in order to maintain a mean arterial pressure of >_60mmHg but the 
mean SVRI in the N- acetylcysteine group was still less than in those patients studied by 
Harrison and colleagues none of whom required vasopressor support (1123 vs 1221 
dyn.sec.cm"S.m 2). An inability to increase VO2 in response to increased tissue perfusion 
is a strong predictor of poor outcome in critically ill patients (Hayes et al 1993, Hayes et 
al 1997). Some of the disparity in results may have been because patients in the present 
study were more severely ill. It is possible that, despite randomisation, patients in the 
control group had less severe disease because fewer received noradrenaline or renal 
replacement therapy at the time the study was performed. However, at baseline there 
were no significant differences between the groups in haemodynamic pattern, gas 
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exchange data, or prothrombin time and the method of data analysis examined changes 
both within and between groups. Overall, the data do not support the hypothesis that N- 
acetylcysteine improves global measures of tissue oxygen extraction or uptake either 
through delivery dependent or independent mechanisms in patients with fulminant hepatic 
failure. 
There was a variable haemodynamic response to N- acetylcysteine. In some patients 
cardiac output clearly increased although changes within and between the groups were 
not statistically different. In view of the relatively small numbers of patients in each group 
this could reflect type II error, although a heterogeneity of response was clearly present. 
Similar observations have been made in patients with liver dysfunction other than 
fulminant hepatic failure (Devlin et al 1997) and in patients with sepsis (Spies et al 1994, 
Rheinhart et al 1995) in whom an inconsistent response to N- acetylcysteine occurred, 
although in these studies the authors only made measurements 60 -90 minutes after 
starting the infusion. In patients with sepsis in whom cardiac output increased a lower 
mortality was observed in comparison with non -responders (Spies et al 1994), and it is 
possible that disease severity is a determinant of the haemodynamic response to the drug. 
If patients in the present study were sicker than those in the study by Harrison and 
colleagues (1991) this could explain why haemodynamic changes were less marked; 
significant increases in cardiac output, mean arterial pressure, and left ventricular stroke - 
work index (LVSWI) were all documented 30 minutes after starting the N- acetylcysteine 
in the earlier study. In the present study cardiovascular status was monitored for 5 hours. 
Previous studies in patients with sepsis syndrome (Spies et al 1994) and septic shock 
(Galley et al 1997) observed only transient cardiovascular changes after starting N- 
acetylcysteine, occurring during the first hour of infusion. These changes occurred when 
plasma concentrations of N- acetylcysteine are high following the loading dose. The data 
in the present study support the hypothesis that these changes are unpredictable and are 
not sustained during subsequent infusion. A recent small, randomised, controlled, double 
blind trial in patients with septic shock suggested that N- acetylcysteine actually depressed 
cardiac function over a 48 hour period (Peake et al 1996). The contrast between the 
immediate and delayed effects of the drug indicate the importance of evaluating its 
therapeutic actions over a prolonged period. 
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I chose not to calculate derived indices of cardiac function such as stroke volume index 
and LVSW1 in the present study and focus on primary physiological measurements. Both 
stroke volume and stroke work have been widely used in the critical care literature to 
examine changes in cardiac function. However, these calculated variables are highly 
dependent on both cardiac preload and afterload and are poor indices of contractility 
(Parrillo 1993, Walley 1997). This is particularly the case during administration of drugs 
which have vasodilatory properties such as N- acetylcysteine. 
There was no relationship between the total plasma N- acetylcysteine concentration and 
changes from baseline in any of the physiological variables examined. This was not 
entirely unexpected. The paucity of information regarding the metabolism and active 
forms of N- acetylcysteine in vivo was considered in the introduction to this chapter. It 
would have been interesting to measure reduced and oxidised forms of N- acetylcysteine, 
plasma cysteine concentrations, and reduced and oxidised plasma glutathione 
concentrations, but the facilities were unavailable. It is also likely that intracellular 
concentrations of these substances are of greater relevance than plasma concentrations. 
A wide range of plasma concentrations was found in the patients despite using a 
standardised infusion regimen. In addition, the peak concentrations were lower than 
those typically found in patients treated within 20 hours of paracetamol overdose 
(Prescott et al 1989). The study was not designed for pharmacokinetic analysis and 
insufficient samples were collected to enable this. Reduced peak plasma concentrations 
may have occurred because of enhanced metabolism or an increase in the volume of 
distribution of the drug in fulminant hepatic failure. The drug is primarily distributed into 
extracellular water (Borgstrom et al 1986, Olson et al 1988) and it is likely that in patients 
with fulminant hepatic failure, in whom oedema secondary to capillary leak is a frequent 
feature, the volume of distribution of the drug is increased. The data in this study indicate 
the need for pharmacokinetic and pharmacodynamic studies of N- acetylcysteine in 
critically ill patients in order to utilise this drug appropriately. 
This study indicates that global improvements in tissue oxygen delivery and uptake are an 
unlikely mechanism of action of N- acetylcysteine in patients with severe fulminant hepatic 
failure. This conclusion contrasts with that of Harrison and colleagues (1991) and I have 
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argued that there were many confounding factors in that study. My conclusion is in 
keeping with recent work which suggests that pathological oxygen supply dependency 
does not exist in most resuscitated critically ill patients (Russell and Phang 1994, Gasman 
et al 1996) and that optimising haemodynamic variables to supranormal physiological 
levels does not confer any survival benefit (Hinds and Watson 1995, Heyland et al 1996). 
Conclusions 
1) Clinically significant pathological supply dependency is not present during N- 
acetylcysteine infusion in patients with fulminant hepatic failure. Methodological 
factors explain many of the contradictory results of earlier studies. 
2) N- acetylcysteine infusion does not improve global indices of tissue oxygenation in 
patients with fulminant hepatic failure. 
3) The place of N- acetylcysteine in the treatment of critically ill patients is unclear, 
and the mechanism of action of the drug incompletely understood. 
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CHAPTER 4 
ENERGY EXPENDITURE IN FULMINANT HEPATIC FAILURE 
OBJECTIVES 
The objectives of this chapter were: 
I) To measure energy expenditure in a homogeneous group of patients with 
paracetamol -induced fulminant hepatic failure. 
2) To compare this group of patients with healthy control subjects and with physically 
anhepatic patients studied during liver transplantation. 
3) To investigate the clinical determinants of energy expenditure in patients with 
paracetamol- induced fulminant hepatic failure. 
4) To investigate the value of predictive formulae for estimating energy requirements 
in patients with fulminant hepatic failure. 
5) To investigate the nature of the acute phase response in patients with paracetamol - 
induced fulminant hepatic failure and its relationship to energy expenditure. 
BACKGROUND 
There is a large literature concerning the effect of many types of critical illness on 
energy expenditure (Chiolero et al 1997, Burzstein et al 1989). These indicate that 
increases of the order of 30 -50% over resting energy expenditure are associated with 
multiple trauma and sepsis. There is, however, only one previous study which 
examines energy expenditure in patients with acute liver failure (Schneeweiss et al 
1993). The factors which influence energy expenditure in acute hepatic failure are 
extremely complex in comparison with other forms of critical illness. The liver 
normally accounts for approximately 25% of basal metabolic rate (Ganong 1991). 
These figures are consistent with the decreases in whole body oxygen consumption 
typically observed following hepatectomy in patients with chronic liver disease 
undergoing liver transplantation (Svensson et al 1989). The metabolic function of the 
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liver is severely deranged in fulminant hepatic failure as evidenced by the profound 
decreases in synthetic and detoxification functions which accompany the condition. It 
has been estimated that at least 85% of functioning liver cell mass is destroyed in 
fulminant hepatic failure (Ramsoe et al 1980). It might therefore be anticipated that a 
decrease in energy expenditure accompanies this condition. Patients with fulminant 
hepatic failure frequently demonstrate clinical features of a stress response such as 
fever and tachycardia. Severe fulminant hepatic failure is frequently accompanied by a 
high cardiac output, low systemic vascular resistance and hypotension, similar to 
patients with septic shock in whom energy expenditure is increased (Voerman et al 
1993). Complications such as acute renal failure, infection, cerebral oedema, and 
tissue hypoperfusion may each have an effect. Finally, treatments such as mechanical 
ventilation, sedation, and vasopressor drugs all influence metabolic rate (Chiolero et al 
1997). 
In their study in patients with acute liver failure, Schneeweiss and colleagues (1993) 
examined 12 patients with acute liver failure of variable severity. The degree of 
encephalopathy varied between 1 and IV and prothrombin time from 31 to >160 
seconds. Only one patient required haemodynamic support with vasopressor drugs 
and cardiac output was not measured in any cases. Only one patient was undergoing 
mechanical ventilation and it is unclear if any patients received sedative drugs. The 
aetiology of liver failure was hepatitis B (5), Amanita phalloides poisoning (3), non -A 
non -B hepatitis (3), and halothane hepatitis (1). The principal findings of the study 
were that energy expenditure was increased by approximately 30% in patients with 
acute hepatic failure in comparison with matched healthy control subjects. 
Several questions are raised by this well -conducted study. Firstly, do patients with 
paracetamol- induced fulminant hepatic failure have a similar level of energy 
expenditure. The mechanism of hepatic injury is different in these patients (Flanagan 
and Meredith 1991) and the onset of disease is frequently more rapid than in viral 
hepatitis. The different criteria associated with poor outcome for paracetamol and 
non -paracetamol induced fulminant hepatic failure reflect these differences (O'Grady 
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et al 1989). Secondly, patients with Grade III or IV encephalopathy resulting from 
paracetamol -induced fulminant hepatic failure are usually tracheally intubated and 
mechanically ventilated for airway protection, and to facilitate monitoring and 
treatment. Energy expenditure under these circumstances may be altered by the 
administration of drugs or vasopressor agents. The determination of energy 
expenditure is clinically relevant to the administration of nutrition in these patients, 
particularly as hepatic handling of substrate is likely to be significantly impaired. 
MATERIALS AND METHODS 
Patients 
16 patients with paracetamol- induced fulminant hepatic failure were studied. All 
patients were in grade 111 /1V hepatic encephalopathy and receiving mechanical 
ventilation via an endotracheal tube using a Servo 900C ventilator. All patients were 
sedated with propofol (1- 2mg.kg'.hour') and alfentanil (10 -40 tg.kg"1.hour "1) by 
infusion and were paralysed with atracurium (0.5- 1.5mg.kg'.hour'). Blood pressure 
was monitored continuously using an indwelling arterial catheter and cardiac output 
was measured semi -continuously using a pulmonary artery catheter and cardiac output 
computer (Baxter Vigilance system). Patients were studied within 24 hours of 
instituting mechanical ventilation following resuscitation with fluids and 
vasoconstrictors as clinically indicated. Studies were only performed during periods of 
cardiovascular stability when changes in haemodynamic support were not required. 
Patients who required renal support were receiving continuous venovenous 
haemofiltration throughout the study period. 
Energy Expenditure Measurements 
Metabolic measurements were made with the Deltatrac metabolic monitor. Prior to 
each measurement the machine was calibrated against a standard gas mixture (95% 
oxygen, 5% carbon dioxide) and ambient barometric pressure. Calibration was also 
checked 3 monthly using an alcohol burning test. 
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Ventilated patients: Measurements were made in the respirator mode using 
inspiratory gas sampling and collection of all expired gas from the ventilator. A 
careful check for leaks in the system or around the endotracheal tube was made prior 
to commencing measurement and no changes to FI02 or ventilator settings were made 
during, or for one hour preceding, the measurement period. 
Spontaneously breathing subjects: Volunteers were studied following an overnight 
fast in a quiet thermoneutral room with subjects supine and breathing air. 
Measurements were made in the canopy mode for a total of 40 minutes (10 minutes 
acclimatisation, 30 minutes steady state measurement). 
After measurements had reached a steady state oxygen consumption, carbon dioxide 
elimination, and respiratory quotient (RQ) were measured each minute for 30 minutes 
and the mean energy expenditure calculated for the period. Interventions known to 
alter oxygen consumption in ventilated patients such as physiotherapy, tracheal 
suction, and turning (Weissman et al 1984) were not carried out during or for one 
hour prior to metabolic measurements. Previous studies have shown that a 30 minute 
period of measurement approximates closely to total energy expenditure in critically ill 
patients, particularly under conditions of coma and deep sedation (Weissman et al 
1986, Frankenfield et al 1994). 
At the start of each 30 minute study period hemodynamic variables and pulmonary 
artery temperature were recorded, and arterial blood was sampled and analysed for 
whole blood lactate concentration and acid -base status using a YSI 2300 Stat Plus 
analyser and an IL BGE 1400 series respectively. All measurements were carried out 
within 5 minutes of sample collection. No patient received parenteral or enteral 
nutrition during the 12 hours prior to or during the study. If required intravenous 
glucose was administered to keep blood glucose concentration between 4- 6mmo1.1 -1. 
Energy expenditure for each subject was expressed in kJ.kg-1.hour 1. In addition to 
raw data a temperature -corrected estimation of energy expenditure was calculated for 
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each patient in the fulminant hepatic failure and anhepatic liver transplant groups 
using a correction factor of 10% per °C in accordance with the study by Manthous et 
al (1995). Predicted resting energy expenditure was also calculated for each of the 
patients with fulminant hepatic failure using the Harris -Benedict equation, and 
corrected to 37 °C using the same algorithm. 
Control Groups 
Liver Transplantation: 16 patients undergoing uncomplicated elective liver 
transplantation were studied. In all cases the piggyback surgical technique was used. 
Inferior vena caval blood flow was maintained throughout the anhepatic period by use 
of a side -clamping vena caval clamp and portal venous drainage was maintained in all 
cases via a temporary portacaval shunt. During the period of measurement all patients 
were anaesthetised using propofol (6mg.kg'.hour'), alfentanil (30- 401.tg.kg"'.hour1), 
and midazolam (0.2mg.kg'.hour') by infusion and muscle paralysis was maintained 
with atracurium (0.5- 1.5mg.kg'.hour'). All patients received dopamine 2- 3µg.kg" 
'.miñ' throughout the procedure. The mean energy expenditure for a 30 minute 
period from 10 to 40 minutes after the start of the anhepatic period (defined as the 
time of application of the inferior vena caval clamp at the level of the hepatic veins) 
was calculated. Raw data were corrected to 37 °C using the same algorithm described 
above. 
Healthy volunteers: 16 healthy volunteers were studied. Subjects were chosen to 
represent an age and sex matched control group with reference to the fulminant 
hepatic failure patients. 
Measurements of Cytokines and C- reactive protein (CRP) concentrations. 
CRP, IL -6, and TNF concentrations were measured in 10 of the patients with 
paracetamol -induced fulminant hepatic failure, and in a group of 6 healthy subjects 
matched for age and sex. Control subjects in this part of the study were selected at the 
time batch analyses were performed and were different from those in whom energy 
expenditure was measured. 
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Blood was drawn from the arterial catheter and immediately centrifuged. Serum was 
divided into aliquots and stored at -60 °C for subsequent analysis. 
Cytokine Assays 
Measurement of IL -6 and TNF. 
Measurement of IL -6 and TNF in plasma was performed by enzyme -linked 
immunosorbent assay (ELISA)(Goldie et al 1995). For IL -6, microtitre plates (Costar, 
High Wycombe, UK) were coated with monoclonal anti -IL -6 antibody (Boerhinger- 
Mannheim) at 2.tg.ml "' in 50mM NaCO3/NaHCO3 pH 9.6 for 4 hours at room 
temperature. Samples were diluted 1/5 in 20mM Tris- buffered saline pH 7.4 
containing 1% bovine serum albumin (TBS -BSA) and incubated at 4 °C for 18 hours. 
The second antibody was goat polyclonal anti -IL -6 (R &D Systems, Abingdon, UK) at 
2µg.m1"'. These were detected with peroxidase- conjugated anti -goat IgG Fab 
fragments (Boerhinger- Mannheim, Lewes, UK). For TNF, paired antibodies 
(Boerhinger- Mannheim, Lewes, UK) were used in accordance with manufacturers 
instructions. Standard curves for each ELISA were constructed using recombinant 
human IL -6 or TNF (R &D systems, Abingdon, UK). The substrate was 33', 55'- 
tetramethylbenzidine (TMB) in 100mM sodium acetate /citrate, pH 4.9. The reaction 
was stopped with l00µ1 of 1M sulphuric acid per well and plates were read at 490nm 
using a Dynatech MR5000 plate reader. Cytokine concentrations in samples were 
calculated from standard curves calculated using Assaytop computer software 
(Biosoft, Cambridge, UK). The reproducibility for these assays determined within the 
laboratory was good (table 4.1) 
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TABLE 4.1: Coefficients of variation ( %CV) for the measurement of IL -6 and TNF 
and sensitivity by ELISA using the method described. 
Intra assay %CV Inter assay %CV Sensitivity pg.m1 "' 
IL-6 3 6 75 
TNF 5 8 15 
Measurement of C- reactive protein in sera 
CRP concentrations in plasma were measured by sandwich ELISA. 96 well plates 
were coated with goat anti -human CRP at a dilution of 1:5000. Plates were blocked 
using 1 % BSA prior to washing. Sera were diluted 1:10 000 and were added to the 
coated plates. Standard curves were constructed using human C- reactive protein 
calibrator (Dako, Glostrup, Denmark). Samples and standards were incubated 
overnight and following washing, the second antibody, peroxidase conjugated anti- 
human CRP, was added. The substrate used was TMB and the reaction was stopped 
using 1M sulphuric acid. Plates were read at 490nm using a Dynatech MR5000 
automated plate reader. Concentrations in samples were calculated from standard 
curves using Assaytop computer software. The lower limit of sensitivity taking into 
account sample dilutions was 1001..t.g.m1' (table 4.2). 
TABLE 4.2: Coefficients of variation ( %CV) and sensitivities of ELISA for 
measurement of serum CRP concentration. 
Intra assay %CV Inter assay %CV Sensitivity (mg.1-1) 
CRP 7 15 1 
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Statistical analysis: The agreement and bias between energy expenditure 
measurements and predicted energy expenditure by the Harris -Benedict formula were 
compared with the Bland and Altman method. Differences between the fulminant 
hepatic failure group and each control group were examined using Student's t test. 
Differences within the fulminant hepatic failure group were examined using the Mann - 
Whitney U test. Relationships between physiological variables and energy expenditure 
within the fulminant hepatic failure group were investigated by calculating the product 
moment correlation coefficient. 
For the cytokine data comparisons between the fulminant hepatic failure group and 
control group were made using the Mann- Whitney U test. Correlations between 
variables were made by calculating Spearman's Rank Correlation Coefficient. 
P <0.05 was considered statistically significant. 
RESULTS 
The clinical characteristics of the patients with fulminant hepatic failure are shown in 
Table 4.3. Cardiac index was elevated in all cases and 5 patients were receiving 
noradrenaline at the time of study. Patients were hyperlactataemic, but the acid -base 
disturbance which accompanied this abnormality varied widely between patients. Data 
for patients studied during the anhepatic period of liver transplantation, and for 
healthy volunteers, are shown in table 4.5. 
Energy expenditure data for the patients with fulminant hepatic failure is shown in 
Tables 4.4 and compared with the control groups in table 4.5 and figure 4.1. There 
was no relationship between energy expenditure and cardiac index (r = -0.17), or 
heart rate (r = -0.28). No difference in energy expenditure was found between patients 
with or without acute renal failure, or between patients receiving noradrenaline and 
those with an adequate blood pressure without the need for vasoconstrictor support. 
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The pulmonary artery blood temperature varied between patients as a result of muscle 
paralysis, fluid administration, and haemofiltration, but there was no overall 
relationship between blood temperature and energy expenditure within the fulminant 
hepatic failure group (r = 0.35). There was a weak correlation between glucose 
requirement and the RQ (r = 0.57, p <0.05). 
The agreement between predicted and measured energy expenditure for the fulminant 
hepatic failure patients was poor even after correction for temperature (table 4.6). 
There was no overall bias between the methods (mean bias -0.13 (95% confidence 
intervals -0.54 to 0.28) kJ.kg "'.hour', but the limits of agreement were wide and 
clinically highly significant (limits of agreement -1.63 to 1.37 kJ.kg'.houf', figure 
4.2). 
Uncorrected energy expenditure in patients with fulminant hepatic failure was 18% 
higher than in healthy control subjects (p= 0.0005) and was 24% higher after 
correction for temperature differences (p= 0.0001). The healthy control group was 
well- matched for age, sex, and weight (Table 4.5). In comparison with the patients 
studied during the anhepatic phase of liver transplantation temperature- corrected 
energy expenditure was 29% greater in the fulminant hepatic failure group (p <0.0001, 
Table 4.5). The group data are illustrated in figure 4.1. Patients undergoing liver 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































TABLE 4.5: Resting energy expenditure in patients with fulminant hepatic failure, age /sex 
matched healthy control subjects, and patients with chronic liver disease studied during 


















Sex (F/M) 11/5 11/5 13/3 
MREE 4.05 (0.52) 3.44 (0.27) * t 3.15 (0.61) tt 
(kJ.kg'/hour') 
TC REE 4.28 (0.56) - 3.32 (0.73) ttt 
(kJ.kg' /hour') 
MREE measured resting energy expenditure; TC REE measured resting energy 
expenditure corrected to 37 °C using 10 % °C'' 
* p= 0.0005 compared with MREE in liver failure group, t p= 0.0001 compared with TC 
REE in liver failure group, tt p= 0.0001 compared with MREE in liver failure group, ttt 











































































































































































Table 4.6: Measured and predicted (Harris- Benedict formula) energy expenditure for 
patients with fulminant hepatic failure. 
Patient Energy Expenditure 
Predicted Measured Bias 
1 4.18 4.15 0.03 
2 5.01 4.63 0.38 
3 2.69 3.92 -1.22 
4 4.75 5.51 -0.76 
S 4.16 4.75 -0.58 
6 4.40 3.70 0.70 
7 3.15 4,48 -1.33 
8 4.61 5.28 -0.66 
9 4.74 3.80 0.94 
10 4.33 3.77 0.56 
11 5.04 4.65 0.40 
12 3.97 4.39 -0.43 
13 2.95 4.11 -1.16 
14 4.73 3.80 0.93 
15 4.04 3.88 0.16 
16 3.60 3.70 -0.10 
Mean (SD) 4.15(0.72) 4.28(0.56 -0.13(0.76) 
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Data for plasma cytokine and CRP concentrations are illustrated in figure 4.3. The 
median plasma CRP concentration was 71(range 8- 100)mg.l"1; CRP was not detected in 
the healthy volunteers (P <0.01). The patients with fulminant hepatic failure had 
significantly elevated concentrations of TNF (130[0- 350]pg.m1 "1) and IL -6 (1.0[0 - 
11.4]ng.m1"1 in comparison with healthy volunteers (TNF and IL -6 not detected, P <0.01 
in both cases)(figure 4.3). No correlation was found between CRP and IL -6 or TNF, or 
between IL -6 and TNF concentrations. There was no significant relationship between 


























































































































































































































































































The data indicate that energy expenditure is 20 -25% higher in ventilated critically ill 
patients with paracetamol- induced fulminant hepatic failure than in awake healthy control 
subjects. In interpreting the data several factors require consideration. The estimation of 
metabolic rate by means of indirect calorimetry assumes that energy is derived entirely 
from oxidative metabolism of substrates and that individuals are in a steady state, 
particularly with regard to carbon dioxide balance (Ferraninni 1988). Factors known to 
disrupt steady state such as altered alveolar ventilation, sudden changes in 
cardiorespiratory variables or rapid acid -base balance disruption did not occur. In all 
patients a steady state was attained as evidenced by the small variation in measurement 
observed during the study period. The mean coefficient of variation for oxygen 
consumption measurements (the principal determinant of energy expenditure) during the 
30 minute measurement period was 3.7% (range 2.0 -8.3 %) which compares extremely 
favourably with other energy expenditure studies in the critically ill and, as documented in 
chapter 2, is equivalent to the resolution of Deltatrac measurements. 
The presence of significant anaerobic metabolism in some patients was difficult to 
exclude; most were hyperlactataemic, and in some a metabolic acidosis was present. The 
interpretation of acid -base abnormalities occurring in association with severely impaired 
liver function is complex. Metabolic alkalosis may occur because of hypokalaemia or 
impaired hepatic urea synthesis, and is found more frequently than metabolic acidosis 
(Hawker 1993). When present, metabolic acidosis may indicate tissue hypoperfusion 
(Bihari et al 1985) but could also result from acute renal failure which was present in all 6 
patients in whom the base excess was < -2mmo1.14. Hyperlactataemia is often considered 
indicative of tissue hypoperfusion in critically ill patients and is associated with reduced 
survival (Bakker et al 1991, Marecaux et al 1996). However, it is recognised that 
hyperlactataemia and lactic acidosis are not equivalent (Hotchkiss and Karl 1992). 
Accumulation of plasma lactate, in the absence of anaerobic metabolism, can result from 
reduced plasma lactate clearance, accelerated glycolysis, or impairment of the enzyme 
pyruvate dehydrogenase (a primary regulator of aerobic glycolysis). These processes 
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occur in patients with sepsis (Hotchkiss and Karl 1992), and may be present during 
fulminant hepatic failure. In particular, plasma lactate clearance is reduced in the presence 
of hepatic and renal insufficiency (Kriesberg 1980). My own study with N- acetylcysteine, 
and a study by Hanique and colleagues (1994a), indicate that increasing oxygen delivery 
in patients with fulminant hepatic failure does not increase global oxygen consumption or 
decrease plasma lactate concentrations. Thus although it was not possible to exclude the 
presence of anaerobic metabolism in some of the patients with fulminant hepatic failure, 
the presence of metabolic acidosis and hyperlactataemia cannot be considered reliable 
indicators in this group of patients. Furthermore, indirect calorimetry underestimates 
rather than exaggerates total energy expenditure in the presence of significant anaerobic 
metabolism, which would not alter the principal findings of the study. 
Urinary nitrogen excretion was not measured and as a result oxidation rates for individual 
substrates could not be calculated in the patients. The accurate assessment of nitrogen 
balance in patients with renal failure requiring haemofiltration, and in patients in whom an 
abnormal distribution of body fluids is present, is extremely difficult, and these were both 
features in most of the patients with fulminant hepatic failure. Calculation of energy 
expenditure from VO2 and VCO2 alone, without accurate nitrogen excretion data, has a 
negligible effect on energy expenditure estimations even in hypermetabolic critically ill 
patients (Burzstein et al 1977, Burzstein et al 1989). Thus a 100% error in the 
measurement of urinary nitrogen excretion causes an error of only 1% in the calculation 
of energy expenditure (Burzstein et al 1989). 
As a result of muscle paralysis, and heat loss from haemofiltration circuits or during 
surgery, many of the patients with fulminant hepatic failure and those studied during 
transplantation were hypothermic. Under these circumstances the normal counter - 
regulatory mechanisms which generate heat through muscle activity are abolished. 
Manthous and colleagues (1995a) found a close relationship between VO2 and body 
temperature during cooling of critically ill febrile patients equivalent to approximately 
10% change per °C. In view of the significant influence of body temperature on metabolic 
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rate, and the wide range of temperature values in the patients studied, I normalised data 
to 37 °C assuming changes of 10 %. °C-1. However, the differences in energy expenditure 
between the groups studied were of similar magnitude and significance both before and 
after applying this correction factor. 
Energy expenditure was 20 -25% higher in patients with fulminant hepatic failure 
compared to matched awake healthy subjects. The patients with acute liver failure were 
all fully paralysed with muscle relaxant drugs and sedated with hypnotic and opioid drugs. 
These agents have all been shown to significantly decrease energy expenditure in 
comparison to the awake spontaneously breathing state. Mechanical ventilation in 
conjunction with muscle paralysis reduces oxygen consumption in critically ill patients by 
20 -25% (Manthous et al 1995b, Viale et al 1988, Marik and Kaufman 1996, Boulanger et 
al 1994), and opioid analgesia and sedative drugs have each been shown to decrease 
energy expenditure by more than 10% (Swinamer et al 1988, Boyd et al 1992). Taking 
these additional factors into account the data indicate that metabolic rate is substantially 
increased in patients with paracetamol- induced fulminant hepatic failure in comparison 
with healthy control subjects. This conclusion is consistent with the study by Schneeweiss 
and colleagues (1993) who found metabolic rate was approximately 30% higher in a 
heterogeneous group of patients with non paracetamol- induced acute hepatic failure than 
in control subjects. In that study patients were not sedated or paralysed and only 1 of the 
12 patients studied was mechanically ventilated. 
In the patients with fulminant hepatic failure the agreement between predicted and 
measured energy expenditure was poor even after correction for temperature. Previous 
studies have shown that the predictive value of the Harris- Benedict and other equations 
used for estimating energy expenditure is low in critically ill patients, and that these 
equations frequently give misleading results (Chiolero et al 1997). Various stress factors 
have been suggested for use with predictive equations in order to correct for the effects 
of altered temperature, and other factors such as injury severity. The patient group in the 
present study was relatively homogeneous in terms of diagnosis, illness severity, and 
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method of treatment. The low predictive value of the Harris -Benedict equation even after 
normalising data to 37 °C indicates that direct measurement of energy expenditure in 
individual patients is advisable when an accurate assessment of metabolic rate is required. 
There were no significant correlations between energy expenditure and haemodynamic 
variables, temperature, or noradrenaline requirements and there was no difference 
between patients with or without renal failure, although numbers for comparison were 
small. The absence of an association between these factors, which are frequently linked 
with energy expenditure, was surprising, but presumably reflects the complex nature of 
the metabolic response in patients suffering from fulminant hepatic failure, and the 
influence of drug therapy on cardiovascular variables. 
Patients were studied in the fasting state in order to eliminate the effects of substrate - 
induced thermogenesis. Patients who were hypoglycaemic on bedside testing received 
dextrose by infusion and this was titrated to ensure normoglycaemia. The thermogenic 
effect of carbohydrate is small and is unlikely to have influenced the results significantly. 
Schneeweiss et al (1993) found that glucose supply in patients with acute liver failure was 
able to normalise substrate utilisation, presumably by counteracting the effects of 
impaired liver glucose metabolism. There was a weak correlation between the respiratory 
quotient and the rate of glucose infusion which suggests that, in the absence of normal 
hepatic glucose release, exogenous glucose supply was a major source of substrate for 
oxidation. 
Measured energy expenditure was approximately 29% higher in patients with fulminant 
hepatic failure than in patients undergoing elective liver transplantation who were 
physically anhepatic. These patients were also paralysed and sedated and in this respect 
were directly comparable with the fulminant hepatic failure group. Energy expenditure in 
the patients undergoing transplantation may have been affected by their underlying 
disease or by the stress response to surgery, and these patients were also older than the 
fulminant hepatic failure group. The administration of "renal dose" dopamine in these 
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patients may also have had a thermogenic effect. Despite these confounding factors the 
data provide further evidence that, despite the loss of functioning liver cell mass, 
metabolic rate in patients with fulminant hepatic failure is not equivalent to an anhepatic 
state. It is clear from the present study that other factors substantially increase metabolic 
rate in this disease. 
Infection is a common complication of fulminant hepatic failure and the presence of 
infection during critical illness is associated with increased energy expenditure (Kreymann 
et al 1993, Chiolero et al 1997). The patients in the present study were all studied within 
24 hours of admission to the intensive care unit when septic complications are relatively 
rare in fulminant hepatic failure. Routine microbiological screening also failed to detect 
evidence of infection in any patients and I consider it unlikely that this was a contributing 
factor. 
Plasma concentrations of CRP, TNF, and IL -6 were all significantly elevated in the 
patients. TNF is activated early in the course of the inflammatory response and infusion 
of TNF reproduces the clinical features of the systemic inflammatory response in humans 
(Blackwell and Christman 1996). Animal studies of paracetamol- induced hepatotoxicity 
have shown that TNF appears in the plasma within hours of paracetamol administration 
and subsequently decreases in a phasic manner (Blazka et al 1995). Similar findings have 
been made in models of sepsis, and some human studies suggest that the magnitude and 
duration of the TNF response is associated with survival (Blackwell and Christman 
1996). No correlations between survival or other clinical variables were demonstrated in 
the present study but numbers were small and measurements were only made on one 
occasion. Similar findings were made by Sekiyama and colleagues (1994) in patients with 
virus- induced liver failure. TNF is also renally cleared and the presence of acute renal 
failure in many of the patients means that interpretation of plasma concentrations is not 
straightforward. IL -6 is produced by many cell types and plasma concentrations usually 
increase after the peak in TNF and possibly in response to it. The exact function of IL -6 
in the inflammatory response is incompletely understood. In experimental animals infusion 
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of IL -6 does not reproduce a sepsis -like state and blocking with monoclonal antibodies 
does not appear to be beneficial (Blackwell and Christman 1996). However, IL -6 
concentrations appear to correlate more closely with outcome than any other cytokine. 
Several groups have documented an association between high plasma IL -6 concentrations 
and subsequent death in septic patients (Blackwell and Christman 1996, Goldie et al 
1995), and Izumi and colleagues (1994) made a similar observation in patients with 
fulminant hepatic failure. 
Plasma CRP concentrations were elevated in all patients. The plasma half -life of CRP in 
humans is 19 hours and it is not known to be stored significantly in hepatocytes. It is 
therefore likely that, despite the presence of severe liver damage, hepatocytes were 
continuing to generate an acute phase protein response. This finding is consistent with 
studies by Sekiyama et al (1994) in viral liver failure, and Izumi et al (1994) in a mixed 
group of patients with fulminant hepatic failure. The levels of CRP found in these and the 
present study are significantly lower than is usually associated with sepsis, which may 
reflect the reduced synthetic ability of the liver in fulminant hepatic failure. IL -6 is a 
potent stimulus for CRP production by hepatocytes (Heinrich et al 1990), and a 
correlation between plasma IL -6 concentration and CRP has been noted in virus- induced 
fulminant hepatic failure (Sekiyama et al 1994, Izumi et al 1994). Given the small 
numbers of patients studied correlations between cytokines and clinical variables were not 
expected in the present study. Wigmore and colleagues (1998) have shown that white 
blood cells from patients with fulminant hepatic failure have reduced ability to produce 
TNF and IL -6 in vitro, which may indicate early activation in vivo with subsequent 
exhaustion in this condition. This, in conjunction with the effect of increased plasma 
concentrations of pro -inflammatory cytokines on other tissues, probably explain the 




1) Energy expenditure is significantly increased in patients with paracetamol- induced 
fulminant hepatic failure. 
2) The Harris -Benedict equation has low predictive value for estimating metabolic rate in 
patients with fulminant hepatic failure. 
3) Fulminant hepatic failure is accompanied by a marked systemic inflammatory response 
and acute phase protein response which probably account for increased metabolic rate. 
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CHAPTER 5 
THE EFFECT OF GRAFT REPERFUSION ON HAEMODYNAMICS AND GAS 
EXCHANGE DURING LIVER TRANSPLANTATION 
OBJECTIVES 
To describe in detail the changes in pulmonary and systemic haemodynamics, gas 
exchange and metabolic rate which occur after reperfusion during liver transplantation. 
BACKGROUND 
In the introduction to this thesis a review of the physiological changes associated with 
different stages of the liver transplant procedure was made. These changes are most 
dramatic, and are associated with most morbidity, during and immediately following 
reperfusion of the donor graft. The pathophysiology of reperfusion are incompletely 
understood and in particular there have been no studies which document in detail the 
alterations in gas exchange which occur or their relationship to haemodynamic changes 
and acid -base balance. These are important because they may contribute to potentially 
fatal complications such as acute intracranial hypertension which can occur at this time. 
My aim in this chapter was to use indirect calorimetry to study in detail the physiological 
changes which occur at reperfusion. 
METHODS 
Patients 
Twenty patients undergoing orthotopic liver transplantation were prospectively studied 
(mean age 52, range 21 to 67). In 8 patients venovenous bypass from portal and femoral 
veins to axillary vein was used during the anhepatic phase. In the remaining 12 patients 
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the piggyback technique was used. In all of these patients a temporary portacaval shunt 
was constructed during the anhepatic period. Anaesthesia was maintained with a 
propofol /alfentanil infusion regime supplemented with midazolam. An atracurium 
infusion was used for muscle relaxation and the lungs were ventilated with an air /oxygen 
mixture using a Servo 900C ventilator. Ventilator settings were adjusted to achieve a 
PaCO2 of 3.5 -4.5 kPa early in the operation and were not altered during the study period. 
All patients received dopamine at 3p.g.kg'min -1, and aprotinin at a rate of 500,000 units 
per hour following a loading dose of 2 million units. Arterial, central venous, and 
pulmonary artery pressures were monitored continuously. Cardiac output was measured 
semi -continuously using a thermodilution technique (Baxter Vigilance system). 
Haemodynamic data were collected continuously to computer via the analogue output of 
the monitors. Fluids and blood products were administered as clinically indicated, and 
following reperfusion boluses of adrenaline were given to treat hypotension if required. 
No patients received bicarbonate or other alkali therapy during the study period. 
Measurements 
Metabolic gas exchange was measured with the Deltatrac metabolic monitor. The 
accuracy of the machine was checked every 3 months by an alcohol burning test (for RQ) 
and a flow generator calibration. Before each use the machine was allowed to warm up 
for 30 minutes and was then calibrated for atmospheric pressure using an aneroid 
barometer. A gas calibration was carried out before each measurement against a standard 
mixture (95% 02, 5% CO2). All data were collected each minute to computer using 
software supplied by the manufacturer. 
In each patient an arterial blood sample was drawn as part of the routine perioperative 
monitoring before and approximately 30 minutes after reperfusion. Samples were 
processed within 5 minutes of collection using an IL BGE 1400 series analyser which was 
checked daily using a quality control sample. Five minute averages for all haemodynamic 
data and metabolic data were calculated retrospectively at the times of blood sampling in 
each patient. From this data the following derived variables were calculated before and 
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after reperfusion: 
Mixed expired CO2 pressure (PECO2) _ (PB.atm.- SVP(H2O)).FECO2 
(PB.atm., barometric pressure; SVP(H2O), saturated vapour pressure of water at 37 °C) 
Pulmonary deadspace ratio (VD /VT) = (PACO2- PECO2)/PACO2 
(PACO2, alveolar CO2 pressure, assumed to equal PaCO2) 
Alveolar ventilation (VA) = (VCO2.95) /PACO2 
Alveolar oxygen pressure (P A02) = FIO2 - SVP(H2O) - PACO2/RQ 
Alveolar to arterial oxygen tension gradient (A -a gradient) = PAO2 - PaO2 
Differences between physiological variables before and after reperfusion were compared 
using Student's paired t test. The relationship between changes in physiological variables 
at reperfusion was investigated by calculating the Pearson product moment correlation 
coefficient. P <0.05 was considered statistically significant. 
RESULTS 
The indications for surgery were as follows: primary biliary cirrhosis (8 patients), primary 
sclerosing cholangitis (3 patients), alcoholic cirrhosis (4 patients), chronic rejection of 
liver transplant (2 patients), and fulminant hepatic failure (3 patients). No patients 
suffered cardiac arrhythmias at reperfusion and there were no cases of primary graft non- 
function. All patients had successful transplants and were alive at one month. The mean 
time of blood sampling after reperfusion was 28 minutes (SD 11 mins). Continuous 
monitoring of metabolic gas exchange revealed increases in VO2 and VCO2 which 
consistently occurred within 2 -3 minutes of graft reperfusion (figure 5.1). Changes in 
physiological variables at reperfusion are summarised in table 5.1. 
Boluses of adrenaline were required after reperfusion to maintain arterial blood pressure 
in 16 patients. The maximum dose required in any patient was 0.8mg and no patients 
required infusions of adrenaline or other inotropic drugs. There was no correlation 
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between adrenaline usage and haemodynamic or gas exchange changes. 
Physiological changes were compared between patients transplanted using venovenous 
bypass and piggyback surgical techniques. In patients transplanted with the piggyback 
technique the increase in PaCO2 and hydrogen ion concentration was less than with 
venovenous bypass (table 5.2). Changes in the other measured variables were similar. 
There were significant correlations between changes in PaCO2 and VCO2 (r = 0.5, 
P <0.02), cardiac output and VCO2 (r = 0.58, P <0.01), and cardiac output and VO2 (r = 
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Figure 5.1: Typical example of changes in VO2, VCO2, and PECO2 
after reperfusion in an individual patient during constant 
ventilation. 
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TABLE 5.1: Comparison between haemodynamic variables, metabolic gas exchange and 
associated physiological parameters before and after graft reperfusion. All values mean 




Cardiac output (1.min'.m 2) 4.6 (1.3) 5.9 (1.5) 1.2 (1.0)t 
MAP (mmHg) 74 (13) 70 (15) -4 (15) 
MPAP (mmHg) 15 (4) 24 (6) 9 (6)t 
PVRI (dyne. sec.cm 5.m 2) 125 (87) 137 (69) 12 (23) 
VCO2 (ml.min-'.m -2) 138 (30) 176 (37) 38 (17) t 
RQ 0.87 (0.12) 0.82 (0.10) -0.05 (0.09) tt 
VO2 (ml.min'.m 2) 160 (32 217 (46) 57 (25) t 
FI02 0.46 (0.09) 0.46 (0.09) 0 
Pa02 (kPa) 25.7 (6.75) 21.79 (6.38) -3.86 (5.31)* 
PAO2 (kPa) 38.51 (9.01) 37.23 (9.17) -1.28 (0.84)t 
A -a gradient (kPa) 12.86 (5.99) 15.44 (8.02) 2.58 (5.58) 
PaCO2 (kPa) 4.40 (0.73 5.27 (0.90) 0.88 (0.56) t 
PECO2 (kPa) 2.21 (0.31) 2.78 (0.37) 0.57 (0.23) t 
VD /VT 0.49 (0.06) 0.46 (0.09) -0.03 (0.05)* 
VA (1.min') 3.02 (0.62) 3.23 (0.70) 0.22 (0.27)* 
[H +] (nmol.l-1) 44.8 (9.6) 52.8 (9.9) 8.15 (5.9)t 
SBC (mmol.1 -1) 20.8 (2.9) 19.9 (2.4) -0.96 (1.6)tt 
MAP, mean arterial pressure; MPAP, mean pulmonary artery pressure; PVRI, pulmonary 
vascular resistance index; RQ, respiratory quotient; FI02, inspired oxygen fraction; Pa02, 
arterial oxygen tension; PAO2, alveolar partial pressure of oxygen; A -a gradient, alveolar 
to arterial oxygen tension gradient; PaCO2, arterial carbon dioxide tension; PECO2, 
mixed expired carbon dioxide partial pressure; VD /VT, deadspace ratio; VA, alveolar 
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Figure 5.2. A: Relationship between changes in PaCO2 and VCO2 
at reperfusion. B: Relationship between changes in cardiac index and 
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TABLE 5.2: Comparison of physiological changes occurring at reperfusion between 
patients transplanted using the piggyback technique and those transplanted using 
venovenous bypass during the anhepatic phase. * P <0.02 between the groups. All 
other differences non -significant. 
Piggyback 
(n = 12) 
Venovenous Bypass 
(n = 8) 
Cardiac output (1.miri'.m 2) 1.2 (0.8) 1.3 (1.2) 
MAP (mmHg) -7 (12) 1 (18) 
MPAP (mmHg) 7 (6) 11 (6) 
VCO2 (mLmiri'.m 2) 32 (12) 47 (20) 
RQ -0.07 (0.08) -0.01 (0.09) 
VO2 (ml.miri'.m 2) 56 (20) 59 (33) 
PaO2 (kPa) -3.33 (3.35) -4.66 (7.60) 
PAO2 (kPa) -1.25 (0.69) -1.34 (1.07) 
A -a gradient (kPa) 2.1 (3.3) 3.3 (8.1) 
PaCO2 (kPa) 0.61 (0.41) 1.27 (0.53) * 
PECO2 (kPa) 0.48 (0.13) 0.69 (0.29) 
VD /VT -0.04 (0.13) -0.02 (0.04) 
VA (1.miri') 204 (271) 233 (277) 
Hr concentration (nmol.1 "') 5.59 (5.50) 11.74 (4.60) * 
Standard bicarbonate (rnmol.l"') -0.8 (1.4) -1.3 (1.07) 
in 
DISCUSSION 
The principal finding in this chapter is that reperfusion of the donor graft during liver 
transplantation is associated with dramatic changes in gas exchange and metabolic 
rate. Clinically significant increases in VO2 and VCO2 occurred within minutes of 
removing the vascular clamps and restoring blood supply to the graft. These changes 
were associated with the well -established observation that cardiac output and 
pulmonary artery pressure increase at reperfusion and systemic vascular resistance 
decreases (Aggarwal et al 1987, Estrin et al 1989, Webster et al 1994). 
The accuracy of physiological measurements made during a period of rapid change 
was an important consideration in considering these findings. The validity of 
thermodilution measurements of cardiac output is decreased by rapid changes or 
fluctuations in blood temperature, and rapid infusion of intravenous fluids both of 
which occur frequently at the time of reperfusion (Nishikawa et al 1993). Data were 
not analysed in the immediate post -reperfusion period, and an automated 
semicontinuous method of determining cardiac output was used which has the 
advantage of eliminating operator error and averaging multiple data points. Bottiger 
et al (1997) showed that the agreement between this method and conventional bolus 
thermodilution was good during liver transplantation if about 30 minutes had elapsed 
from reperfusion. It is therefore unlikely that large errors occurred in measurements 
of cardiac output in the patients. As discussed in the previous chapters the accuracy 
of the Deltatrac metabolic monitor is reduced in the presence of a high or fluctuating 
F102, anaesthetic gases, or the presence of gas leaks in the circuit, but these were not 
relevant in this study. The assumption that the patient is at steady state was a further 
consideration. Ventilation was not altered during the study period, but the significant 
changes in cardiac output, acid -base status, and deadspace ratio which were observed 
all represent disruptions to steady state which may have influenced the validity of VO2 
estimations. Inaccuracy attributable to these factors should decline exponentially with 
time as a new equilibrium is established after reperfusion. The data indicate that 
devices which assume the presence of a steady state when determining VO2 following 
graft reperfusion may be inaccurate until an equilibrium has been re- established. The 
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time required for this to occur is unknown and is likely to vary between patients. 
Following changes in ventilation the majority of this process occurs within 20 minutes 
(Nunn 1977, Taskar et al 1995) and it is likely that errors attributable to 
haemodynamic, acid -base, and deadspace changes were small 30 minutes after 
reperfusion assuming the patients were otherwise stable. This conjecture was 
supported by the observation that VO2 plateaued within 5 -10 minutes, and then did 
not fluctuate significantly in the majority of patients. 
The increase in PaCO2 which occurred has several explanations. Firstly, increased 
aerobic metabolism by the graft resulted in an increase in CO2 production which was 
not compensated for by increased ventilation, which intentionally remained 
unchanged. Secondly, the small decrease in standard bicarbonate concentration 
indicated an acute metabolic acidosis which probably resulted from the release of an 
acid load from the graft and other ischaemic tissues. Welte et al (1996) found that 
gastric intramucosal pH decreased during the anhepatic phase of liver transplantation 
which was consistent with the presence of gut ischaemia, and this resolved following 
reperfusion. In the patients in the present study there was no correlation between the 
changes in standard bicarbonate or hydrogen ion concentration and PaCO2 which may 
indicate that buffering of the acid load was not a major determinant of the PaCO2 
change. Impaired CO2 elimination might have contributed to the increase in PaCO2, 
but despite constant ventilator settings a small but statistically significant decrease in 
deadspace ratio and an increase in alveolar ventilation were observed, which would 
augment rather than impair CO2 elimination. The most likely explanation for these 
changes was increased pulmonary perfusion and a decrease in the V/Q ratios of non- 
dependent alveoli, attributable to increased pulmonary artery pressure and cardiac 
output. 
The observed increase in VCO2 following reperfusion correlated with the increase in 
PaCO2. This association was expected under conditions of constant ventilation where, 
in the absence of severe pulmonary disease, alveolar and arterial pCO2 are virtually 
identical (Nunn 1977). The results also indicate that altered pulmonary blood flow 
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may be an important determinant of VCO2 because a correlation was found between 
changes in cardiac output and VCO2. This observation is consistent with those made 
by Shibutani et al (1994) in patients undergoing aortic aneurysm surgery in whom 
decreases in VCO2 correlated strongly with decreases in cardiac output. 
An increase in arterial CO2 tension causes vasodilatation (Nunn 1977). In patients 
with acute respiratory distress syndrome Thorens et al (1996) showed that acute 
hypercapnia, induced over 30 -60 minutes by a reduction in minute ventilation, 
increased cardiac output and pulmonary artery pressure and decreased systemic 
vascular resistance. Although many factors may be important, the similarity between 
these changes and those occurring in patients following graft reperfusion suggest that 
altered CO2 tension may contribute to the haemodynamic changes which occur 
following reperfusion during liver transplantation. 
A possible clinical relevance of altered CO2 metabolism relates to cerebral blood flow 
in patients with abnormal cerebral autoregulation or intracranial hypertension. 
Neurological complications are common following reperfusion in patients undergoing 
liver transplantation for fulminant hepatic failure, but cerebral oedema can also 
complicate chronic liver disease (Donovan et al 1998). The exact aetiology of the 
acute increases in intracranial pressure which occur following reperfusion is unclear 
and is probably multifactorial, but cerebral vasodilatation in response to increased 
arterial CO2 tension is a possible contributing factor. Gunning and colleagues (1990) 
noted the similarity between the acute intracranial hypertension which can occur 
following deflation of limb tourniquets in at risk patients and the changes which occur 
at reperfusion, when substances from previously ischaemic tissues are released into 
the circulation including a significant acid load. The cerebrovascular response to acute 
hypercapnia in patients with normal autoregulation is extremely rapid ( <10 
seconds)(Poulin et al 1996). An increase in middle cerebral artery blood flow 
velocity, measured by transcranial Doppler, occurs following reperfusion in patients 
with chronic liver disease and can be attenuated, but not completely abolished by 
hyperventilation prior to reperfusion (Doblar et al 1995). The data indicate that an 
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increase in minute ventilation is advisable prior to reperfusion in order minimise the 
risk of C07- induced cerebral vasodilatation in patients at risk of cerebral 
complications. 
PaCO2 and hydrogen ion concentration increased less in patients transplanted using 
the piggyback technique although changes in standard bicarbonate concentration were 
not statistically significant. This indicates that the acidaemia following reperfusion was 
greater when venovenous bypass was used although buffering resulted in no 
difference in systemic acidosis. Steib et al (1997) found cardiac output and oxygen 
delivery were higher during the anhepatic phase of transplantation with the piggyback 
technique in comparison with venovenous bypass. Better organ perfusion, particularly 
of splanchnic tissues, during the anhepatic phase of transplantation may account for 
the smaller acid load released into the systemic circulation at reperfusion with the 
piggyback technique. This hypothesis is explored in the next chapter and may be 
clinically important if acidaemia or other ischaemic metabolites contribute to 
cardiovascular or neurological instability. 
There was a relationship between changes in cardiac output and VO2 following 
reperfusion. There are two possible explanations for this: firstly, VO2 may be supply - 
dependent at this time, particularly if the increase in cardiac output improves oxygen 
delivery to tissues which were ischaemic during the anhepatic period (Steib et al 
1987). Alternatively, metabolism by the new liver, resulting in increased oxygen 
demand, may be the major determinant of cardiac output and therefore oxygen 
delivery. Previous studies have suggested that the change in VO2 at reperfusion is a 
clinically useful measure of graft function (Svensson et al 1989, Steltzer et al 1992, 
Gubernatis et al 1989). However, several factors could influence VO2 at this time. In 
particular, if the change in VO2 is in part attributable to factors other than metabolism 
of the graft, such as adrenaline usage and oxygen debt in splanchnic tissues incurred 
during the anhepatic phase, the sensitivity and specificity of this test are unlikely to be 
high. This may explain why some authors have observed a large increase in VO2 in 
patients in whom primary liver non- function occurred (Albaladejo et al 1994). 
134 
In most patients the increase in VO2 was slightly larger than the increase in VCO2 and 
this was reflected by a small but statistically significant decrease in the RQ. A similar 
observation was made by Svensson et al (1989) and it is possible that this occurred 
because of altered substrate utilisation at the tissue level such as restoration of hepatic 
lipolysis. An alternative explanation is that the excess oxygen consumption was due to 
free radical formation, which consumes oxygen without the production of CO2. Free 
radical production has been demonstrated after reperfusion, may continue for up to 24 
hours, and has been implicated in the process of reperfusion injury (Bzeizi et al 1993, 
1997). Indirect evidence that this occurs also comes from work demonstrating acute 
depletion of plasma antioxidants following reperfusion (Goode et al 1994). 
Despite significant changes in pulmonary artery pressure and blood flow A -a oxygen 
tension gradient, a measure of physiological shunt, did not change in the majority of 
patients. Small decreases in PAO2 and Pa02 were observed which were largely 
explained by the increase in PACO2 and which were not clinically important in the 
patients in this study. These changes might become relevant in patients with limited 
physiological reserve because of coexisting pulmonary disease, which occurs in both 
chronic and acute liver disease (Krowka et al 1996, Baudouin et al 1995). However, 
the data indicate that the routine use of high inspired oxygen fractions at reperfusion, 
which is frequently recommended, is unnecessary. Indeed, the use of high inspired 
oxygen fractions increases lung atelectasis during anaesthesia (Rothen et al 1995). 
CONCLUSIONS. 
1) Increases in VO2, VCO2, and PaCO2 occur following reperfusion because of 
oxygen uptake by the new liver, and the perfusion of tissues which were ischaemic 
during the anhepatic period. 
2) The degree of acidaemia following reperfusion is greater when venovenous bypass 
is used in comparison with the piggyback technique. This is associated with a 
greater increase in PaCO2 and may be relevant in patients with cardiovascular or 
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neurological instability. 
3) During routine liver transplantation the effect of reperfusion on arterial oxygen 
tension is not clinically significant. 
4) Carbon dioxide elimination is augmented by increased pulmonary perfusion and a 
decrease in physiological deadspace. However, an increase in metabolic rate and 
buffering of the acid load released in association with reperfusion make it advisable 
to routinely increase minute ventilation at this time. 
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CHAPTER 6 
OXYGEN TRANSPORT AND UPTAKE DURING LIVER 
TRANSPLANTATION: A COMPARISON BETWEEN VENOVENOUS 
BYPASS AND PIGGYBACK SURGICAL TECHNIQUES. 
OBJECTIVES 
1) To compare cardiac output during liver transplantation, using either venovenous 
bypass or the piggyback technique, using a semicontinuous method of 
measurement. 
2) To compare whole body oxygen consumption, carbon dioxide elimination, and 
indices of tissue hypoxia with each surgical technique using indirect calorimetry to 
avoid the measurement errors associated with the reverse Fick method. 
INTRODUCTION 
In the introduction to this thesis the different surgical techniques in use for performing 
liver transplantation were described. In particular the possible benefits of the 
piggyback technique for maintaining haemodynamic stability and tissue oxygenation 
during the anhepatic period were discussed. Other than anecdotal reports and 
retrospective series of patients there are few studies which compare the 2 techniques. 
Steib et al (1997) found that cardiac output and oxygen delivery were better 
maintained during the anhepatic period when the piggyback technique was compared 
with venovenous bypass, but from their data it is not clear whether this was associated 
with improved oxygen uptake or reduced tissue ischaemia. The interpretation of this 
and other previous work is not straightforward because conclusions were based on 
small numbers of data points, and the reverse Fick method was used to calculate 
oxygen consumption. In chapter 3 of this thesis it has been demonstrated that the 
reverse Fick method is inaccurate in patients in whom the cardiac output and mixed 
venous oxygen saturations are hign, as is typical in many patients undergoing liver 
transplantation. In addition, when the relationship between oxygen delivery and 
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consumption is examined during periods of change mathematical coupling has the 
potential to cause artificial correlations. In this chapter a prospective observational 
study is described in which the piggyback and venovenous bypass techniques are 
compared in relation to cardiac output and gas exchange data. The methodology 
attempts to eliminate or reduce the effect of factors which confuse the interpretation 
of oxygen kinetics studies. 
METHODS 
Patients and techniques: 
Sixteen patients undergoing liver transplantation were studied prospectively. In 8 
patients venovenous bypass was established from the femoral and portal veins to the 
axillary vein prior to cross -clamping the inferior vena cava above and below the 
hepatic veins. During the anhepatic period bypass flow rate was increased to the 
highest achievable value using a centrifugal pump. In the remaining 8 patients the 
piggyback technique was used: inferior vena caval flow was preserved throughout the 
anhepatic period with the only interference to blood flow being the application of a 
side -biting clamp to the vena cava at the level of the hepatic veins. In 6 patients a 
temporary portacaval shunt was constructed prior to recipient hepatectomy; in the 
other 2 patients, a test period of portal vein cross -clamping suggested adequate 
collateral circulation and the portal vein remained cross -clamped during the anhepatic 
period. The choice of technique was made by the surgeon. In all patients the grafted 
liver was reperfused via the portal vein. The groups were comparable for age, 
diagnosis and Childs -Pugh scores (table 6.1). 
The same total intravenous anaesthetic technique was used in all cases using infusions 
of propofol, midazolam, and a;fentanil (see previous chapter). An atracurium infusion 
provided full muscle relaxation and the lungs were ventilated through a Servo 900C 
ventilator using an air -oxygen mixture. In the early stages of the procedure the minute 
volume and the F102 were adjusted to achieve an arterial carbon dioxide tension 
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(PaCO2) of 4- 5.5kPa and an arterial oxygen tension (PaO2) of 15- 25kPa. Thereafter 
changes in ventilator setting were made only if clinically indicated. All patients 
received a dopamine infusion at a rate of 2p.g.kg"i.min 1 throughout the procedure, and 
aprotinin at a rate of 0.5 million units per hour following a loading dose of 2 million 
units. 
TABLE 6.1: Demographic data for the patients studied. Mean (range). 
Piggyback Venovenous bypass 
Age 53 (45 -60) 55 (44 -67) 
Diagnosis 
Primary biliary cirrhosis 4 3 
Alcoholic liver disease 2 1 
Primary Sclerosing Cholangitis 1 2 
Non A, non B, non C hepatitis 1 
Chronic rejection 2 
Child's Grade 2A, 3B, 3C 2A, 4B, 2C 
Sex (F/M) 4/4 5/3 
Arterial and central venous pressures were monitored continuously. Cardiac output 
was measured semicontinuously with a thermodilution technique (Baxter Vigilance 
system). All haemodynamic data were recorded to computer each minute from the 
monitors using an analogue /digital converter . Every 30 minutes arterial blood gas 
analysis was carried out using an IL BGE 1400 series analyser which was checked 
daily using a quality control sample, and whole blood lactate measured using a YSI 
2300 Stat Plus analyser. 
The Deltatrac metabolic monitor was used to measure oxygen consumption and 
carbon dioxide elimination. The accuracy of the machine was checked every 3 months 
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by an alcohol burning test. Before each use the machine was calibrated for 
atmospheric pressure using an aneroid barometer and a gas calibration was carried 
out using a standard mixture (95% 02, 5% CO2). Measured gas volumes are 
expressed at standard temperature and pressure. 
Identical methods of heat preservation were employed in all patients. A heating 
blanket was placed under the patients and over the lower limbs (Cincinatti Sub -zero 
Norm -O -Temp, CSZ Products Inc, Cincinnati, Ohio). After induction of anaesthesia 
the limbs were wrapped in garngee and polythene. All intravenous fluids and blood 
products were administered at 37 °C using a blood warmer /rapid infusion system 
(Level 1, Level 1 technologies Inc., Rockland, MA, USA). 
Data Collection 
All cardiac output and gas exchange data were recorded each minute to computer 
throughout the procedure. Retrospectively the mean for these variables was calculated 
for 4 time periods: 
I (Baseline): The 20 minute period immediately prior to ligation of the hepatic artery. 
II ( Anhepatic): The mean of data for the entire anhepatic period. 
III (Post reperfusion 30): The mean of data for a 20 minute period starting 30 minutes 
after vascular reperfusion of the graft. 
IV (Post reperfusion 90): The mean of the 20 minute period from 90 to 110 minutes 
after graft reperfusion. 
Pulmonary artery blood temperature was recorded during the baseline period, 
immediately prior to reperfusion, and at 90 minutes post -reperfusion. Blood samples 
were analysed at the following time points: 
Time point A: during time period I. 
Time point B: during the 10 minutes prior to reperfusion (end anhepatic). 
Time point C: during time period III. 
Time point D: during time period IV. 
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Statistical Analysis 
Data were compared using non parametric tests. As multiple tests were performed 
Bonferroni's correction was applied as appropriate. Correlations between pooled data 
were investigated by calculating the product moment correlation coefficient. 
RESULTS 
All patients had functioning grafts and were alive at 3 months following surgery. In 
one patient in the venovenous bypass group, bypass was abandoned after 20 minutes 
because of problems with the portal venous flow. In this patient the procedure was 
completed without bypass. In the remaining 7 patients the mean bypass flow was 2.1 
1.min'(SD 0.7, range 1.3 -3.0 1.min'). There were no significant differences in gas 
exchange, cardiac output, or acid -base variables between the groups during the 
baseline period (table 6.2). The mean duration of the anhepatic period was 
significantly shorter in the piggyback group (piggyback group median 50 (range 44- 
196) minutes; venovenous bypass group 77 (69 -127) minutes, P <0.02). 
Data for median VO2, VCO2, and cardiac index for the groups for the 4 time periods 
are illustrated in figure 6.2 and table 6.2. Individual data for VO2 are illustrated in 
figure 6.1. Analysis within groups indicated that VO2 decreased during the anhepatic 
phase in both groups and increased following reperfusion (table 6.2). In the 
venovenovenous bypass group a further increase in VO2 occurred between 30 and 90 
minutes post -reperfusion; VO2 plateaued during this period in the piggyback group. A 
significant increase in VCO2 occurred in both groups following reperfusion. Cardiac 
index decreased during the anhepatic period in the venovenous bypass group, but did 
not change significantly in the piggyback group. Plotting changes between the groups 
indicated that all 3 variables decreased more during the anhepatic period in the group 
in which venovenous bypass was used, with differences persisting following 
reperfusion (figure 6.2). Statistical analysis of these differences was done by 
comparing changes in the physiological variables between the baseline and anhepatic 
periods, and between the anhepatic and post reperfusion periods. Bonferroni's 
correction for multiple tests was applied to these analyses. 
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Between the baseline and anhepatic periods decreases in VO2 and cardiac index were 
significantly greater in the venovenous bypass group (figure 6.3). The range of 
changes in cardiac output was wider in the venovenous bypass group. A trend 
towards a greater decrease in VCO2 was observed which was not statistically 
significant. For acid -base variables the only significant difference was a greater 
increase in H+ concentration in the venovenous bypass group (table 6.3). 
At reperfusion there were no significant differences between the groups for changes in 
any of the gas exchange or acid -base variables (table 6.4). 
Pulmonary artery blood temperature was similar for the 2 groups at the baseline time 
point. Core temperature was significantly lower in the venovenous bypass group both 
immediately before reperfusion and at 90 minutes after reperfusion. This occurred 
because of a more significant decrease in temperature in the venovenous bypass group 
during the anhepatic period (table 6.5). 
In order to explore further the relationship between changes in cardiac output, 
temperature, VO2 and VCO2 during the anhepatic period data from all 16 patients 
were pooled. A correlation was found between changes from the baseline to the 
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Figure 6.1: Individual data for VO2 during each time period 
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Time period 
VENOVENOUS BYPASS A PIGGYBACK 
Figure 6.2: VO2, VCO2, and cardiac index for each time 
period for the groups. All values median (1st, 3rd quartile). 
Statistical analysis within groups in table 6.3, and between 
groups in figure 6.3 and table 6.5. 
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TABLE 6.3: Changes in acid -base variables from timepoint A (baseline) to timepoint B 
(end anhepatic) in patients undergoing liver transplantation with venovenous bypass 
or with the piggyback technique. All values median (1S1, 3rd quartile). t P = 0.028. No 
other significant differences between the groups. 
Change between time point A and time point B (end anhepatic) 
Venovenous bypass (n = 8) Piggyback (n = 8) 
Lactate (mmol.L"') 0.87 (0.49,1.28) 0.83 (0.70,1.07) 
PaCO2 (kPa) 0.1 (- 0.2,0.70) 0.26 (- 0.01,0.47) 
[W] (nmo1.L'1) 5.70 (3.1,7.90) 1.75 ( -0.45, 3.28)t 
SBC (mmol.L -1) -2.0 (- 0.7, -3.7) -0.15 (0.8, -1.5) 
TABLE 6.4: Changes in acid -base variables between time point B (end anhepatic) and 
time point C (post reperfusion), and for gas exchange variables between time period II 
(anhepatic) and time period III (post reperfusion 30). All values median (1d, 3rd 
quartile). No significant differences between the groups. 





PaCO2 (kPa) 1.3 (0.8,1.7) 0.8 (0.3,1.0) 
[H1 (nmol.L -1) 11.3 (7.6,16.0) 9.1 (4.1,10.2) 
SBC (mmol.L "') -1.1 (- 0.6, -1.9) -1.7 (- 1.1, -2.7) 
VO2 (ml.min') 41 (35,54) 64 (55,75) 
VCO2 (ml.min') 24 (20,33) 26 (23,36) 
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TABLE 6.5: Comparison between blood temperature during liver transplantation for 
patients in the venovenous bypass and piggyback groups. All values median (lst, 3rd 
quartile). 
Temperature ( °C) 
Venovenous Bypass Piggyback 
Baseline 36.2 (35.8,37.0) 36.6 (36.1,37.1) ns 
Pre -reperfusion 35.5 (34.9,36.1) 36.9 (36.6,37.0) P =0.027 
Post -reperfusion 36.6 (35.9,37.1) 37.7 (37.3, 38.2) P =0.047 
TABLE 6.6: Correlations between changes in VO2, VCO2, cardiac index, and 
temperature between the baseline and anhepatic periods using data from all 16 
patients studied. 
Variables Correlation Coefficient (r) P value 
AVO2 vs Atemperature 0.67 P<0.01 
AVO2 vs Acardiac index 0.63 P<0.01 
OVCO2 vs Atemperature 0.67 P<0.01 
AVCO2 vs Acardiac index 0.40 ns 
Acardiac index vs Atemperature 0.50 P=0.05 
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DISCUSSION 
The principal finding of this study was that cardiac output and VO2 decreased less 
during the anhepatic period of liver transplantation when the piggyback technique was 
used in comparison with venovenous bypass. The use of the continuous cardiac 
output computer enabled many data points to be collected and averaged for each of 
the study time periods. Previous studies during liver transplantation have used 
intermittent thermodilution measurements to collect cardiac output data. As cardiac 
output may change rapidly during liver transplantation, as a result of acute alterations 
in venous return from surgical manipulation or blood loss, "snapshots in time" are 
potentially subject to considerable inaccuracy. Bottiger and colleagues (1997) has 
shown that continuous cardiac output measurements agree closely with intermittent 
thermodilution during liver transplantation except in the immediate post reperfusion 
period. In the present study the averaging of large numbers of data should have made 
comparisons between patients more meaningful. The limitations of the Deltatrac 
metabolic monitor for measuring gas exchange in ventilated patients, and during liver 
transplantation, have been discussed in previous chapters. Although measurement 
errors can potentially occur it is likely that these are considerably smaller in this 
setting than with the reverse Fick method which would also introduce the potential for 
mathematical coupling. 
This was an observational study which was not prospectively randomised. The 
surgical technique used in each patient was decided at the time of surgery by the 
surgeon. Patients were reasonably matched for diagnosis, Child's Pugh score, and 
baseline physiological status. In view of the relatively small numbers of patients 
examined it is possible that differences between the groups other than the surgical 
technique employed, or bias attributable to the surgeon, may have influenced results. 
The data confirm the findings of previous studies, which used intermittent 
measurements, that cardiac output is well maintained during the anhepatic phase with 
the piggyback technique (Figueras et al 1993, Belghiti et al 1995, Steib et al 1997). 
The data are also consistent with studies which documented a decrease in cardiac 
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output during the anhepatic phase despite the use of venovenous bypass (Kang et al 
1989, Shaw et al 1984, Cheema et al 1995). The decrease in cardiac output which 
occurs using venovenous bypass is dependent on the degree of fluid loading and 
bypass flow rates (Kindscher et al 1993, Steib et al 1997). Excessive fluid loading is 
usually avoided because of the risk of fluid overload following reperfusion, and bypass 
flow rates are frequently limited by the size and position of vascular cannulae. 
Consistent with these problems were the more predictable changes in cardiac output 
which occurred in the piggyback group in comparison with the venovenous bypass 
group. The only previous prospective comparison of the 2 techniques had similar 
findings, with a mean difference in cardiac index during the anhepatic period of 1.1 
L.min-1.m_2 based on 2 data points measured using intermittent thermodilution (Steib 
et al 1997). 
Several factors are likely to contribute to the decrease in VO2 which occurs during the 
anhepatic phase of liver transplantation. The physical removal of the liver, which in 
health accounts for approximately 25% of basal metabolic rate, results in a decrease in 
energy expenditure and therefore VO2 by the body (Svensson et al 1989). Within 
groups analysis indicated a decrease in VO2 during the anhepatic period in both 
groups, but the magnitude of the decrease was significantly greater in the patients in 
whom venovenous bypass was used. The groups were comparable for diagnoses and 
severity of liver disease and it is unlikely that differences in hepatic oxygen uptake 
explained the differences observed between the 2 surgical techniques. 
Given the differences in cardiac output and therefore global DO2 between the groups 
it is possible that VO2 differed because it was supply limited during the anhepatic 
period. In a study using gastric tonometry during liver transplantation, in which 
venovenous bypass was employed, Welte et al (1996) found evidence of gastric 
mucosal acidosis during the anhepatic period which they attributed to reduced 
splanchnic perfusion, and which resolved following reperfusion. Inadequate oxygen 
delivery to tissues may result from either inadequate perfusion pressure or flow and 
may occur more frequently with venovenous bypass. Anaerobic metabolism results in 
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an accumulation of acid and lactate. In the present study there were no statistically 
significant differences between the groups in lactate concentrations or acidosis prior 
to reperfusion although patients in the venovenous bypass group were more 
acidaemic. Following reperfusion there were no statistically significant differences 
between the groups for these variables. Steib et al (1997) were also unable to 
demonstrate differences in plasma lactate concentrations when comparing patients 
transplanted with these techniques. Many factors contribute to acidosis and 
hyperlactatemia during liver transplantation such as blood usage, temperature, fluid 
administration and extrahepatic lactate clearance. The sensitivity of these markers to 
indicate tissue hypoxia during liver transplantation may therefore be low. It is also 
possible that the small numbers of patients studied make conclusions subject to type II 
statistical error. This may explain why this study does not confirm the differences in 
the degree of acidaemia following reperfusion with the 2 techniques found in the 
previous chapter which included data from more patients. 
An alternative explanation for the differences between the groups is altered oxygen 
demand. Temperature has a major effect on metabolic rate and hypothermia occurs 
frequently during liver transplantation. Patients in the venovenous bypass group had 
lower pulmonary artery blood temperatures during the anhepatic period than those 
operated on using the piggyback technique and these differences persisted following 
reperfusion. A change in oxygen consumption of approximately 10% per degree 
Celsius has been demonstrated during cooling of febrile critically ill patients 
(Manthous et al 1995). It is therefore likely that differences in temperature between 
the groups contributed significantly to the differences in VO2 observed. Identical 
methods of temperature conservation were employed in both groups. Differences 
probably resulted from heat loss associated with extracorporeal circulation in the 
venovenous bypass group, and the shorter duration of the anhepatic period using the 
piggyback technique with which fewer anastomoses are required. Temperature 
differences persisted at 90 minutes following reperfusion indicating the importance of 
temperature conservation during liver transplantation. Hypothermia can have 
detrimental effects on coagulation, platelet function, cardiac function, and electrolyte 
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balance in addition to affecting metabolic rate. If differences in body temperature 
between the techniques persist into the immediate postoperative period, as is likely 
based on the data in this study, clinically relevant differences in time to recovery of 
consciousness may occur. These questions require examination in further studies. 
If differences in the decrease in VO2 during the anhepatic phase were primarily a 
result of supply limitation a greater oxygen debt might be expected in the venovenous 
bypass group. The difficulty interpreting acid -base changes in this setting have been 
discussed above but a greater increase in VO2 following reperfusion might have been 
anticipated in the venovenous bypass group as oxygen debt was paid off. Again, many 
factors interact at this time but the parallel changes which occurred support the notion 
that body temperature was an important factor in this study. 
The relation between cardiac output, temperature and VO2 were confirmed when 
correlations were examined for pooled data. These correlations confirm the 
physiological associations between these variables but do not enable conclusions to be 
drawn regarding the relative importance of cardiac output and temperature in 
explaining the differences between the groups. The weak correlation between changes 
in cardiac index and temperature was interesting. These variables correlate during 
cooling of febrile patients (Manthous et al 1995) which raises the possibility that some 
of the difference in cardiac output between the groups in the present study occurred 
as a result of differences in metabolic demand because of temperature differences. 
Differences in VCO2 between the groups were less marked than for VO2 and did not 
reach statistical significance. This may also represent type II error, but was also not 
unexpected because CO2 stores in the body are large and are influenced by factors 
other than aerobic metabolism, notably acid -base status. 
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CONCLUSIONS 
1) Cardiac output is greater during the anhepatic period of liver transplantation when 
the piggyback technique is used compared to venovenous bypass. 
2) VO2 is greater during the anhepatic period with the piggyback technique. This 
probably occurs because of better oxygen delivery to tissues and differences in 
oxygen demand as a result of temperature differences. 
3) Hypothermia appears to be less severe when the piggyback technique is used in 
comparison with venovenous bypass. 
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CHAPTER 7 
A COMPARISON BETWEEN REPERFUSION VIA THE PORTAL VEIN 
AND VIA THE HEPATIC ARTERY DURING LIVER TRANSPLANTATION. 
OBJECTIVES 
I) To compare changes in VO2 and VCO2 associated with reperfusion via the portal 
vein or the hepatic artery. 
2) To compare the acid -base changes occurring following reperfusion with each 
technique. 
3) To compare the cardiovascular changes which occur at reperfusion with each 
technique. 
BACKGROUND 
Graft reperfusion during liver transplantation is associated with complex physiological 
changes some of which were investigated in chapter 5. The clinical relevance of these 
changes can be considered in 2 categories: immediate and delayed. The immediate 
effects include alterations in cardiovascular and acid -base status, together with rapid 
changes in metabolic rate, which may acutely compromise cardiac, vascular and 
cerebral function. The delayed effects are more subtle and less well described but 
probably result from the process of reperfusion injury to the graft itself Reperfusion 
injury is initiated at the time of vascular reperfusion and is characterised by endothelial 
injury in hepatic sinusoids, a reduction in blood flow these vessels, and hepatocyte 
damage, all of which result in graft dysfunction in the post operative period (Bzeizi et 
al 1997). Some degree of reperfusion injury probably occurs in all transplanted livers, 
but it comprises a spectrum from clinically insignificant to primary non -function 
requiring re- transplantation. The clinical and economic costs of reperfusion injury are 
significant particularly if prolonged intensive care or re- transplantation are required 
(Spanier et al 1995). The aetiology of reperfusion injury is incompletely understood 
but oxygen derived free radicals have a central role in the initiation and progression of 
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the process (Bzeizi et al 1997). Improvements in organ retrieval techniques, 
subsequent preservation, and a reduction in ischaemic times have dramatically 
improved graft survival but primary graft dysfunction remains a significant clinical 
problem. 
At the time of graft reperfusion itself, the ideal technique would minimise both 
immediate and delayed complications. The previous chapter compared the piggyback 
and venovenous bypass techniques focusing on the anhepatic period. Traditionally 
reperfusion is performed via the portal vein which is frequently a technically easier 
vessel to anastomose. The portal vein carries a higher flow (typically 1L.min 1) in 
comparison with the hepatic artery (typical flow 0.5L.min-1)(Ganong 1991). Early re- 
anastomosis re- establishes normal venous drainage from the gut which may be 
compromised during the anhepatic period even when venovenous bypass is used. 
Potential disadvantages of portal vein reperfusion include the rapid large increase in 
venous return which may compromise cardiac function, and the simultaneous release 
into the circulation of ischaemic metabolites from both the gut and the graft which 
could contribute to cardiovascular and cerebral complications at this time (Carton et 
al 1994). The oxygen content of portal venous blood during health is significantly 
lower than in arterial blood and following reperfusion may be reduced further from 
normal levels as a result of haemodilution and oxygen debt in the gut. Reperfusion via 
the hepatic artery has not traditionally been practised because of lower total flow and 
uncertainties regarding the adequacy of flow within the graft itself, although the 
oxygen content and pressure of blood in this vessel are higher. Anatomical anomalies 
may also make the hepatic artery technically more difficult to anastomose. However, 
there are potential advantages to this approach which include less cardiovascular 
disturbance and a staged release of ischaemic metabolites into the systemic 
circulation. 
There are no studies in human liver transplantation which compare in detail 
reperfusion via the portal vein with primary hepatic arterial reperfusion. This chapter 
describes a prospective observational study in which these techniques were compared 
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with respect to changes in oxygen consumption (as a marker of graft oxygen uptake), 




20 patients were prospectively studied (10 in each group)(table 7.1). The study was 
not randomised and the decision regarding which technique was employed was made 
by the surgeon at the time of operation based on operative findings. In all patients the 
piggyback technique was employed. The use of temporary portacaval shunting is 
indicated in table 7.1). The cases in which no shunt was used had a period of portal 
occlusion at the time of recipient hepatectomy during which no haemodynamic 
disturbance occurred. Anaesthetic management and cardiovascular monitoring in all 
cases were identical to that described in the previous chapters. VO2 and VCO2 were 
measured throughout using the Deltatrac metabolic monitor recording data to 
computer each minute. Calibration and technique of metabolic recordings were as 
previously described. 
Management of repeifüsion 
Portal vein group: In these cases the portacaval shunt was taken down and 
reperfusion occurred after the portal vein anastomosis was completed. This was 
followed by hepatic arterial anastomosis. 
Hepatic artery group: In these cases the portacaval shunt was left in place while the 
hepatic artery was anastomosed and reperfusion performed. Thereafter the portacaval 
shunt was taken down and portal vein anastomosis carried out. 
Preservation of grafts and flushing prior to reperfusion was identical in both groups. 
Following reperfusion adrenaline was administered to treat haemodynamic 
disturbance as clinical indicated. 
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Table 7.1: Demographic and descriptive data. n = 10 in each group 
Diagnosis 
Portal vein group Hepatic artery group 
Primary Biliary Cirrhosis 4 6 
Alcoholic Liver Disease 2 1 
Cryptogenic Cirrhosis 0 2 
Chronic Active Hepatitis 0 1 
Subacute Hepatic Failure 2 0 
Chronic Rejection of Transplant 1 0 
Primary Sclerosing Cholangitis 1 0 
Age (mean (range) 51 (35 -60) 45 (24 -65) 
Sex (F/M) 6/4 8/2 
Use of portocaval shunt (n /l0) 6/10 8/10 
Measurements 
VO2 and VCO2 
The following time periods were chosen for analysis: 
Time period I (pre -reperfusion): The mean of the 10 minute period immediately 
prior to reperfusion. 
Time period II: The mean of the 10 minute period from 10 -20 minutes 
following reperfusion of the graft. 
Time period III: The mean of the 10 minute period from 10 -20 minutes 
following reanastomosis of the second vessel. 




As discussed in chapter 5 cardiac output measurements are unreliable in the 
immediate post- reperfusion period. Cardiac output was therefore compared 
immediately prior to reperfusion (during time period I) and following anastomosis of 
the second vessel (time period III). Mean arterial pressure was compared 10 minutes 
before and 10 minutes after reperfusion, and 10 minutes before and after 
reanastomosis of the second vessel. 
Acid -base variables and temperature: 
The evolution of acid -base changes following reperfusion were examined by 
measuring plasma whole blood lactate, hydrogen ion, and standard bicarbonate 
concentrations and PaCO2 at the following time points: 
Time point A: prior to reperfusion. 
Time point B: 30 minutes following reperfusion. 
Time point C: 60 minutes following reperfusion. 
Pulmonary artery blood temperature was compared immediately before and 1 hour 
after reperfusion. 
Post- reperfitsiorn injruy 
As an index of post -reperfusion injury the plasma alanine aminotransferase (ALT) 
concentrations were compared 24 hours after transplantation. 
Statistical analysis. 
Changes in physiological variables between the periods of interest were compared 
between the groups. Data were not normally distributed. The Mann -Whitney U test 
with Bonferroni's correction for multiple comparisons was used for analysis. 
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RESULTS 
19 patients survived transplantation with good graft function and were alive 3 months 
following surgery. One patient in the hepatic artery group developed a portal vein 
thrombosis requiring surgical intervention on day 4 post transplantation, and 
subsequently an hepatic artery thrombosis on day 5 post transplantation. This was 
complicated by graft failure, and the patient died prior to a further liver becoming 
available. 
The groups were similar for all physiological variables prior to reperfusion (table 7.2). 
Changes in VO2 for each patient over the 4 time periods are illustrated in figures 7.1 
and 7.2. In the portal vein group a single large increase in VO2 occurred following 
reperfusion, with little further change occurring after anastomosing the hepatic artery. 
In the hepatic artery group the increase in VO2 was biphasic with a significant further 
increase in VO2 occurring when the portal vein was anastomosed. These differences 
between the groups were statistically significant (figure 7.2). The overall increase in 
VO2 between time periods I and IV was similar for both groups. Typical plots of 
continuous data for a patient in each group are shown in figure 7.3. Changes in blood 
temperature over the period of interest were also similar for both groups (Table 7.3). 
Changes in VCO2 for each group between the time periods were not significantly 
different between the groups except between time periods III and IV when the 
increase was statistically greater in the hepatic artery group, although the magnitude 
of this difference was small (figure 7.4). 
Cardiovascular changes are shown in tables 7.4 and 7.5. Within both groups a small 
decrease in mean arterial pressure accompanied reperfusion but differences between 
the groups were not significant. No change in mean arterial pressure occurred when 
the second vessel was opened. Cardiac index increased over the study period in both 
groups; there was no difference in the magnitude of these changes between the 
groups. However, adrenaline usage over the reperfusion period was significantly 
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Figure 7.2: Changes in oxygen consumption (VO2) after reperfusion 
with the portal vein or hepatic artery first. n = 10 in each group. 
Upper panel shows medians (1st, 3rd quartiles). Lower panel shows 


























1 s » 
r !r,. : '9". : : s 
Hepatic Portal 
artery vein 






.: ' I~, Y .. 
Figure 7.3: Example of continuous data for VO2 from a 
patient reperfused via the hepatic artery or via the 
portal vein. Each data point represents 1 minute. 
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TABLE 7.2: Baseline data prior to reperfusion for patients reperfused via the hepatic 
artery or portal vein (n = 10 in each group). All values median (15`, 3rd quartile). No 
significant differences between the groups. 
Hepatic artery group Portal vein group 
VO2 (mL.min 1) 163 (150, 185) 177 (127, 203) 
VCO2 (mL.miri 1) 132 (128, 159) 151 (135, 157) 
Cardiac index (L.min 1.m "2) 5.4 (5.1, 8.2) 5.1 (4.7, 6.7) 
MAP (mmHg) 78 (73, 85) 74 (63, 85) 
Blood temperature ( °C) 36.6 (36.3, 37.4) 36.7 (36.4, 37.2) 
Blood Lactate (mmol.L "1) 1.55 (1.35,1.82) 1.90 (1.75, 2.09) 
H"" concentration (nmol.L -1) 40.0 (37.1, 44.4) 42.1 (40.9, 47.0) 
SBC (mmol.L "1) 22.3 (20.5, 23.3) 22.1 (21.0, 23.6) 
PaCO2 (kPa) 4.12 (3.88, 4.56) 4.67 (4.36, 4.96) 
TABLE 7.3: Changes in temperature within the groups over the study period. All 
values median (1s`, 3rd quartile). No significant differences between the groups. 
Temperature ( °C) 
Pre- reperfusion 1 hour Post- 
reperfusion 
Change 
Hepatic artery 36.6 (36.3, 37.4) 37.0 (36.8, 37.7) 0.4 (0.3, 0.5) 
Portal vein 36.7 (36.4, 37.2) 37.1 (36.8, 37.4) 0.4 (0.3, 0.7) 
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Figure 7.4: Changes in carbon dioxide elimination (VCO2) after 
reperfusion with the portal vein or hepatic artery first. 
Upper panel shows median (1st, 3rd quartiles) VCO2 for each time 
period. Lower panel shows changes for individual patients 
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Figure 7.5: Adrenaline usage following reperfusion 
using the portal vein or hepatic artery. 
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Table 7.4: Comparison of changes in cardiac index between the groups. All values 
median (1s`, 3`d quartile). * P <0.01 for changes within groups. No significant 
difference between groups. 
Cardiac index (L.mini'.m 2) 
Pre- reperfusion Post- reperfusion (both vessels) 
Hepatic artery group 5.4(5.1,8.2) 6.4(5.4,8.6)* 
Portal vein group 5.1 (4.7,6.7) 6.8(6.1,7.4)* 
Table 7.5: Comparison of changes in mean arterial pressure for the groups. All values 
median (15`, 3`d quartile). * P <0.01 within groups. No significant differences between 
groups. * P <0.01 compared with pre -reperfusion values. 
Mean Arterial Pressure 
Reperfusion 2nd vessel 
Pre Post Pre Post 
Hepatic artery group 78(73,85) 67(58,70)* 68(61,77) 72(62,76) 
Portal vein group 74(63,85) 64(57,70)* 66(60,68) 68(61,71) 
Acid -base data are shown in figures 7.6 to 7.9. These indicate a trend towards greater 
acidaemia following portal vein reperfusion than in the hepatic artery group. Changes 
in blood lactate concentration and standard bicarbonate concentration were similar 
between the groups. The rate of increase in PaCO2 was slower in the hepatic artery 
group. 
The time between reperfusion and and opening of the second vessel was significantly 
longer in the portal vein group than in the hepatic artery group (median (15`, 
3rd 
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quartile): 52 (45, 69) vs 25 (20, 36), P <0.01). There was no significant difference 
between plasma ALT concentrations 24 hours post transplantation between the 
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Figure 7.6: Changes in blood lactate concentration following reperfusion. 
Upper panel shows median (1st, 3rd quartile) lactate concentration at 
each time point. Lower panel compares changes between each time 
point for the 2 groups. 
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Figure 71: Changes in hydrogen ion concentration following reperfusion. 
Upper panel shows median (1st, 3rd quartile) hydrogen ion concentration at 
each time point. Lower panel compares changes between each time 
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Figure 7.8: Changes in standard bicarbonate concentration 
following reperfusion. Upper panel shows median (1st, 3rd quartile) standard 
bicarbonate concentration at each time point. Lower panel compares 
changes between each time point for the 2 groups. 
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Figure : Changes in PaCO2 following reperfusion. 
Upper panel shows median (1st, 3rd quartile) PaCO2 at each 
time point. Lower panel compares changes between each time 
point for the 2 groups. 171 
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Figure 7.10: Plasma Alanine aminotransferase (ALT) concentrations 
24 hours post transplantration in patients reperfused via the 
hepatic artery or portal vein. No significant differences 
between the groups. 
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DISCUSSION 
The principal findings of this study were that the increase in VO2 which occurred 
following reperfusion via the hepatic artery was biphasic, in contrast to the single 
rapid increase which followed portal vein reperfusion. Cardiovascular parameters 
were similar for both groups but the vasopressor requirement in the portal vein group 
was significantly greater. Acidaemia and PaCO2 increased more rapidly in the portal 
vein group. 
As in previous chapters methodological factors warrant consideration in interpreting 
the data. The limitations of the Deltatrac metabolic monitor have been discussed 
previously. Of particular relevance to this study was the problem of physiological 
steady state in the immediate post reperfusion period and its effect on the accuracy of 
measurements. Ten minutes were allowed for equilibration after each vessel was 
opened before data was analysed, and a 10 minute period was then averaged. A 
longer equilibration period was not feasible as the second vessel was opened after 
approximately 20 minutes in some cases. As discussed in chapter 5 inaccuracy from 
unsteady state is difficult to quantify at this time, but should decrease exponentially 
with time after reperfusion. In most patients a plateau was reached within a few 
minutes as shown in figure 7.3, suggesting that the majority of re- equilibration 
occurred rapidly and subsequent changes were not a major source of error for VO2 
estimation. 
Limited cardiovascular data were collected and the analysis of derived haemodynamic 
variables was avoided. Measurement of cardiac output with the continuous 
thermodilution method used is inaccurate in the post -reperfusion period because of 
rapid changes in temperature, infusion of fluids, and cardiovascular instability 
(Bottiger et al 1997). Comparison between values from the pre -reperfusion and 1 
hour post -reperfusion periods were considered useful and indicated no differences 
between the groups. It has already been shown that relatively minor changes in 
cardiac output occur after reperfusion when the piggyback technique is used, so it 
was not surprising that differences between the groups in this study were not 
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significant. 
The most clinically relevant cardiovascular complication of reperfusion during liver 
transplantation is systemic hypotension which occurs primarily because of 
vasodilatation (Carton et al 1994). Controversy exists regarding the importance of 
myocardial dysfunction at this time, in part because most studies have based 
conclusions on calculated variables such as stroke work and stroke volume. For these 
variables to accurately reflect myocardial function preload and afterload conditions 
must remain constant which is not the case during the reperfusion period. Most 
studies indicate that myocardial dysfunction is not usually severe following 
reperfusion (Carton et al 1994). The most frequent complication is arrhythmia which 
results from acute electrolyte and acid -base disturbance and reduced coronary 
perfusion from systemic hypotension and elevated cardiac filling pressures. No 
difference was found in mean arterial pressure between the groups in the present 
study, but the requirement for vasopressors was significantly greater in the portal vein 
group. These data are consistent with less vasodilatation, and possibly myocardial 
dysfunction, in the hepatic artery group but further specific studies are required to 
confirm this hypothesis. 
This study was observational, was not randomised and the choice of technique was 
made by the surgeon. In addition, the time required for anastomosis of the second 
vessel was significantly longer in the portal vein group. These are all potential sources 
of bias which may have influenced the results obtained, and require consideration if a 
larger outcome study is planned. 
The primary objective of the study was to compare changes in VO2 between the 
groups and clear differences were found. Several factors may contribute to the 
changes in VO2 which occur following reperfusion. Oxygen uptake by the graft 
probably accounts for most of the increase observed and previous studies have related 
the magnitude of this change to graft function (Svensson et al 1989, Steltzer et al 
1992, Gubernatis et al 1989). Oxygen debt incurred in other tissues during the 
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anhepatic period, particularly the gut, is also relevant as suggested in the previous 
chapter. It is unknown if tissue oxygen extraction either in the graft or in other organs 
is impaired in the post reperfusion period, but if present this may result in regional 
oxygen supply dependency which is not apparent from global measures such as VO2. 
The importance of temperature has also been discussed in the previous chapters, as 
was the possible contribution of oxygen derived free radicals. Endotoxaemia occurs 
during liver transplantation (Miyata et al 1989, Welte et al 1996) which could alter 
VO2 by stimulating the systemic inflammatory response syndrome (Oudemans -van 
Straaten et al 1996). Furthermore, adrenaline may alter VO2 as was discussed in the 
introduction to this thesis. The relative contribution of these various factors make 
interpretation of the data in a human study performed under clinical conditions 
difficult. A previous study attempted to quantify oxygen uptake across the 
transplanted liver by measuring flow and oxygen content in hepatic arterial, portal 
venous, and hepatic venous blood but the measurement errors associated with this 
method are so large that the validity of the data is questionable (Russell et al 1995). 
In the present study the piggyback technique was used in all cases making the groups 
comparable in this respect. Temperature changes over the reperfusion period were 
also similar. Leaving aside the contribution of hypothetical factors such as 
endotoxaemia and free radical formation there are 2 likely explanations for the 
differences between the groups: 
Differences in hepatic oxygen uptake: It is possible that oxygen uptake by the graft 
was slower in the hepatic artery group, most likely as a result of less efficient oxygen 
supply. If correct, this observation is important because it suggests warm ischaemia of 
the graft is prolonged which could increase ischaemic injury and adversely affect 
subsequent function. The portal venous system is a high -flow, low pressure, low 
resistance circulation which drains directly into the hepatic sinusoids from which 
oxygen diffuses to hepatocytes. In contrast, the hepatic arterial system is a complex 
high pressure system with high resistance in the hepatic arterioles. Blood reaches the 
sinusoids via a variety of routes each associated with a drop in pressure from arterial 
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to sinusoidal levels (Williams and Warwick 1980). The chief pathway is via a system 
of capillaries which form a plexus around the interlobular hepatic ductules and drain 
into various branches of the portal veins, venules, and hepatic sinusoids. This system 
is rich in capillary sphincters such that, in health, blood flow is dynamically altered 
according to regional requirements within the liver. The function of this system in 
reperfused livers following cold preservation is unknown. Only a small proportion of 
hepatic arterial blood directly enters the sinusoids (Williams and Warwick 1980). 
Hepatocytes distant to the portal triads exist under conditions of relative hypoxia, and 
oxygen consumption by these cells is likely to be limited by supply. Abnormal blood 
flow within the graft is common following reperfusion (Bzeizi et 1997) so that 
differences between hepatic arterial and portal venous reperfusion could be clinically 
relevant. The overall changes in VO2 over the study period were similar between the 
groups but this is unlikely to be a sufficiently sensitive marker of later graft function. 
Similarly, there was no difference between the groups in the 24 hour ALT values, a 
useful marker of reperfusion injury, but a larger study is needed to specifically address 
this question. In future work tests of graft function such as indocyanine green 
clearance production may be valuable as a more sensitive and specific marker of early 
graft function (Jalan et al 1994). 
Differences in oxygen debt: An alternative explanation for the differences observed 
relates to the rate at which oxygen debt incurred during the anhepatic period is paid 
off. The best clinical indices of oxygen debt are acid -base balance. Considering all 
acid -base parameters together the overall pattern observed suggested that in the 
portal vein group reperfusion was associated with a sudden release of acid from the 
graft and other tissues such as the gut. By the time the hepatic artery was perfused the 
oxygen debt had been cleared and little further change occurred. Conversely, in the 
hepatic artery group a lesser degree of acidaemia occurred following reperfusion but a 
further acid load followed portal vein anastomosis. The second load may originate 
from the gut or from the graft itself. Assuming ischaemic metabolites contribute to 
physiological instability following reperfusion this decrease in the rate of release may 
be beneficial at least in high risk patients. A clear relationship between altered cerebral 
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blood flow velocity and tourniquet release has been demonstrated in humans 
undergoing limb surgery, and closely linked to the release of ischaemic metabolites 
particularly changes in PaCO2 (Hirst et al 1990). This may be of particular relevance 
to the post reperfusion liver transplant patient. Increases in cerebral blood flow and 
cerebral blood flow velocity have been clearly demonstrated following reperfusion in 
patients undergoing elective liver transplantation and may persist for several hours 
(Doblar et al 1995, Skak et al 1997, Philips et al 1998). The factors which mediate 
this phenomenon are unresolved but hyperventilation prior to reperfusion has been 
shown to attenuate the increase in cerebral blood flow velocity which occurs (Doblar 
et al 1995). The rate of rise of PaCO2 was slower in the hepatic artery group and it is 
a reasonable hypothesis that this might be associated with less cerebrovascular 
disturbance. 
The relation between different acid -base variables following reperfusion merits further 
consideration in the light of the findings of this study, particularly as the changes in 
standard bicarbonate concentration were unremarkable. The increase in PaCO2 
following reperfusion is attributable to several factors which were discussed in chapter 
5. The primary determinant of VCO2 is alveolar ventilation. Minute ventilation 
remained constant over the study period although it was shown in chapter 5 that a 
small increase in alveolar ventilation occurs in association with increased pulmonary 
perfusion following reperfusion. The increase in PaCO2 thus results from increased 
metabolic production. This occurs in part from buffering of the released acid load, 
which should be associated with a decrease in standard bicarbonate concentration. In 
addition, carbon dioxide originates from increased aerobic metabolism by tissues. 
Carbon dioxide produced by oxidative phosphorylation is transported in the blood in 
three forms: dissolved, as carbamino compounds (primarily bound to haemoglobin), 
and as bicarbonate (Nunn 1977). Of these bicarbonate is quantitatively most 
important. Bicarbonate is generated in red blood cells from CO2 by carbonic 
anhydrase and then effluxes into the plasma in exchange for chloride ions (the 
Hamburger effect). Hydrogen ions produced in this reaction are buffered by reduced 
haemoglobin within the red cells themselves. Reperfusion during liver transplantation 
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is associated with a rapid decrease in mixed venous haemoglobin oxygen saturation so 
that the buffering capacity of haemoglobin at this time is large (Riano et al 1991). 
Thus increased production of carbon dioxide within tissues, as metabolic rate 
increases, is associated with significant bicarbonate generation. This may explain why 
the release of an acid load at reperfusion is not accompanied in all cases by acidosis. 
High capacity for red cells to carry carbon dioxide and convert it to bicarbonate is 
also the likely explanation for the less marked differences between the two groups in 
VCOZ in comparison with VO2 following reperfusion. 
CONCLUSIONS 
1) Reperfusion of the donor liver via the hepatic artery rather than the portal vein was 
associated with a slower increase in VOZ. 
2) The release of acid load following reperfusion occurred more gradually when the 
hepatic artery was used in comparison with the portal vein. 
3) Adrenaline requirement was less when the hepatic artery was used suggesting 
greater cardiovascular stability. 
4) No differences in early graft function were apparent from this observational study 




This thesis has centred on oxygen kinetics in patients with liver disease. In patients 
with fulminant hepatic failure oxygen transport and uptake were examined with 
particular reference to the effect of N- acetylcysteine, and energy expenditure was 
assessed in comparison with truly anhepatic patients during liver transplantation and 
healthy control subjects. During liver transplantation the changes in gas exchange 
which occur after graft reperfusion were documented in detail, and two surgical 
techniques for managing the anhepatic period and for reperfusing the donor graft were 
compared with reference to oxygen balance. In reviewing previous studies of oxygen 
kinetics in the critically ill it was clear that, despite the large number of studies which 
exist, conclusions are contradictory and consensus regarding the importance of 
oxygen balance in the critically ill is lacking. It is my belief that much of this confusion 
is attributable to the methodology used in previous work. A primary objective of this 
thesis was to examine the best available means of investigating oxygen kinetics in 
patients with liver disease so that potentially confounding factors in the data obtained 
were recognised. 
In chapter 3 two important types of measurement error were examined: the 
reproducibility of oxygen consumption measurements and the effect of mathematical 
coupling on the relationship between oxygen delivery and consumption. Gas exchange 
measurements of oxygen consumption, made using an automated metabolic monitor, 
were compared with calculations by the reverse Fick method. This study was 
performed under the clinical conditions present in most patients examined in 
subsequent studies, that is a cardiovascular pattern characterised by high cardiac 
output and small arteriovenous oxygen content difference, and no significant lung 
injury or requirement for high inspired oxygen fractions. The agreement between 
these methods of measurement was very poor, and two important observations were 
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made. First, the relative reproducibility of the Fick method was much worse that the 
gas exchange method suggesting most of the measurement error occurred from Fick 
calculations. Second, the Fick method gave values consistently less than gas exchange 
measurements. 1 have considered in detail the errors associated with each method of 
measurement and related these to the conditions present in the patients studied. 
Although the Fick method for determining oxygen consumption is theoretically 
correct it assumes complete accuracy of all physiological measurements. The problem 
with the Fick method is propagation of error. The simple mathematical model derived 
in chapter 3 to examine the magnitude of errors in the final calculation of oxygen 
consumption clearly illustrates that when the cardiac output is large and the 
arteriovenous oxygen content is small the reproducibility of data with the Fick method 
is likely to be poor even if primary physiological measurements are of acceptable 
accuracy. In the patients examined in this thesis, therefore, gas exchange 
measurements were considered most accurate. This may not be the case in other 
patient groups. For example, in a patient with acute lung injury, high inspired oxygen 
fractions, high airway pressures, and low mixed venous oxygen saturation the Fick 
method may perform better. 
The bias between the methods of measurement is a consistent finding in studies which 
compare the methods and may be due, in part, to pulmonary oxygen consumption. 
Some studies have used this hypothesis to estimate pulmonary oxygen consumption in 
experimental animals and critically ill humans and at the present time there is no other 
way of investigating this in vivo (Light 1988, Jolliet et al 1996). Pulmonary oxygen 
consumption calculated in this way is a highly derived variable which will inevitably be 
associated with significant inaccuracy. Studies in this area are interesting and 
potentially valuable, but errors require careful consideration when interpreting data. 
Work published to date on this subject has not included any assessment of 
reproducibility. 
The importance of mathematical coupling has been central to interpreting the oxygen 
kinetics literature and was examined in chapter 3. In recent years a consensus has 
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emerged that mathematical coupling does explain much of the dependence of oxygen 
consumption on delivery in the critically ill, although agreement is far from universal 
(Schumacker 1998). Although studies have clearly shown that mathematical coupling 
can explain oxygen supply dependency few studies have clarified under what 
circumstances this is most likely to happen. This is important because gas exchange 
methods are unavailable in most intensive care units and, as noted above, there are 
circumstances in which they are insufficiently accurate. In considering this question it 
was concluded that several factors favour coupling error when interpreting oxygen 
kinetics data. These are summarised in table 8.1. 
TABLE 8.1: factors which increase the chance of mathematical coupling error in 
oxygen kinetics studies. 
Large measurement errors in the primary variables 
Small arterial- venous oxygen content difference which magnifies error by propagation 
Plotting too few data over too small a range of DO2 
Pooling data from many patients during analysis rather than analysing changes in 
individuals 
Study designs which favour positive or negative measurement errors 
I believe these factors apply to many published oxygen kinetics studies in the critically 
ill. A retrospective review supports this conjecture in that studies which used gas 
exchange methods or made many Fick calculations over a wide range of oxygen 
delivery have generally failed to demonstrate oxygen supply- dependency whereas 
those which apparently confirm it made a small number of Fick calculations in 
conjunction with modest changes in oxygen delivery, often pooling data prior to 
statistical analysis (Russell and Phang 1994). 
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This consideration of measurement errors was designed around the study which re- 
evaluated the effect of N- acetylcysteine on oxygen kinetics in patients with fulminant 
hepatic failure. The results of an earlier influential study in this area were potentially 
subject to the errors described above and this was confirmed by the results of my study 
which found no evidence of improved global oxygen consumption in patients with 
fulminant hepatic failure during N- acetylcysteine infusion. The cardiovascular effects were 
also less marked than previously reported and although the number of patients studied 
was small these observations were more in keeping with findings in other groups of 
critically ill patients. Pharmacokinetic factors may well explain the immediate yet transient 
effects observed in some of the patients in this and other studies, and there is a clear need 
for studies to define the optimum dose and regimen for N- acetylcysteine in critically ill 
patients. 
Although the study in this thesis indicates N- acetylcysteine is unlikely to significantly alter 
global oxygen transport and uptake in patients with fulminant hepatic failure, the 
observed effect on outcome in this patient group remains unexplained. This benefit has 
only been demonstrated by one research group and, although widely accepted, it is 
possible that the finding is erroneous. Alternatively, it is possible that N- acetylcysteine has 
alternative mechanisms of action in the critically ill. The drug could alter regional blood 
flow. A study in critically ill patients with hepatic dysfunction demonstrated improved 
indocyanine green (ICG) clearance, indicative of either improved hepatic blood flow or 
ICG extraction, following N- acetylcysteine (Devlin et al 1997), and in a study in septic 
patients gastric tonometry suggested a modest reduction in gastric mucosal acidosis in 
those patients in whom cardiac output increased following administration of the drug 
although no improvement was observed in patients in whom global haemodynamic 
measurements were unchanged (Spies et al 1994). In patients with sepsis syndrome, N- 
acetylcysteine attenuated the decrease in gastric intramucosal pH and OER which 
occurred during transient hyperoxia in comparison with control patients (Reinhart et al, 
1995). These effects may be mediated via a vasodilatory effect on microvascular blood 
flow. Patients with fulminant hepatic failure have elevated plasma concentrations of cyclic 
guanosine monophosphate (cGMP) (Schneider et al 1994, Harrison et al 1996), and 
nitrite (Wendon et al 1994) which are indirect markers of nitric oxide activation. N- 
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acetylcysteine infusion further increases plasma cGMP concentrations in patients with 
fulminant hepatic failure which may indicate enhanced nitric oxide synthesis (Harrison et 
al 1996). A similar mechanism, probably mediated via the sulphydryl group on the 
molecule, may explain the ability of N- acetylcysteine to reverse tolerance to the 
vasodilator actions of organic nitrates (Horowitz et al 1988, Boesgaard et al 1992). 
Although there is little work documenting in detail the haemodynamic effects of N- 
acetylcysteine in healthy humans, it appears from studies in patients who have recovered 
from fulminant hepatic failure that the vasodilatory action of the drug is either absent or 
much less marked in normal individuals (Harrison et al 1991, 1996). 
If the hypothesis that N- acetylcysteine beneficially alters microvascular blood flow within 
tissues is correct, this might improve regional tissue oxygenation even if global measures 
of oxygen consumption and extraction remain unchanged. A mismatch between oxygen 
demand and supply within tissues is hypothesised during sepsis (Walley 1996), and is 
supported by animal models (Humer et al 1996). Similar derangements may also be 
present in patients with fulminant hepatic failure, in whom control of vascular tone is 
clearly abnormal. 
Animal models indicate that pre- treatment with N- acetylcysteine may be protective in 
experimental endotoxaemia (Zhang et al 1994, Peristeris et al 1992) and ARDS (Bernard 
et al 1984, Bernard 1991, Modig and Sandin 1987) if given before the experimental 
insult. Post -insult treatment with N- acetylcysteine decreased oxidant stress, pulmonary 
neutrophil influx and lung leak in a rat model of lung injury (Leff et al 1993). It is 
hypothesised that these actions might be mediated via replenishment of antioxidant 
defences either through enhanced glutathione synthesis or via a direct antioxidant 
mechanism. Oxidant defences are depleted in critically ill patients, notably those with 
sepsis (Goode and Webster 1993, Goode et al 1995) and ARDS (Gadek and Pacht 1996). 
Depletion of antioxidant defences has also been associated with the development of 
multiple organ failure and death in the critically ill (Borrelli et al 1996, Cowley et al 
1996). These studies suggest a potential therapeutic benefit via restoration of antioxidant 
defences. Human studies have demonstrated replenishment by N- acetylcysteine of plasma 
cysteine concentrations and red blood cell and granulocyte glutathione concentrations in 
183 
patients with ARDS (Bernard 1991, Bernard et al 1996, Laurent et al 1996). A direct 
antioxidant action for N- acetylcysteine in vivo is also supported by in vitro studies which 
indicated potent free radical scavenging activity (Aruoma et al 1989), and recent animal 
work has also shown that N- acetylcysteine may be capable of modulating the release of 
the protein Nuclear Factor KB which has a pivotal role in initiating the systemic 
inflammatory response (Blackwell et al 1996). An immune modulating effect would be 
consistent with earlier animal work documenting suppression of TNF -a release by N- 
acetylcysteine (Peristeris et al 1992, Zhang et al 1994). 
Although N- acetylcysteine is reported to decrease mortality in fulminant hepatic failure 
clinical studies in patients with ARDS and sepsis have equivocal results. In a prospective 
randomised controlled study in patients with mild to moderate acute lung injury N- 
acetylcysteine significantly reduced ventilator days and improved indices of oxygenation 
(Suter et al 1994). However the incidence of ARDS and mortality were not reduced. A 
small prospective double -blind controlled study also observed a non -significant trend 
towards a decrease in lung injury scores in the N- acetylcysteine- treated group in patients 
with established ARDS (Bernard et al 1997). Jepsen and colleagues (1992) prospectively 
randomised 66 patients with established ARDS to receive N- acetylcysteine or placebo 
infusions for 6 days. These authors were unable to demonstrate any improvement in 
oxygenation indices, ventilator requirement or mortality in the N- acetylcysteine group, 
and associated a significant anticoagulant effect with the drug. In another prospective 
randomised controlled trial Molnar et al (1998) studied the effect of N- acetylcysteine 
infusion, commenced following admission to the intensive care unit, in a mixed group of 
23 critically ill patients who required one or two organ system support. They found no 
beneficial effect on organ function, intensive care unit stay or mortality in comparison 
with a matched control group. There was also no difference in total plasma antioxidant 
potential or microalbuminuria (an index of capillary permeability) between the groups 
although plasma antiooxidant potential was normal in the majority of patients at study 
entry. 
Free radical production is implicated in mediating tissue damage following reperfusion of 
previously ischaemic tissues (the ischaemia- reperfusion syndrome). Liver transplantation 
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is a situation where true pre -insult treatment with antioxidant drugs is feasible. Reactive 
oxygen species are generated following graft reperfusion during orthotopic liver 
transplantation (Bzeizi et al 1993, 1997), a time at which acute depletion of plasma 
antioxidants has been demonstrated (Goode et al 1994). Experimental work has 
suggested that N- acetylcysteine may reduce reperfusion injury in transplanted livers either 
through an antioxidant mechanism (Nakano et al 1995, Fukuawa 1995) or by improving 
blood flow within the graft (Koeppel et al 1996, Thies et al 1997). Steib and colleagues 
(1998) hypothesised that treatment with N- acetylcysteine prior to graft reperfusion may 
be beneficial in human liver transplantation. However, in a prospective randomised 
controlled study of 60 patients undergoing elective liver transplantation they were unable 
to demonstrate any clinical benefit from N- acetylcysteine started during the anhepatic 
phase. Similar findings were reported by Bromley et al (1995). 
It is clear from this review of the literature that, if not via improved global oxygen 
kinetics, a possible beneficial therapeutic effect of N- acetylcysteine in critically ill human 
patients has a sound theoretical and experimental basis, but is unproven in clinical studies. 
Further work in this area is clearly warranted. 
In chapter 4 the energy expenditure of patients with fulminant hepatic failure was 
investigated. This was considered of particular interest because of the many contrasting 
factors which may influence metabolic rate in this condition, in particular the massive loss 
of functioning liver cell mass which, in health, is metabolically highly active. The patients 
in this study were paralysed, sedated, and ventilated which made meaningful comparison 
with a control group problematic. It was therefore not surprising that predictive equations 
for estimating energy expenditure were of little value. Comparing patients with healthy 
control subjects indicated that energy expenditure is significantly elevated in fulminant 
hepatic failure despite the effects of paralysis and sedation on metabolic rate. This finding 
was confirmed from the comparison with patients studied during the anhepatic phase of 
liver transplantation. In health metabolic rate is determined primarily by lean body mass, 
and 20 -25% of this is attributable to hepatic metabolism. The studies in chapter 4 
indicated that alterations in liver metabolic rate per se are not the primary determinant of 
energy expenditure during fulminant hepatic failure. Instead, other systemic factors 
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predominate. Patients have the clinical features of the systemic inflammatory response 
syndrome which is characterised by hypermetabolism in other forms of critical illness. In 
the patients with fulminant hepatic failure TNF and IL -6 concentrations were elevated and 
it is likely that these, and other inflammatory factors, mediate the increase in energy 
expenditure in this condition. It was interesting that an acute phase protein response, as 
measured by C reactive protein concentrations, was present even though this is thought to 
require intact hepatic synthetic function. This may indicate residual synthetic function 
within the liver or perhaps an alternative source of acute phase proteins. 
This study clearly indicates a significant increase in energy requirements in patients with 
fulminant hepatic failure. In other forms of critical illness the metabolic response to 
increased energy requirements includes marked increases in hepatic gluconeogenesis and 
lipolysis both of which are likely to be significantly impaired during fulminant hepatic 
failure. The combination of markedly increased glucose demand and reduced hepatic 
synthesis explains the frequent occurrence of hypoglycaemia in this condition. 
In chapters 5 -7 oxygen kinetics in patients undergoing liver transplantation were 
examined. Physiological studies during clinical liver transplantation are difficult because 
many factors influence the variables under consideration which can each change rapidly, 
in particular at the time of graft reperfusion. The approach used in this thesis was to 
average as many data points as possible for the periods of interest in order to measure as 
accurately as possible the true status of patients at particular time points or during 
particular periods. The use of a continuous cardiac output monitor was of particular value 
in this respect. In chapter 5 the changes in cardiovascular and gas exchange variables 
which occur following reperfusion were documented in detail. It was clear that a 
substantial increase in metabolic rate occurs at this time. This observation has been made 
by some previous authors many of whom have suggested this to be a valid marker of graft 
function. It is clear, however, that many factors influence metabolic rate at this time in 
addition to oxygen uptake by the graft, notably oxygen debt from the anhepatic period 
and the effect of pro -inflammatory mechanisms which accompany the ischaemia- 
reperfusion process. 
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Reperfusion is the time point at which most clinically relevant complications occur during 
liver transplantation, probably as a result of rapid cardiovascular, electrolyte, and acid - 
base alterations and from the release of undefined substances from the graft. In chapters 6 
and 7 the effect of different surgical techniques on some of these variables was examined. 
In comparing the piggyback technique with venovenous bypass during the anhepatic 
phase it was found that cardiac output and oxygen consumption were higher with the 
piggyback technique. Changes in cardiac output following reperfusion were less marked 
with the piggyback technique. There was also the suggestion that acidaemia was reduced 
with this technique consistent with less tissue hypoxia. A significant difference between 
the groups was in preservation of body temperature which was better in the piggyback 
group. This was a small observational study which was not randomised and therefore 
potentially subject to bias. No conclusions can be made regarding outcome. It should 
progress to a formal randomised study of sufficient power to determine clinical benefit 
but, as is frequently the case in research of this nature, I suspect that a trial of this nature 
will never be performed. Despite these shortcomings it is a reasonable conclusion that, in 
those patients studied, the data indicate better overall metabolic stability with the 
piggyback technique. 
Chapter 7 compared reperfusion via the portal vein and hepatic artery. A major 
consideration here was the contrast between the early and late complications of 
reperfusion and the fact that interventions might not benefit both concurrently. As with 
the previous chapter this study was observational and subject to potential bias with 
respect to randomisation, but the data indicated clear differences between the groups. 
With the portal vein oxygen uptake increased far more rapidly, but at a cost of greater 
acid -base disturbance and requirement for pharmacological cardiovascular support. The 
clinical implication of this finding is greater overall stability when the hepatic artery is 
used for reperfusion. Of concern is the possibility that, if most of the increase in oxygen 
consumption is attributable to graft uptake, oxygenation of the graft is less rapid with the 
hepatic artery. A future study should specifically compare early graft function with each 
technique of reperfusion. 
Cardiovascular and neurological instability occur most frequently at reperfusion in 
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patients undergoing transplantation for fulminant hepatic failure. These patients are 
relatively infrequent, clinically complex, and therefore difficult to study. From the studies 
in this thesis it is an attractive hypothesis that optimal management includes the use of the 
piggyback technique, reperfusion via the hepatic artery, and an increase in minute 
ventilation immediately prior to reperfusion. 
The most difficult patients to manage are frequently the most difficult to study. Critically 
ill patients with liver failure are amongst the most metabolically complex to manage. Few 
would disagree that the delivery and metabolism of oxygen are central to understanding 
the pathophysiology of critical illness. This thesis has attempted to address these issues in 
patients with liver failure on a whole body scale. Further understanding will require 
information on oxygen balance at an organ, tissue, and cellular level. This is the major 
challenge for future research in this area. 
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COMMONLY USED FORMULAE AND EQUATIONS 
Body Surface Area (BSA): m` 
(Height)°'725 x (Weight)°'425 x 71.84 x 10-4 
Cardiac Index (CI): 
Cardiac output/BSA 
Systemic Vascular Resistance (SVR): dynes. sec.cni s 
[(Mean arterial pressure- central venous pressure) /cardiac index] x 80 
Pulmonary Vascular Resistance (PVR): dynes.sec.cni s 
[(Mean pulmonary artery pressure -pulmonary capillary wedge pressure) /cardiac 
index] x 80 
Oxygen delivery (DO2): mL.miii' 
Cardiac output x [(haemoglobin concentration x 1.34 x arterial oxygen saturation) + 
(0.003 x Pa02)] 
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